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Hypothesis*&"Aims!
The! pathophysiology! of! obesity! links! inflammation! and! oxidative! stress! with!insulin! resistance! and! fatty! liver! disease.! ! Bariatric! surgery! leads! to! significant!weight! loss.! !The!surgery! itself!provokes!an! inflammatory! response.! !Fatty! livers!are!more!vulnerable!to!toxic!insults,!especially!factors!that!might!cause!ischaemia9reperfusion!injury.! !The!inflammatory!response!to!laparoscopic!bariatric!surgery,!in! the! context! of! fatty! liver! disease,! has! not! been! specifically! investigated!previously.!!The!main!hypothesis!at!the!outset!of!this!work!is:!!
Administration+ of+ N.acetylcysteine+ will+ reduce+ the+ post.operative+ inflammatory+
response+and+liver+injury+after+laparoscopic+bariatric+surgery.+!This!thesis!sets!out!to!answer!the!following!questions:!
• Does!bariatric! surgery!have!a! significant! impact!on!markers!of!oxidative!stress,!inflammation!and!liver!injury!in!morbidly!obese!patients?!
• What! is! the! relationship! between! liver! injury! and! oxidative! stress! and!inflammatory!markers?!
• Do!these!relationships!change! in!the!short!and!medium9term!(6!months)!after!surgery?!!! !
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1.1!Aims!of!Chapter!The! aim!of! this! chapter! is! to! describe! the! background! and! evolution! of! bariatric!surgery!and!set!this!in!the!context!of!modern!surgical!practice.! !The!chapter!goes!on! to! explain! the! link!between!obesity,! insulin! resistance! and! chronic! low9grade!inflammation,!with!a!review!of! the! literature!on!the!beneficial!effects!of!bariatric!surgery.!!
1.1.1 Bariatric!Surgery!N!A!definition!In!a!historical!sense,!obesity!was!not!perceived!or!characterised!as!a!disease!(1).!!The! vast! majority! of! the! population! in! pre9industrialised! societies! were!malnourished.!!Being!overweight!was!a!sign!of!wealth!and!affluence.!!Following!the!move!away!from!an!agrarian!lifestyle,!obesity!began!to!be!recognised!as!a!cosmetic!issue! in! the! late! 19th! century!(2).! ! Today,! high9calorie,! highly! processed! food! is!easily! available! in! Europe! and! North! America.! ! Lifestyles! are! increasingly!sedentary.! ! Along! with! cultural! influences,! these! factors! have! lead! to! an!increasingly!high!prevalence!of!obesity!in!the!general!population!(3).! !The!impact!of! increasing!levels!of!obesity! includes!higher!rates!of!chronic!diseases,! including!diabetes! mellitus,! hypertension,! cardiovascular! disorders! and! osteoarthritis.!Obesity! is! now! described! as! a! disease! –! an! entity! with! symptoms! that! requires!specific! treatment!(4).! ! For!a!majority!of! the!obese!population,! control!of!weight!through! behavioural! modification! is! unsuccessful!(5).! ! Over! the! last! 70! years,!surgical!and!pharmacological!interventions!have!developed!to!combat!weight!gain!and!effect!weight!loss,!in!an!effort!to!reverse!or!attenuate!the!effects!of!obesity!(6).!!The!term!“bariatric”!is!derived!from!the!Greek!“baros”!meaning!“weight”.!Bariatric!surgery! refers! to! the! subspecialty! branch! of! gastrointestinal! surgery! concerned!with!causing!deliberate!weight!loss!in!an!effort!to!improve!the!patient’s!health.!!! !
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1.2!A!brief!history!of!Bariatric!Surgery!Bariatric! surgery!was! first! popularised! in! the!United! States! of!America!(7).! ! The!precise!reasons!are!due!to!cultural,!historical!and!financial!factors!that!are!outwith!the! scope! of! this! thesis,! and! this! is! a! brief! synopsis.! ! By! the! 1950s,! increasing!numbers! of! patients! were! reported! to! be! surviving! extensive! emergency! small!bowel!resections,!with!varying! levels!of!post9operative!morbidity!(8).! !The!rising!incidence!of!obesity! in! the!USA! led! to! increasing!pressure!on!medical!services! to!treat!this!new!disease!(9).!!!In!a!fee9for9service!system,!medical!practitioners!were!economically!incentivised!to!innovate!treatments!for!this!group!of!patients!(10).!!!!
1.2.1!Experimenting!with!jejunoNileal!bypass!Arnold!Kremen!and!colleagues!at! the!University!of!Minnosota!devised!a!series!of!experiments! on! dogs! in! the! early! 1950s! to! define! more! clearly! the! relative!importance! of! different! sections! of! the! small! bowel! in! maintaining! health!(11).!!Ten! groups! of! dogs!were! subjected! to! different! variations! of! the! surgery,!which!involved!taking!50970%!of!the!small!bowel!out!of!circuit!(by!exterioring!the!ends!to! the! skin)! and! anastomosing! proximal! small! bowel! to! the! distal! end,! including!variations!that!preserved!or!bypassed!the!ileo9caecal!valve.!!Some!dogs!underwent!two! operations.! ! Weight,! intestinal! transit! times! and! faecal! fat! content! were!measured! serially.! ! Kremen! et+ al! concluded! that! up! to! 70%! of! the! small! bowel!could!be!removed,!that!sacrifice!of!the!ileum!lead!to!significant!fat!malabsorption!and! preservation! of! the! ileo9caecal! valve! lengthened! transit! times.! ! Most!importantly,!they!demonstrated!that!jejuno9ileal!bypass!was!relatively!safe!and!the!dogs,! in!general,! remained!alive!and!reasonably!healthy.! ! In! their!conclusion,! the!authors! mentioned! that! they! had! already! begun! to! apply! these! findings! to!patients!(11).! ! A! letter! published! in! reply! to! the! study! enthusiastically! stated!“…this! questionable! method! of! controlling! obesity! will! have! the! necessary!experimental! foundation”!(11).! ! Notably,! long9term! data! beyond! 24!weeks!were!not! presented! and! the! dogs! did! not! have! detailed! evaluation! of! biochemical! and!haematological!parameters.!!Over! the! next! twenty! years,! various! configurations! of! jejuno9ileal! bypass! were!performed!(12).! !These!malabsorptive!procedures!were!associated!with!dramatic!
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weight! loss! but! also! dangerous! nutritional! deficiencies! and! a! significant! risk! of!liver!cirrhosis!and!failure.!!Many!patients!required!reversal!of!the!bypass,!leading!to!weight!regain.! !A!second!strain!of!weight!loss!procedures!developed,!involving!restriction! of! intake! by! modification! of! the! stomach! and/or! gastro9oesophageal!junction!(13).! ! Buchwald! has! written! a! comprehensive! overview! of! the!development! of! these! different! modes! of! weight! loss! surgery!(6).! ! He! uses! the!terms! of! evolutionary! biology! to! liken! developments! in! malabsorptive! and!restrictive!surgeries!to!different!genealogies.!!!!There! was! a! plethora! of! small! anatomical! variations! in! jejuno9ileal! bypass!operations,!all!of!which!cause!weight! loss!by!reducing! the!absorptive!capacity!of!the!small!bowel!(6).!!It!is!striking!that!most!of!these!operations!were!devised!on!a!virtually!experimental!basis!and!performed!in!patients!without!any!clear,!objective!prior! evidence! of! their! safety! and! efficacy.! ! These! short! case! series! are! as!much!advertisements! for! a! particular! technique! as! scientific! reports! and! all! of! the!described! procedures! have! long! been! abandoned! because! they! proved! to! be!dangerous!or!ineffective.!!In!the!1970s,!jejuno9ileal!bypass!was!widely!performed.!!Ninety!percent!of!patients!achieved!significant!weight!loss,!but!complications!rates!were!high!(13).!!!Most!patients!had!troublesome!side!effects,!including!intractable!diarrhoea! and! sequelae! of!malnutrition,! leading! to! a! high! proportion! of! patients!undergoing!reversal!surgery!(14).!!!!
1.2.2!Introduction!of!gastric!bypass!for!weight!loss!Mason!and! Ito!at! the!University!of! Iowa!began!to!perform!gastric!bypass!(GB)! in!the! late! 1960s!(15).! ! Subtotal! Gastrectomy! with! gastrojejunostomy! was!increasingly!used!to!treat!duodenal!ulcers.!!These!patients!experienced!significant!restriction!of!intake,!troublesome!post9prandial!symptoms!of!“dumping”!and!relief!of! their! ulcer! symptoms,! all! of! which! led! to! weight! loss.! ! A! series! of! dog!experiments!in!a!histamine9induced!ulcer!model!confirmed!their!findings!that!GB!leads! to! thickening!of! the! antral!mucosa! and!prevents! further!ulceration! in!both!duodenum!and!jejunum!(16).!!!The!initial!report!on!34!patients!concludes!that!GB!leads!to!significant!weight!loss!although!they!did!not!recommend!it!for!treatment!of! ulcers! alone!(15).! ! Subsequently,! GB!was! also! used! to! treat! intractable! peptic!
! 23!
ulceration!when!other!types!of!non9resectional!anti9reflux!surgery!had!failed.! !GB!was!then!modified!by!Alden!to!include!a!Roux9en9Y!reconstruction.!!In!1977,!three!centres!reported!comparative!studies!of!GB!versus!jejuno9ileal!bypass!that!showed!GB! was! safer,! with! less! frequent! and! less! serious! complications!(14,! 17,! 18).!!Griffen!et+ al! also!noted! that! the! incidence!of! liver!disease!was! lower! in! their!GB!group!(14).!!!!Scopinaro!reported!results!of!biliopancreatic!diversion!(BPD)! in!1979!(19).! !This!included!a!partial!Gastrectomy!with!Roux9en9Y!reconstruction!and!preserved!flow!(either!enteric!or!bilio9pancreatic)!through!all!segments!of!bowel.!!Weight!loss!and!resolution! of! co9morbidities! was! very! impressive! although! there! was! still! a!significant! incidence!of! protein!malnutrition.! !BPD!was! subsequently! adapted!by!Marceau! in!Canada!to! include!a!sleeve!Gastrectomy!and!duodenojejunostomy!–!a!duodenal! switch! (DS)!(13).! ! By! preserving! the! pylorus,! transit! of! food! into! the!ileum!was!slowed,!reducing!diarrhoea!and!cramping.!!!Restrictive! surgery! also! developed! over! the! same! time! period!(7).! ! Mason!introduced!partial!partition!of! the!proximal! stomach,! stapled!gastroplasty,!which!he!felt!was!safer!and!quicker!to!perform.!By!the!1980s,!the!most!widely!accepted!restrictive!procedure!was!the!vertical!banded!gastroplasty!(VBG)!(12).!!VBG!had!a!good! safety! profile! and! resulted! in! significant! early!weight! loss.! ! However! long9term!weight!regain!was!common.!!The!principle!of!proximal!restriction!just!below!the! gastro9oesophageal! junction! has! evolved! to! include! gastric! banding!operations!(6).!!The!development!of!high!grade!plastics!facilitated!the!design!of!the!adjustable!gastric!band,!which!is!an!inflatable!synthetic!band!that!can!be!wrapped!around! the! top! of! the! stomach,! restricting! the! aperture! just! below! the! gastro9oesophageal! junction!(19,! 20).! ! These! operations! are! safe,! the! bands! are!removable! and! weight! loss! results! are! good! although! less! dramatic! than! GB! or!BPD9DS.!
1.3!Modern!Bariatric!Surgery!Over!the!last!10!years,!the!numbers!of!patients!undergoing!bariatric!surgery!in!the!United! Kingdom! has! grown! exponentially!(21).! ! As! evidence! about! the! safety,!tolerability! and! efficacy! of! the! operations! has! mounted,! clinicians! and! patients!
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have! sought! surgical! treatment!with! enthusiasm!(22).! ! In! contrast! to! the!United!States,! where! open! bariatric! surgery! had! already! been! popularised! by! the!1980s!(23),!the!introduction!of!minimally!invasive!or!laparoscopic!techniques!was!crucial!to!its!broadening!acceptance!in!the!UK!(21).!!!!Laparoscopic! gastric! bypass! surgery! is! associated! with! shorter! length! of! stay,!lower! rates! of! complications! and! mortality! and! lower! hospital! costs!(24,! 25).!!Respiratory!complications!are! lower!after! laparoscopic! rather! than!open!surgery!!(0.94%!versus!3.87%,!respectively;!p<0.01)!(26).! !Laparoscopic!bypass!surgery!is!also! associated! with! a! decreased! stress! response,! with! lower! post9operative! C9reactive! protein! (CRP)! and! Interleukin! (IL9)! 6! levels,! despite! longer! operating!times!(27).!!Starting!with! the!US!National! Institute! of!Health!Consensus! Statement! regarding!the!safety!and!efficacy!of!bariatric!surgery!in!1991,!an!attempt!has!been!made!to!standardise! and! rationalise! the! various! types! of! surgical! procedures!(28).! ! By!2004,!the!American!Society!for!Metabolic!and!Bariatric!Surgery!(ASMBS)!had!also!issued! a! consensus! statement! agreeing! that! four! operations! were! deemed!acceptable! and! established! treatments:! Roux9en9Y! gastric! bypass! (RYGB),!laparoscopic! adjustable! gastric! banding! (LAGB),! vertical! banded! gastroplasty!(VBG)!and!biliopancreatic!diversion!and!duodenal! switch! (BPD/DS)!(29).! ! In! the!UK,! the! National! Institute! of! Clinical! Excellence! also! issued! guidance,!recommending!surgery! in!suitable!and!motivated!patients!who!had! failed! to! lose!weight!by!non9surgical!interventions!!(30).!!!Surgery!can!be!offered!to!patients!with!a!BMI!over!40!kg/m2!or!in!patients!with!a!BMI! over! 35! kg/m2! who! have! associated! complications,! such! as! diabetes,!hypertension,! sleep! apnoea! and! life9limiting! arthritis! !(30).! ! The! Society! of!American! Endoscopic! and! Gastrointestinal! Surgeons! also! published! guidance,!recommending! laparoscopic! surgery! where! the! necessary! expertise! and!appropriate! patient! indications! allowed!(31).! ! BPD/DS! was! increasingly! being!performed! in! two! stages! laparoscopically,! with! a! first! operation! consisting! of! a!vertical! sleeve! gastrectomy! (LSG).! ! This! operation! removed! the! left! side! of! the!stomach,!leaving!a!tubular!stomach!along!the!lesser!curve.!!Over!the!last!10!years,!
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multiple! centres! noted! that! weight! loss! with! LSG!was! comparable! to! RYGB! and!often! more! effective! than! LAGB.! ! ASMBS! updated! their! advice! in! 2012! to!recommend!LSG!as!an!effective!and!safe!primary!weight! loss!operation!(32).! !By!this!time!VBG!had!become!less!popular!and!is!now!not!performed!routinely!in!the!UK!(21).!




A!recent!updated!meta9analysis!of!studies!published!from!2003!to!2012!shows!that!these! impressive!results!have!proved!durable!(36).! !The!authors! included!LSG! in!their! review!and!concluded! that! its! safety!profile,!weight! loss! results!and!rate!of!resolution! of! co9morbidities! were! equivalent! to! RYGB.! ! The! post9surgical! fall! in!BMI!are!shown!in!Figure!1.1.!!Data!from!this!meta9analysis!are!presented!overleaf!in!Table!1.3.!!
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The! Swedish! Obese! Subjects! Study! was! a! nationwide! longitudinal! and! cross9sectional!study!of!obese!patients!undergoing!surgery!or!non9surgical!intervention,!followed! up! for! up! to! 20! years.! ! Various! reports! from! this! large! database! have!indicated!that!bariatric!surgery!lead!to!significant!reductions!in!co9morbidities!and!long9term!mortality,!and!improvements!in!quality!of!life!(37).!!The!first!report! from!a!US!national!bariatric!database!shows!similar!results,!with!the! efficacy! and! safety! profile! of! LSG! sitting! in! between! LAGB! and! RYGB!(38).!!Morbidity!and!mortality!data!are!shown!in!Table!1.2.!
!!
Table! 1.2! Outcomes! from! the! American! Bariatric! Surgery! Centre! Network! report!
(based!on!Hutter!et#al,!2011)!!(38)!
! !

















! ! ! !RCT! 15!(12!<!17)! 11!(7!<!14)! 16!(8!<!24)! 14!(12!<!16)!
OBS! 14!(10!<!19)! 8!(6!<!9)! 12!(10!<!14)! 12!(10!<!14)!
Year!2!
! ! ! !RCT! 14!(12!<!17)! 11!(8!<!14)!
!
13!(11!<!15)!
OBS! 13!(8!<!17)! 9!(7!<10)! 13!(7!<!20)! 12!(10!<!14)!
Year!5!
! ! ! !RCT!
!
11!(5!<!28)!











! ! ! !RCT! 72!(65!<!80)! 33!(23!<!44)! 70!(41!<!98)! 60!(51!<!69)!
OBS! 63!(54!<!72)! 34!(34!<!35)! 51!(44!<!59)! 46!(44!<!48)!
Year!2!
! ! ! !RCT! 74!(66!<!83)! 54!(33!<!75)!
!
71!(63!<!79)!
OBS! 80!(66!<!94)! 52!(49!<!56)! 47!(43!<!51)! 64!(55!<!72)!
Year!5!
! ! ! !RCT!
!
41.6!(<9!<!93)!































RCT! 21!(12!<!33)! 13!(5!<!26)! 13!(0.7!<!44)! 17!(11!<!23)!
OBS! 12!(7!<!17)! 8!(3.9!<!13)! 9!(6!<!13)! 10!(7!<!13)!
! ! ! ! !Diabetes!
Remission!
!
! ! ! ! !RCT! 95!(88!<!99)! 74!(36!<!96)!
!
92!(85!(97)!




! ! ! ! !RCT! 81!(68!<!92)! 54!(13!<!90)!
!
75!(62!<!86)!




! ! ! ! !RCT! 80!(62!<!94)! 40!(4.7!<!87)!
!
76!(56!<!91)!




! ! ! ! !RCT! 95!(84!(100)! 94!(49!<!100)!
!
96!(87!<!100)!
OBS! 95!(86!<!99)! 71!(48!<!89)! 91!(80!<!97)! 90!(81!<!95)!!
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1.3.2!Common!operations!for!weight!loss!The! main! four! operations! performed! for! weight! loss! in! the! UK! at! present! are:!RYGB,!LAGB,!BPD/DS!and!LSG.!!Schematic!diagrams!of!these!operations!are!given!in!Figure!1.2.! !A!number!of!newer! innovations!are! increasingly!being!trialled!but!these!are!outwith!the!scope!of!this!review!(39).!!
1.3.2.1!RouxNenNY!Gastric!Bypass!This! is! the! most! commonly! performed! procedure,! >50%! of! all! weight! loss!surgery!(21).! ! Although! there! are! multiple! published! technical! adjustments,!broadly! the!operation! includes!(40):! fashioning!of! the!most!proximal!part! of! the!stomach! into! a!pouch!of! 15930ml3!using! staplers,! construction!of! a!Roux! loop!of!jejunum,! with! the! proximal! end! approximately! 709100cm! distal! to! the! pylorus!disconnected,!brought!up!and!anastomosed!to!the!gastric!pouch,!and!the!distal!end!of! the! biliopancreatic! limb! anastomosed! approximately! 1009150cm! from! the!gastric!anastomosis,!forming!a!common!channel.!!Thus!dietary!intake!is!restricted!by!a!small!gastric!pouch.!!Food!bypasses!the!rest!of!the!stomach!and!duodenum!to!pass! down! the! alimentary! limb,!whereupon! 100cm!distally! it!mixes!with! gastric!and!pancreaticobiliary!secretions!and!is!absorbed!in!the!small!bowel.!!!!RYGB! was! presumed! to! work! by! restricting! intake! mechanically! due! to! small!gastric!pouch!size!and!behaviourally,!as!patients!sought! to!avoid!unpleasant!side!effects!like!discomfort!from!early!satiety,!so!called!“plugging”!as!food!gets!held!up!in!the!gastric!pouch,!and!“dumping!syndrome”!which!occurs!due!to!rapid!transit!of!food!into!the!small!bowel!causing!flushing,!nausea!and!diarrhoea!(41).! !The!rapid!resolution!of!resolution!of!diabetes!mellitus!within!weeks!of!surgery!gave!rise!to!interest! in! the!hormonal!actions!of!gastric!bypass!(see!also!Table!1.6)!(34).! ! It! is!now!recognised!that!weight!loss!and!resolution!of!co9morbidities!occur!through!a!combination!of!different!mechanisms,! including!but!not! limited!to!changes! in!gut!hormone! levels! affecting! insulin! release,! hunger! and! satiety,! changes! in! taste!preference!and!adaptations!in!energy!homeostasis!and!regulation!(42).!!Intestinal!is!not!significant!after!gastric!bypass!(43).!
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1.3.2.2!Adjustable!Gastric!Banding!There! are! various! gastric! banding! devices! commercially! available! and! the!procedure!involves!placement!of!a!silastic!inflatable!band!around!the!cardia!of!the!stomach! just! below! the! oesophagogastric! junction.! ! This! acts! as! a! constant!restrictive!presence!and!can!be!tightened/loosened!by!instillation/removal!of!fluid!via! a! subcutaneous! port.! ! The! mode! of! action! was! thought! to! be! restrictive!although!transit!and!manometric!studies!now!suggest!that!the!band!acts!neurally,!possibly!by!compressing!the!vagus!nerve!at!the!oesophageal!hiatus,!to!activate!the!satiety!mechanism!(44).!!These!neural!changes!probably!contribute!to!behavioural!changes!and!result!in!a!reduction!in!energy!intake!and!weight!loss.!!LAGB!remains!the!safest!procedure!in!the!short!term,!with!30!day!complication!rates!of!2.396.1%!and!mortality!of!<0.1%!(45).!!There!are!concerns!of!long!term!safety.!!At!least!1%!of!patients!will!experience!band!erosion,!with!erosion!occurring!in!mean!4.9%!of!cases!in!one!meta9analysis!(46).!!This!may!be!an!underestimate!as!in!one!study!of!665!patients! treated!over!12!years,!21%!of!bands!had! to!be!removed!during! the!study!period!(47).!!
1.3.2.3!Biliopancreatic!Diversion/Duodenal!Switch!This! involves! two! stages,! that! can! be! performed! separately! or! in! one! operation:!creation!of!a!sleeve!gastrectomy!by!removing!90%!of!the!stomach!and!a!duodeno9ileal! bypass,! which! involves! transecting! the! first! part! of! the! duodenum! and! the!ileum!and!anastomosing!the!jejunum!proximally!to!the!pylorus!and!distally!to!the!ileum! just! 100! cm! proximal! to! the! ileocaecal! valve.! ! The! very! short! common!channel! of! 100cm! or! less! causes! profound!malabsorption!(43).! ! Average! excess!weight! loss! after! BPD9DS! is! >70%,! which! is! greater! than! the! other! operations!discussed,! with! more! nutritional! complications!(35).! ! Operative! mortality! and!complication! rates! are! higher!(35)! and! this! operation! is! less! widely!performed!(21).!!! !
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1.2.3.4!Laparoscopic!Sleeve!Gastrectomy!Using!staplers,!the!left!part!of!the!stomach!is!excised!starting!from!a!point!on!the!greater! curve! approximately! 5! cm! proximal! to! the! pylorus! (to! preserve! the!antrum),! running! in!a! straight! line! cephalad! towards! the!angle!of!His!(48).! !This!leaves!a!tubular!stomach!remnant,!whose!width!is!calibrated!during!stapling!using!a!bougie!(32).!!Staple!line!reinforcement!is!used!by!some!surgeons!to!decrease!the!risk!of!leakage!and!bleeding!(49).!!Various!calibre!bougies!are!used!from!32!to!60!French!guage!depending!on!surgeon!preference!(50).!!The!narrower!the!calibre!is,!the! greater! the!weight! loss! expected! although! some! authors! are! also! concerned!about!increasing!risks!of!staple!line!leakage!and!bleeding!(49,!51).!!!!LSG!was! first!performed!as!the! first!stage!procedure!of!BPD9DS! in!very!high!BMI!patients! (>60kg/m2),! to! reduce! the! risk! of! complications! and! effect! some! initial!weight! loss!before!proceeding!with! the!more! risky! second!stage!of! surgery!(32).!!However,!the!results!of!LSG!alone!were!comparable!to!RYGB,!with!similar!rates!of!resolution!of!co9morbidities!(52,!53).! !The!proportion!of!patients!undergoing!LSG!as!a!primary!surgical!treatment!has!increased!over!the!last!6!years!(50,!54).!!Long9term!weight!loss!results!are!also!emerging,!confirming!its!efficacy!is!durable!(38).!!Eid!et+al!reported!48%!excess!weight!loss!after!mean!follow9up!of!73!months!in!the!largest!series!to!date!of!69!patients!(55).!!!!Although!LSG!was!seen!primarily!as!a!restrictive!procedure!with!reduction!in!both!calibre!and!total!volume!of!the!stomach,!it!is!apparent!that!other!mechanisms!may!contribute!to!weight!loss!and!resolution!of!diabetes!(56).!!These!include:!resection!of! the! fundus! reduces! ghrelin! production! changing! hunger! and! satiety!(57),!increase!in!gastric!emptying!may!affect!nutrient!delivery!to!the!small!bowel!(57),!adaptations! to! gut! hormone! release! affect! glycaemic! control!(58),! ! and! post9operative!circulating!cytokine!profiles!are!similar!to!RYGB!(59).!!!!
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1.3!Obesity!and!Inflammation!The! link! between! obesity! and! a! low9grade! chronic! inflammatory! state! was!highlighted!by!a!number!of! studies!showing! that! serum!C9reactive!protein! (CRP)!levels!were!elevated!in!obesity!and!correlated!with!a!higher!risk!of!cardiovascular!events!(61).! ! CRP! is! a! so9called! acute! phase! protein! secreted! by! the! liver! in!response!to!inflammatory,!infective!and!other!toxic!insults.!!It!has!a!role!in!innate!immunity,! activating! complement! and! opsonising! pathogens!(62).! ! It! has! an!important! clinical! use! to!monitor! the! response! to! and! resolution!of! such! insults.!!Interleukin96! (IL96)! is! another! pro9inflammatory! cytokine! released! acutely! and!increases! secretion! of! CRP!(63).! ! ! Visser! et+ al! demonstrated! in! a! study! of! over!16000! people! that! CRP! levels! are! higher! in! overweight! and! obese! individuals!compared! with! lean! controls!(64).! ! Smaller! scale! studies! have! shown! increased!expression!of!IL96!is!also!associated!with!obesity!and!is!linked!to!increased!adipose!tissue! mass,! and! such! an! association! with! adiposity! is! seen! with! other! pro9inflammatory! cytokines! including! tumour! necrosis! factor! (TNF)! α!(61).! ! Weight!loss! through! diet,! exercise! or! bariatric! surgery! is! clearly! associated! with!diminution! of! circulating! pro9inflammatory! cytokines,! indicating! proof! of! the!concept!(65).! ! The! elevation! in! pro9inflammatory! cytokines! are! a! causative! link!between! obesity,! increased! adipose! tissue,! hyperlipidemia! and! atherosclerotic!cardiovascular!disease!(66).!!




Figure!1.3!The!development!of! insulin! resistance! through! triglyceride!overload!and!
chronic!inflammation!(adapted!from!Xu!et#al,!2003)!!(69)!!
Beyond! a! certain,! as! yet! unknown! threshold,! accumulation! of! intracellular! lipid! in!
adipocytes! leads! to! an! inflammatory! response,! with! local! release! of! cytokines! and!
chemokines,! attracting! and! activating!macrophages,! and! spillover! of! free! fatty! acids!
(FFA)! into! the! circulation.! ! These! activated! macrophages! also! secrete! inflammatory!
mediators.! ! These! may! affect! preadipocytes! and! adipocytes,! inducing! insulin!
resistance.! !The!whole!process!becomes!a!vicious!cycle,!amplifying! the! inflammatory!
response!and!eventually!causes!systemic!insulin!resistance.!!!!
1.3.2!Obesity!and!Oxidative!Stress!Obesity!is!associated!with!oxidative!stress!(70).!!Oxidative!stress!is!the!imbalance!between! oxidant! and! antioxidant! factors! within! cells,! which! leads! to! cellular!damage!and!inflammation!(71).!!Oxidant!molecules,!also!known!as!reactive!oxygen!species! (ROS)! including! free! radicals! such! as! superoxide! (O2!9),! peroxide! (O2!92)!and! hydroxyl! radical! (!OH),! are! produced! as! byproducts! in! the! mitochondria!during! the! oxidation! of! glucose! or! free! fatty! acids! (FFA),! which! is! an! essential!process! in! energy!metabolism.! !ROS! are!potentially! toxic! and!may! combine!with!lipids!and!proteins.!!Lipid!peroxidation!may!alter!the!activity!of!receptors,!decrease!the! activity! of! membrane! bound! enzymes! or! alter! cell! permeability.! ! Protein!
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oxidation! leads! to! formation! of! protein! carbonyls! (PC)! which! again! may! affect!enzyme! activity,! protein9protein,! lipid9protein! and! lipid9lipid! interactions,!including!changes!in!gene!expression!(72).!!A!complex!antioxidant!system!exists!to!neutralise! ROS,! including! both! non9enzymatic! and! enzymatic! processes.! ! Non9enzymatic! antioxidants! include! vitamins! C! and! E! and! glutathione,! which! act! by!trapping! and! reducing! free! radicals,! neutralising! their! effects.! ! The! enzymatic!antioxidant! system! includes! superoxide! dismutase! (SOD),! catalase,! glutathione!reductase!and!peroxidases!(GPX),!which!degrade!ROS!into!less!harmful!molecules!like!water!and!oxygen!(73).!!Olusi!compared!the!concentrations!of!markers!of!lipid!peroxidation! and! antioxidant! enzymes! in! healthy! and! obese! populations,! and!found! that! BMI! positively! correlates! with! circulating! malondialdehyde! (MDA,! a!marker!of!lipid!peroxidation)!and!negatively!correlates!with!SOD!and!GPX!(74).!!Furukawa! et+ al! demonstrated! that! markers! of! oxidative! stress! correlated! with!increasing! adipose! tissue!mass.! ! In! a! cell! model,! the! same! authors! showed! that!oxidative!stress!may!be!mediated!by!increased!levels!of!free!fatty!acids!(70).!!They!found!increased!levels!of!ROS!in!the!adipose!tissue!of!obese!mice,!with!increased!expression! of! nicotinamide! adenine! dinucleotide! phosphate9oxidase! (NADPH!oxidase),! a! key! enzyme! in! mitochondrial! energy! metabolism! and! an! important!source!of!ROS.!!They!also!found!reduced!expression!of!antioxidants!(70).!!!!Pro9inflammatory! cytokines! are! found! in! association! with! increased! oxidative!stress! and! many! of! the! same! factors! lead! to! both! sets! of! findings!(75).! ! The!corollary! is! that! inflammation! and! oxidative! stress! co9exist! and! together! cause!obesity9related!pathology!and!insulin!resistance.!!The!interplay!between!oxidative!stress!and!inflammatory!response!is!depicted!in!Figure!1.4.!!
1.3.3!Inflammation,!Obesity!and!Insulin!resistance!Obesity9related! pro9inflammatory! changes! are! now! believed! to! lead! to! insulin!resistance.!!!In!a!longitudinal!cohort!study!of!almost!6000!patients,!elevated!CRP!at!baseline!whilst! still! normoglycaemic!was! found! to! be! a! very! strong! predictor! of!future! diabetes! mellitus!(76).! ! When! comparing! obese! patients! with! insulin9resistance! to! normoglycaemic! obese! patients,! a! number! of!metabolic! differences!
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are!seen.! !Obese! insulin!resistant! individuals!have!comparatively!higher! levels!of!immune!cells!within!their!adipose!depots,!higher!measures!of!oxidative!stress!and!higher!levels!of!cytokines!(68).!!!!
! !
Figure! 1.4! Reactive! oxygen! species! generated! in! adipose! tissue! promulgate! the!
induction!of!oxidative!stress!remotely,!leading!to!metabolic!syndrome!(adapted!from!
Furukawa!et#al,!2004)!!(70)!!!This! is! thought! to! be! related! to! combination! of! ischaemia!within! the! adipocytes!due! to! their! large! size,! impairment! of! the! endoplasmic! reticulum! leading! to!changes! in!FFA,!glucose!and!protein!metabolism!and!the!changes! in! the!cytokine!milieu! and! oxidative! stress! discussed! above!(75).! ! The! final! common! pathway!relating!these!changes!to!insulin!resistance!is!not!yet!clear.! !Xu!et+al!showed!that!adenosine! monophosphate9activated! protein! kinase! (AMP9kinase)! activity! in! fat!depots! are! lower! in! obese! insulin9resistant! patients! than! in! the! insulin9sensitive!group,! along! with! higher! expression! of! pro9inflammatory! genes! and! worse!markers! of! oxidative! stress!(77).! ! AMP9kinase! dysregulation! leads! to! lipid!accumulation,! changes! in! FFA! metabolism! and! is! associated! with! insulin9resistance!(78).!!!!!!!There! are! an! ever9increasing! number! of! different! cytokines! and! other! potential!ligands!of!interest.!!A!long!but!not!exhaustive!list!is!given!in!Table!1.4!of!mediators!
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%!EBWL! 55.9! 46.2! 55.5! 59.7! 63.6!
%!Resolved!overall! 78.1! 56.7! 79.7! 80.3! 95.1!
%!Resolved!<2!years! 80.3! 55! 81.4! 81.6! 94!
%!Resolved!>2!years! 74.6! 58.3! 77.5! 70.9! 95.9!!
!
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The!main!theories!postulated!to!account!for!the!rapidity!of!surgical!resolution!are!based!on!intestinal!hormonal!regulation!of! insulin.! !As!well!as!the!direct!effect!of!circulating! glucose! concentration! on! insulin! release! from!pancreatic! beta! cells,! a!number!of!other!hormones!are!thought! to!exert!an!effect.! !These!hormones!have!collectively! been! termed! “incretins”! and! include! glucagon9like! peptide! 1! (GLP91)!and! glucose9dependent! insulinotropic! peptide! (GIP).! ! Post9RYGB! and! BPD/DS,!incretin! levels! are! much! higher! after! a! glucose! challenge! or! test! meal,! which!correlate!with!increases!in!insulin!levels!(84).! !To!account!for!this! incretin!effect,!two! competing! hypotheses! are! described:! the! foregut! hypothesis! says! that!bypassing!the!duodenum!and!proximal!jejunum!reduces!release!of!inhibitors!of!the!incretin! hormones;! the! hindgut! hypothesis! suggests! that! bypass! of! the! proximal!intestine!leads!to!greater!than!normal!levels!of!nutrients!to!come!into!contact!with!the! distal! small! bowel,! stimulating! a! greater! incretin! effect!(85).! ! The! other!putative!mechanisms! also! depend! on! the! altered! release! of! other! gut! hormones,!including! peptide! YY! (PYY)! which! suppresses! appetite! and! ghrelin,! involved! in!regulation!of!satiety,!hunger!and!body!weight!(86).!!The!changes!in!gut!hormones!after!RYGB!are!briefly!summarised!in!Table!1.6.!! !
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1.4.3!Bariatric!Surgery!and!Inflammation!Dietary! interventions! and! physical! exercise! programmes! can! lead! to! significant!weight! loss!and! there!have!been!many!studies! showing!short9term!reductions! in!inflammatory! markers!(89).! ! Forsythe! et+ al! neatly! summarise! 65! studies!measuring! various! combinations! of! CRP,! TNFα,! IL96,! Leptin! and! Adiponectin!following!interventions!involving!diets,!physical!activity,!diets!and!physical!activity!combined!and!weight!loss!surgery.!!Of!dietary!interventions!only,!7!of!23!published!studies!showed!no!significant! falls! in! inflammatory!markers.! !17!of!18!studies!of!combined!diet!and!exercise! interventions!showed!significant!reduction! in!weight!and!inflammatory!markers.!!As!expected,!studies!where!weight!loss!and!reduction!of! adipose! tissue!mass!were!greater!were!associated!with!a!greater! reduction! in!inflammatory!markers.! ! In!contrast,!weight! loss!surgery! (25!studies!quoted)!was!associated! with! much! greater! weight! loss! and! thus! a! greater! reduction! in!inflammatory!markers!(89).!!
1.4.3.1!The!effect!of!Bariatric!Surgery!on!ProNinflammatory!cytokines!In!a!systematic!review!of!48!studies,!bariatric!surgery!was!shown!to!significantly!reduce! CRP! from! 1! month! post9operation! onwards,! including! studies! with! >12!month!follow!up.!!On!meta9regression,!fall!in!BMI!was!the!only!significant!predictor!of!fall!in!CRP.!!IL96!was!seen!to!fall!significantly!after!6!months!and!this!reduction!was!also!sustained!in!studies!of!>12months!duration.!!The!percentage!reduction!in!TNFα! following! surgery! was! not! significant!(90).! ! ! The! values! of! CRP,! IL96! and!TNFα!are!tabulated!in!Table!1.7.!!CRP! production! by! the! liver! is! stimulated! by! both! IL96! and! TNFα! and! all! three!markers!are!known!to!be!higher!in!obesity!and!insulin!resistance!(91).!!Taking!the!corresponding!falls! in!CRP!and!IL96!together!with!post9operative!weight! loss!and!improvement! in! insulin!resistance,!these!studies!corroborate!the!various!cell!and!animal! models! highlighting! their! role! in! obesity9related! chronic!inflammation!(92).!!!Cancello!et+al!showed!that!macrophage!infiltration!is!reduced!in!subcutaneous!fat!after!bariatric!surgery,!along!with!a!decrease!in!expression!of!genes! involved! in! chemoattraction! and! inflammation!(93).! ! Greco! et+ al! found!reduced! intramuscular! lipid! deposition,! which! correlated! with! weight! loss! and!
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improvement! in! insulin! resistance,! indicating! that! peripheral! adipose! and! lipid!depots!are!reduced!(94).!!!
!
Table! 1.7! Percentage! reduction! in! CRP,! TNFα! and! IL_6! from! a!meta_analysis! of! 48!
studies!(based!on!Rao,!2012)!!(90)!











Maximum$ 42$ 2877$ 10.1879$ −65.8$±4$**$
1$month$ 6$ 134$ 16.154$ −34.3$±8$**$
3$months$ 3$ 68$ 10.3$ −54.6$±14$**$
6$months$ 20$ 816$ 10.7968$ −54.0$±5$**$
12$months$ 10$ 1738$ 9.8782$ −81.0$±13$**$
>12$months$ 8$ 326$ 9.7289$ −73.1$±5$**$
TNF$
Maximum$ 13$ 360$ 8.2825$ −1.0$±2$
6$months$ 4$ 150$ 5.3072$ −1.3$±5$
12$months$ 4$ 160$ 6.6565$ −1.3$±3$
>12$months$ 4$ 185$ 6.8177$ −2.9$±3$
ILC6$
Max$followC
up$ 16$ 625$ 5.1464$ −27.4$±3$**$
1month$ 3$ 66$ 3.7573$ 10.9$±15$
6$months$ 8$ 416$ 4.7109$ −21.5$±3$**$
12$months$ 4$ 177$ 4.5745$ −36.2$$**$
>12$months$ 4$ 185$ 5.1738$ −33.7$±4$**$!
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also!produced!in!the!liver,!where!levels!are!higher!in!NASH!and!fibrosis,!which!are!more!likely!to!persist!after!surgery!even!after!depletion!of!fat!depots.!!Ghaemi!et+al!measured! CK918! and! inflammatory! markers! in! 44! patients! with! NAFLD!undergoing!a!diet!and!exercise!programme!(97).!!After!6months,!patients!who!had!lost!>5%!body!weight!had!significantly!reduced!liver!function!tests!and!CK918!but!no! significant!differences! in!TNFα!and! IL96,! suggesting! that! a! longer! time!period!with!a!greater!degree!of!weight!loss!is!required!before!reductions!in!inflammatory!markers! are! seen.! ! ! ! It! is! also! not! clear!whether! circulating! TNFα! concentration!reflects! the! local! concentration! in! the! visceral! and!peripheral! adipose! tissue! and!liver,!with!some!inflammatory!markers!having!higher!concentrations!in!the!portal!vein!than!in!the!systemic!circulation!(91).!!In!comparison,!TNFα!also!has!a!shorter!half! life! than! IL96! and!CRP! is! a! very! stable!molecule!(98).! ! The! heterogeneity! of!results! seen! may! reflect! variation! in! the! methods! of! collection,! storage! and!measurement!of!less!stable!markers,!including!TNFα.!!
1.4.3.2!The!effect!of!bariatric!surgery!on!adipocytokines!With! increasing! evidence! for! their! role! in! the! pathogenesis! of! insulin! resistance,!diabetes!and!steatohepatitis,!adipokines!including!adiponectin,!leptin!and!resistin,!have! been!widely! studied! in! the! bariatric! surgery! population.! ! Illan9Gomez! et+ al!measured!adiponectin!in!53!patients!undergoing!RYGB!over!a!year,!and!found!that!levels! were! much! lower! than! lean! controls! pre9operatively,! and! rose! over! the!course!of!the!study!to!almost!double!from!5.82μg/ml!±SD!2.93!to!10.97±5.56!(99).!!The! rise! in! adiponectin! was! accompanied! by! a! fall! in! IL96! and! CRP,! along! with!reductions! in! BMI! and! insulin! resistance.! ! Interestingly,! adiponectin! levels! at!baseline!and!12!months!did!not!correlate!significantly!with!BMI!or!HOMA9IR!but!IL96! did! at! 12months.! ! In! contrast,! Auguet! et+ al! found! that! the! adiponectin! rise!following! LSG! and! RYGB! in! 30! patients! plateaued! at! 6! months! and! negatively!correlated!with!insulin!resistance!but!did!not!correlate!with!the!fall!in!blood!lipid!concentrations!(100).! ! They! also! studied! visfatin! concentration,! a! pro9inflammatory! adipocytokine,! which! fell! after! 12! months.! ! In! contrast! to! other!similar!studies,!they!measured!circulating!TNF!receptors!I!and!II,!which!also!fell!in!concentration!after!6!and!12!months.! !The!same!group!also!measured! leptin!and!chemerin!in!the!same!cohort,!showing!significant!falls!over!12months!(101).!!!
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Miller!et+al!measured!adiponectin!and!other! inflammatory!markers!at!baseline,!3!weeks,!3!months!and!6!months!after!RYGB!(see!Figure!1.5).! !They!found!that!the!post9operative!rise!in!adiponectin!is!already!significant!at!3!weeks!and!no!further!significant! rises! occur!(102).! In! contrast,! leptin! levels! fell! significantly! at! each!timepoint.! !The! fall! in!CRP!only!became!significant!at!6!months.! !They!concluded!that! leptin! levels! are! linked! to! adipose! mass! and! correlate! with! BMI,! unlike!adiponectin.!!The!authors!also!comment!on!the!difficulty!in!measuring!TNFα!levels!and!measured!circulating!TNF!receptor!concentrations! instead!as!these!are!more!stable.!!!Swarbrick! et+ al! measured! adipokines! in! combination! with! different! pancreatic!enzyme! concentrations,! including! pancreatic! polypeptide! and! glucagon,! in! 19!patients! undergoing! RYGB!(103).! ! Pancreatic! enzyme! levels! fell! over! multiple!timepoints! over! 12! months! along! with! falls! in! pro9inflammatory! cytokines! and!improvements!in!insulin!resistance.!!Ianelli!et+al!compared!changes!in!CRP!between!12!patients!undergoing!RYGB!and!10! patients! LSG! at! 6! and! 12! months! after! surgery!(104).! ! They! found! larger!reductions! in!CRP! in! the!RYGB!group,!which! correlated!with!greater! falls! in!BMI!and!improvements!in!insulin!resistance.!!In!a!randomised!trial!comparing!LSG!and!RYGB,!there!were!no!significant!differences!between!procedures!in!the!respective!post9operative!fall!and!rise!of! leptin!and!adiponectin!over!12!months!(see!Figure!1.6)!(59).! ! These! results! indicate! that! production! of! these! adipocytokines! is! not!affected!by!different!methods!of!bariatric!surgery!and!are!unlikely!to!be!under!the!direct!influence!of!gut!hormones,!which!are!affected!differently!by!LSG!and!RYGB.!!
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!
Figure!1.5!Changes! in! Inflammatory!markers!and!cytokines!over! the! first!6!months!
after!RYGB!(adapted!from!Miller!et#al,!2011)!!(102)!!!! !
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1.4.4!Bariatric!Surgery!and!Oxidative!Stress!Given!the!link!between!obesity!and!oxidative!stress,!there!has!been!much!interest!in!the!effect!of!weight!loss!(105).!!Wycherley!et+al!examined!the!effect!of!a!12!week!moderate! diet,! with! and! without! an! exercise! programme! on! 29! patients!(106).!!They!found!that!an!899%!reduction!in!body!weight!was!associated!with!significant!reductions! in! malondialdehyde! (MDA)! and! improvements! in! glycaemic! control.!!Melissas! et+ al! used! intragastric! balloons! to! effect!weight! loss! in! 16! patients! and!found! that! corrected! total! antioxidant! capacity! (cTAC)! increased! by! 33%!after! 6!months,!but!were!still!15%!less!than!non9obese!controls!(107).!!!
1.4.4.1!Circulating!markers!of!oxidative!stress!are!reduced!by!surgery!In! contrast! to! non9surgical! intervention! studies,! bariatric! surgery! is! associated!with!much!more!significant!and!prolonged!weight! loss! !(89).! !Uzun!et+al! showed!that!mean!20922%!excess!weight! loss! (%EWL)! is! associated!with! approximately!20%! reduction! in! MDA! 6! months! after! gastric! banding! in! 40! patients.!(108).!!Endothelial!cell!dysfunction!and!changes!in!nitric!oxide!levels!are!also!implicated!in!obesity9induced!oxidative!stress.! !Lin!et+al!measured!the!combined!nitrite!and!nitrate! (NOx)! in! serum,! along! with! 89iso9prostaglandin! F2α! (89iso9PGF2α)! level!which! is! another! oxidative! stress! marker,! 396! months! after! weight! loss!surgery!(109).! ! They! found! significant! reductions! in! both! markers,! which!correlated! with! weight! loss! and! reductions! in! HOMA9IR! and! triglyceride! levels.!!The!markers!did!not!correlate!with!concomitant!reductions!in!CRP!or!increase!in!adiponectin,!suggesting!that!oxidative!stress!was!related!to!glycaemic!control!and!dyslipidaemia! rather! than! directly! to! inflammatory! status.! ! Cabrera! et+ al!demonstrated! no! association! between! HOMA9IR! and! reductions! in! oxidative!stress!(110).! !They!comprehensively!measured!oxidative!stress! in!20!patients!12!months! after! RYGB,! using! MDA,! glutathione! and! reduced! glutathione,! SOD! and!catalase! as! measures! of! antioxidant! defense! and! total! radical! antioxidant!parameter! (TRAP),! which! is! a! measure! of! total! antioxidant! levels.! ! They! found!significant! increases! in! all! antioxidant! defense! markers! (catalase,! SOD,! TRAP,!glutathione)! and! reductions! in! MDA! and! reduced! glutathione.! ! However,! these!changes! from! baseline! did! not! correlate! with! HOMA9IR! or! CRP.! ! Murri! et+ al!measured! various!markers! at! 15,! 30,! 45! and! 90! days! after! BPD! and! found! that!oxidative!stress!initially!was!greater!after!surgery!before!falling!at!90!days!(111).!!
! 48!
Although! these!changes!were!accompanied!by! improvement! in! insulin!resistance!and! adipocytokines! levels,! they! did! not! examine! any! correlations!with! oxidative!stress.! ! Marfella! et+ al! used! nitrotyrosine! as! a!marker! of! oxidative! stress9related!protein!damage!after!BPD!and!found!that!mean!nitrotyrosine!levels!had!fallen!by!almost! 50%! 1! month! after! BPD!(112).! ! This! was! accompanied! by! a! significant!improvement!in!glycaemic!control,!measured!using!both!fasting!and!post9prandial!studies.! !They!concluded!that!improved!glycaemic!control,!especially!reduction!in!hyperglycaemic!episodes,!is!the!most!important!factor!in!reducing!oxidative!stress.!!A! number! of! other! studies! have! also! shown! that! various! markers! of! oxidative!stress! fall! or! improve! after! bariatric! surgery!(113N117).! ! Although! these! studies!are! fairly! concordant! in! their! findings,! it! should! be! noted! that! they! are! all! small!scale!studies!with!follow!up!limited!to!12!months!or!less.!!At!present!there!are!no!long! term!studies!of!>24!months!of!oxidative!stress!markers.! !There! is!also! little!agreement!on!standardised!measures!of!oxidative!stress.! ! Individual!markers!are!discussed!in!more!detail!in!Chapter!3.!




2.1!Aims!of!Chapter!The! pathophysiology! and! consequences! of! non9alcoholic! fatty! liver! disease!(NAFLD)!are!described,!including!the!development!of!non9alcoholic!steatohepatitis!(NASH).!!An!overview!of!the!diagnosis!of!NAFLD!and!NASH!is!given.!!!The!chapter!then! details! the! phenomenon! of! ischaemia9reperfusion! injury! (IRI)! and! gives! a!review!of!the!clinical!consequences!of!IRI!in!the!context!of!liver!surgery.!!Attention!is!drawn!to!the!inflammatory!mediators!that!are!common!to!obesity!in!general!and!IRI.!!The!relevance!of!IRI!in!the!context!of!fatty!liver!becomes!clearer!in!Chapter!3,!where! the! post9laparoscopy! inflammatory! response! is! discussed.! ! The! chapter!ends! with! a! brief! overview! of! the! published! literature! on! the! effect! of! bariatric!surgery!and!NAFLD/NASH.!!!
2.2!NAFLD!–!a!common!entity!Although!first!described!over!50!years!ago,!it!is!in!the!last!15!years!that!the!clinical!entity! of! non9alcoholic! fatty! liver! disease! (NAFLD)! has! been! recognised! as! a!significant!problem!(122).!Over!80%!of!patients!undergoing!bariatric!surgery!have!fatty!liver!disease,!compared!with!up!to!15%!of!the!non9obese!population!!(123).!Non9alcoholic! fatty! liver! disease! (NAFLD)! is! characterised! by! hepatocyte!accumulation! of! fat,! with! or! without! associated! inflammation! and! fibrosis,! in!patients!who!do!not!consume!more!than!20!grams!per!day!of!alcohol!or!have!viral!hepatitis!or!metabolic!storage!disease,!such!as!haemochromatosis.!!It!is!a!spectrum!of!conditions!extending!from!bland!fatty!steatosis,!a!relatively!benign!condition!in!itself,! through! non9alcoholic! steatohepatis! (NASH)! and! cirrhosis.! Ludwig! et+ al!described! NASH! in! 20! patients,! commenting! on! the! histological! resemblance! to!alcoholic! steatohepatitis! and! speculating! about! the! significance! of! this!pathology!(124).! ! Up! to! 37%! of! obese! individuals! will! have! features! of!NASH!(123).!!Of!these,!a!fifth!may!progress!to!liver!cirrhosis.!!!
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Figure! 2.1! Factors! leading! to! hepatic! steatosis! (reproduced! from! Koo! et# al,!
2013)!(125)!
Changes! in! fatty! acid! (FA)! metabolism! occur! following! increased! uptake! and!
accumulation! in! the! hepatocyte,! stimulating! triglyceride! (TG)! synthesis.! ! Very! low!
density! lipoprotein! (VLDL)! secretion! is! concomitantly! reduced,! adding! to! the!
intracellular!lipid!load.!
2.2.1!Pathophysiology!of!NAFLD!The! accumulation! of! intracellular! lipid,!mostly! triglyceride,! is!multi9factorial! and!thought! to! be! due! to! changes! in! hepatocyte! fatty! acid! metabolism,! leading! to!increased!uptake!of! free! fatty!acids,!changes! in!oxidation!of! intracellular! fats!and!reduced!secretion!of!triglyceride,!in!the!form!of!very!low!density!lipoprotein!(see!Figure!2.1)!(125).!!Hepatic!fatty!acid!metabolism!is!modulated!by!insulin!and!to!a!lesser! extent! other! circulating! hormones,! including! adiponectin.! Impairment! of!mitochondrial! fatty! acid! oxidation! leads! to! production! of! fatty! acid! byproducts!which! themselves! may! exacerbate! insulin! resistance.! ! Peroxisome! proliferator9activated!receptors!(PPARs)!and!their!co9receptor!activators!control!the!fatty!acid!oxidation! and! other! important! parts! of! energy! metabolism!(126).! ! The!accumulation!of!intracellular!lipid!is!thought!to!overwhelm!the!oxidative!capacity!of! the! cell! and! impair! mitochondrial! energy! transfer.! ! This! causes! depletion! of!adenosine! triphosphate! (ATP)! and! leads! to! increased! production! of! reactive!oxygen! species! (ROS),! inducing! oxidative! stress! within! the! cell.! ! Berson! et+ al!showed!that!drugs!such!as!amiodarone!which!are!known!to!induce!steatohepatitis!in! humans! cause! ATP! depletion! and! lipid! peroxidation! (a! marker! of! oxidative!
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stress)!in!rats!(127).!!It! is! believed! that! such! derangement! of! energy! metabolism! leaves! fatty!hepatocytes! vulnerable! to! damage! from! toxins,! ischaemia! and! infections.! ! These!insults! constitute! what! is! called! the! “second! hit”!(128),! leading! to! cytokine9mediated! inflammation! and! eventually! fibrosis!(129).! ! These! insults!may! trigger!further!liver!injury,!precipitating!cirrhosis!and!even!liver!failure.!!!
2.2.2!NAFLD!–!an!important!part!of!the!metabolic!syndrome!!NAFLD! is! related! to! insulin!resistance! !(130).! ! Systemic! insulin!resistance!(IR)! is!associated!with!hyperglycaemia!and!hyperlipidaemia,!contributing!to!the!steatosis.!!Hepatic! steatosis! then! leads! to! worsening! hepatic! IR,! eventually! leading! to!pancreatic!endocrine! failure!and!type!2!diabetes!mellitus!(T2DM)!(131).! !NAFLD!and!NASH!comprise!an! important!component!of! the!metabolic!syndrome!(MetS),!which! can! be! defined! as! a! combination! of! central! obesity! and! any! two! of:!hypertension,! hyperglycaemia! and! dyslipidemia! (see! Table! 1.1)!(33).!!NAFLD/NASH!are!significant!predictors!of!cardiovascular!disease,!independent!of!diabetes!(122).! ! NAFLD! was! associated! with! a! higher! pooled! mortality! rate!compared! with! the! general! population! (odds! ratio,! OR,! 1.57,! 95%! Confidence!Interval,!CI,!1.18!–!2.10),!with!liver!disease!being!the!third!most!common!cause!of!death! compared! with! being! the! eleventh! most! common! cause! in! the! general!population!(132).! ! In! a! pooled! analysis! of! studies! determining! the! presence! of!NAFLD! using! either! ultrasound! or! biopsy! and! controlling! for! presence! of! MetS,!patients!with! NAFLD!were! at! increased! risk! of! cardiovascular! disease! (OR! 1.75,!95%CI!1.38!to!2.23)!(132).! !The!rate!of!survival!of!patients!with!simple!steatosis!was!similar!to!the!general!population!but!patients!with!NASH!had!a!higher!pooled!mortality!(OR!1.81,!95%CI!1.2492.66)!(132).! ! !The!rate!of!progression!of!NASH!to!cirrhosis!was!between!13!and!25%!depending!on!extent!of!fibrosis!in!a!Swedish!study!of!129!patients!(133).!!NASH!has!a!profound!impact!on! long! term! mortality.! ! In! NASH,! liver9related! mortality! rate! was! 11917%!compared!with! only! 1.792.7%! in! patients!with! simple! steatosis! (pooled!OR!5.71,!95%!2.31!to!14.13)!(132).!!!
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Although!ongoing!excess!intake!of!dietary!calories!is!the!most!important!factor!in!the! exacerbation! of! IR! and! NAFLD,! a! number! of! pro9inflammatory! hormonal!changes!occur.! !These!changes!create!a!chronic! inflammatory!state!and!drive! the!development! of! obesity9associated! diseases,! including! atheromatous!cardiovascular! disease,! as!well! as! increase! the! chances! of! developing!NASH! (see!Table!2.1).! !The!increased!deposition!of!central!and!peripheral!adipose!tissue!not!only! exerts! a! mechanical! effect,! in! terms! of! causing! osteoarthritis,! chronic! back!pain!and!obstructive!sleep!apnoea,!but!also!is!a!major!source!of!proinflammatory!cytokines.!!These!cytokines!are!thought!to!link!obesity,!NAFLD!and!IR!(134).!!!!!
!
Figure!2.2!The! link!between! steatosis,!diet!and! inflammatory!mediators! in!adipose!




of! inflammatory! and! pro9apoptotic! pathways! leaves! the! liver! vulnerable! to! further!
damage! and! development! of! NASH.! ! ! Increased! gut! permeability! and! changes! in!
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increased!with!extent!of!fibrosis!and!severity!of!NASH.!!Similarly,!Wieckowska!et+al!found! that! both! circulating! plasma! IL96! and! hepatic! IL96! mRNA! expression! is!increased! in! patients! with! NASH! and! levels! correlate! with! the! extent! of!fibrosis!(137).! !The! increased!expression!of! these!pro9inflammatory!mediators! is!associated!with!increases!in!the!expression!of!other!genes!involved!in!upregulation!of! the! inflammatory! response,! recruitment!of! immune! cells! and!activation!of! the!toll9like! receptor! pathways! (TLR)!(138).! ! TLR! are! thought! to! play! an! important!role! in! progression! of! simple! steatosis! to! NASH! and! may! also! be! activated! by!changes!in!gut!microbes!and!other!environmental!pathogens!(139).! ! !The!chronic!imbalance! within! hepatocytes! towards! a! state! of! oxidative! stress! leads! to!activation!of!hepatic!NF9κβ!and!activating!protein91!(AP91),! through!activation!of!the!TLR!pathway.! ! Videla!et+ al! demonstrated! increased! expression!of!NF9κβ! and!AP91! in!NASH! livers! compared!with!bland!steatotic! livers,!which! correlated!with!increased!markers!of!oxidative!stress!and!insulin!resistance!(140).!!!!Pro9inflammatory!cytokines,! including!TNFα,!are!associated!with!increased!levels!of! intracellular! oxidative! stress!(141).! ! This! may! be! exacerbated! by! insulin!resistance,!which!is!known!to!cause!induction!of!mitochondrial!enzymes!within!the!liver,! including! the! cytochrome9P450! enzymes! involved! in! oxidation! of! lipids,!steroids! and! other! organic! substrates,! including! drug! metabolism!(142).!!!Upregulation! of! these! enzymes! has! been! demonstrated! in! both! cell! and! animal!models!of!NASH,!and!are!associated!with!increased!free!radical!production!(141).!!Increased! markers! of! lipid! peroxidation,! including! malondialdehyde! (MDA)! and!TBARS,!are!associated!with!NASH!and!steatosis!(143).! ! !Lipid!peroxidation!is!also!detected! systemically! and! correlates!with! the! presence! of!NASH,! compared!with!simple!steatosis!(144).!!The!development!of!fibrosis!is!also!related!to!tissue!levels!of!MDA!(145).!!The!processes!are!summarised!in!Figure!2.3.!!
2.3.2!Apoptosis!and!NASH!The!final!common!effect!of!these!inflammatory!stimuli!in!progression!of!NAFLD!to!NASH!is!the!initiation!of!hepatocyte!apoptosis.!!Apoptosis!(programmed!cell!death)!can!occur!via!two!main!pathways!–!the!extrinsic!pathway!is!that!which!is!initiated!
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by!ligand!binding!and!activation!of!a!plasma!membrane!“death”!receptor,!such!as!the! tumour! necrosis! family! of! receptors;! and! the! intrinsic! pathway,! which!originates!from!the!mitochondria,!and!involves!a!loss!of!one!of!many!activities!that!continually!suppress!apoptosis!(146).! ! !Thus,! some!cytokines!such!as!Fas!Ligand!(FasL)!and!tumour!necrosis!factor9related!apoptosis!inducing!ligand!(TRAIL)!may!induce! apoptosis! via! the! extrinsic! pathway,! whilst! intracellular! changes! such! as!oxidative! stress! and! lipid! peroxidation! may! lead! to! activation! of! the! intrinsic!pathway.! ! The! detection! of! higher! levels! of! products! of! apoptosis,! such! as!cytokeratin918!(CK918)! fragments,! in!patients!with!NASH!and! fibrosis!along!with!overexpression! of! death! receptors! such! as! Fas! and! the! TNFα! receptor! in! NASH!liver!tissue!have!highlighted!the!importance!of!apoptosis!in!NASH/NAFLD!(135).!!!CK918! is! a! major! intermediate! filament! protein! in! the! liver,! which! form! an!cytoskeleton! within! the! cell,! associating! with! the! plasma! membrane! forming! a!scaffold! within! the! cell!(147).! ! CK918! is! cleaved! by! caspase! enzymes! during!apoptosis! and! cell! death! and! can! be! detected! in! the! plasma.! ! Two! commercially!available!CK918!assays!are!able!to!detect!different!epitopes!of!CK918!M65!detects!the!full!length!protein!released!during!cell!degradation!and!provides!a!measure!of!total! cell! death,! whilst! M30! detects! a! shorter! fragment! of! CK918! which! is! only!found!after!caspase9mediated!cleavage,!acting!as!a!measure!of!apoptotic!cell!death.!!Wieckowska,! Feldstein! and! colleagues! established! that! CK9189M30! levels! were!increased! in! NASH! compared! with! obese! NAFLD! controls! and! correlated! with!fibrosis! scores!(148,!149).! ! ! Similar! relationships!between!CK918! fragments! and!disease! severity! and! liver! fibrosis! have! been! established! in! viral! and! alcoholic!hepatitis!(150).!!!In!a!mouse!model!of!NASH,!mice!fed!with!a!pan9caspase!inhibitor!for!498!weeks!showed!decreased!histological!evidence!of! liver! fibrosis!as!well!as!reduced! hepatic! collagen!mRNA! expression!(151).! ! The! pathway! through!which!apoptosis!causes!fibrosis!is!not!fully!elucidated,!and!involves!hepatic!stellate!cells!(HSC,!see!Figure!2.3).!!These!reside!in!the!perisinusoidal!tissue!and!act!as!antigen9presenting!cells.! ! It! is! thought! that! the!remnants!of!apoptotic!cells!stimulate!HSC!activity,!leading!to!the!deposition!of!collagen!(152).!!A!model!of!pulmonary!fibrosis!has! shown! that! there! may! be! a! bidirectional! relationship! with! activated! HSC!stimulating!Fas9mediated!apoptosis!as!well!(153)!cited!in!!(152).!!!
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Figure! 2.3! Inflammation! and! Apoptosis! lead! to! fibrosis! and! inflammation(adapted!
from!Canbay!et#al,!2004)!(152)!
Following!an!apoptotic! stimulus,! including!pro9inflammatory! cytokines! like!TNFα!and!
cellular!injury!secondary!to!ischaemia,!hepatocyte!apoptosis!occurs.!!Signals!to!active!
immune!cells!resident!in!the!hepatic!parenchyma,!including!macrophages,!Kupffer!cells!
and! hepatic! stellate! cells! (HSC)! leads! to! uptake! of! cellular! remnants! of! apoptosis!




apoptosis! was! thought! to! be! a! “neutral”! event! that! did! not! produce! further!
inflammatory!stimuli.!
2.3.3!Other!pathological!mechanisms!of!progression!of!NAFLD!to!NASH!Much! of! the! newer! evidence! has! come! from! cross9sectional! studies! of! bariatric!surgery! patients.! ! Vitamin! A! is! an! important! non9enzymatic! cellular! antioxidant!and! NAFLD! is! associated! with! a! decrease! in! its! circulating! levels! (as! retinol),!reflecting! depletion! of! antioxidant! reserves! over! time,! increasing! the! risk! of!progression! to! steatohepatitis! and! fibrosis.! ! In!a! study!of!paired! liver!and!serum!
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samples,!Chaves!et+al!found!that!increasing!severity!of!NAFLD!was!associated!with!deficiency!of! serum!and! liver! retinol! concentrations!(154).! !NAS! correlated!with!liver! retinol! concentration! significantly,! suggesting! that! local! depletion! is! more!important!in!the!progression!of!NAFLD.!! !Folate!deficiency!is!also!associated!with!NAFLD! and!may! amplify! oxidative! stress!(155).! ! ! Liver! tissue! concentrations! of!hydroperoxides,! a! tissue! marker! of! oxidative! stress,! are! increased! in! NASH!compared!with!simple!steatosis.!(156)!Aberrant!Cytochrome!P450!overactivity!is!thought!to!cause!lipid!peroxidation!and!hepatocyte! injury,! with! particular! interest! in! CYP2E1! which! is! overexpressed! in!human! studies! and! animal!models.! ! Using! immunohistochemistry! to! stain! tissue!with!anti9CYP2E1+and!anti9MDA!antibodies,!Bell!et+al!found!that!liver!biopsies!after!bariatric! surgery! had! decreased! levels! of! lipid! peroxidation! and! CYP2E1!activity!(143).! !Decrease! in!steatosis!correlated!significantly!with!the!decrease! in!MDA!and!CYP2E1!staining.!Although!unregulated! free! fatty!oxidation!(due! to!excess! intracellular! lipid)! is!an!important! step! in! the!production!of!ROS,! some! fatty!acids!may!have!a!protective!effect!(157).! ! Depletion! of! liver! n93! long9chain! polyunsaturated! fatty! acid!(LCPUFA)! is! associated! with! oxidative! stress! and! insulin! resistance.! ! Enzymatic!desaturation! of! PUFAs! plays! an! important! role! in! maintaining! physiological!balance! of! lipogenesis! and! free! fatty! acid! oxidation.! ! In! obese! NAFLD! patients,!desaturase!activity!is!decreased!along!with!levels!of!LCPUFA,!and!these!decreases!correlate!with!oxidative!stress!and!insulin!resistance!(158).!!Along!with!high!levels!of!glucose!and!insulin!that!stimulate!fatty!acid!synthesis,!these!changes!may!be!an!important!mechanism!by!which!fat!accumulation!in!the! liver!occurs!(140).! !After!surgery,! total! fat! mass,! including! volume! of! visceral! and! subcutaneous! mass,!decreases! significantly,! which! correlate! with! decreased! plasma! concentration! of!derivatives! of! reactive! oxidative! metabolites,! another! measure! of! oxidative!stress!(159).!!!! !
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2.4!Diagnosis!of!NASH!
2.4.1!Liver!Biopsy!There!is!no!consistent!relationship!between!serum!liver!function!tests!and!extent!of! fatty! infiltration,! fibrosis! and! inflammation.! ! Diagnosis! of! NAFLD! is! made!histopathologically,!with!liver!biopsy.! !Liver!biopsy!carries!a!quoted!1:300!risk!of!major! haemorrhage!(160),! although! image! guidance! in! practice! may! make! it!safer!(161).!The!severity!of!liver!damage!ranges!from!simple!steatosis!(bland!fatty!infiltration)! to! inflammation! (steatohepatitis,! NASH),! fibrosis! and! liver! cirrhosis.!!Brunt! and! colleagues! have! standardised! the! histopathological! criteria! for!NAFLD/NASH.!!They!conducted!a!large!scale!multi9centre!study,!employing!a!long!list!of!standardised!histological!variables.!!Using!logistic!regression,!they!identified!the!variables!most!sensitive!in!making!a!diagnosis!of!NASH!(162).! ! !These!scored!variables!were!measurements!of!the!extent!of!steatosis,!hepatocyte!ballooning!and!lobular! inflammation! and! comprised! the! NAFLD! Activity! Score! (NAS),! with! a!NAS≥5!defining!the!threshold!for!NASH!(see!Table!2.2).!!The!same!group!of!authors!highlighted!the!limitations!of!this!semi9quantitative!score!when!they!reviewed!the!scores!and! individual!histology!of!976!patients! included! in!their!clinical!research!network’s!studies.!!They!found!that!only!75%!of!patients!with!definite!histological!evidence!of!steatohepatitis!had!a!NAS≥5,!with!29%!of!patients!with!NAS≤4!having!definite!evidence!of!steatohepatitis!(163).! !Most!importantly,!they!concluded!that!the! diagnosis! of! NASH! was! strongly! associated! with! clinical! features! of! MetS.!!There! is! also! considerable! variability! of! histological! findings! in! biopsies! from!an!individual,! depending! on! location! and! technique.! ! Maharaj! et+ al! found!approximately! 50%! of! 75! patients! had! diagnostic! agreement! between! three!consecutive!needle!biopsies!from!the!same!entry!site!(164).!!Merriman!et+al!found!only! fair! to! moderate! agreement! in! the! assessment! of! fibrosis,! necrosis! and!inflammation!and!between!41!paired!liver!biopsies!taken!from!right!and!left!lobes!of!the!liver!(165).!!Similarly!Larson!et+al!found!only!74%!agreement!in!assessment!of!inflammation!in!43!paired!liver!biopsies,!although!agreement!for!overall!NAS≥5!was! 93%!(166).! ! Padoin! et+ al! concluded! that! extent! of! fibrosis! might! be!overestimated!by!wedge!liver!biopsy!when!compared!with!needle!biopsy,!perhaps!due!to!the!increased!amount!of!collagen!in!the!periphery!of!the!liver!(167).!!Thus,!
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sole! criterion! for! diagnosis! of! NASH.! ! Judging! the! presence! of! NASH! (versus! simple!
steatosis)!can!only!be!made!after!an!expert!assessment!to!look!for!the!pathognomonic!
hallmarks!of!steatohepatitis.!!!Given! that! simple! steatosis! has! a! relatively! benign! course! compared! with!NASH!(132),! most! efforts! to! improve! non9invasive! diagnosis! are! aimed! at!detecting!steatohepatitis!and/or!fibrosis.! !The!aim!is!to!stratify!patients!into!high!and!low9risk!pools,!with!definitive!liver!biopsy!reserved!for!patients!at!high!risk!of!NASH!with!or!without!fibrosis.!!!
2.4.2!NonNinvasive!diagnosis!of!NAFLD!and!NASH!The!detection!of!steatosis!itself!is!relatively!straightforward!(162).!!Given!its!high!prevalence! in! the! obese! population,! even! a! combination! of! simple! routine!parameters!may!be! used! to! accurately! predict! steatosis.! ! The! fatty! liver! index! is!calculated!using!body!mass!index!(BMI),!waist!circumference!and!gamma9GT,!with!
NAS$Score$ 0" 1" 2" 3"
"
Steatosis! <5%! 5–33%! 34–66%! >66%!




field)! None! 1–2!foci! 2–4!foci! >4!foci!





an!accuracy!of!84%!(168).!!Transabdominal!ultrasound!scanning!has!a!sensitivity!of! 60994%! and! specificity! of! 66995%! in! detecting! fatty! liver,! with! much! higher!accuracy!in!detecting!moderate!or!severe!steatosis!(169).!!!Of! more! clinical! relevance! are! the! techniques! to! detect! fibrosis! and! NASH.!!Transient! elastography! (TE)! is! an! ultrasound9based! method! of! measuring! the!stiffness!of! liver! tissue,!a!correlate!of! fibrosis.! !TE!had!a!sensitivity! in!six!studies!had! a!pooled! sensitivity! of! 79%! in!detecting!Brunt9Kleiner! score!F2! fibrosis! and!94%! in! detecting! F3! fibrosis!(132).! ! However,! mean! BMI! for! patients! in! these!studies! is! 30kg/m2,! indicating! that! the! ability! of! TE! to! record! a!measurement! is!impaired!by!morbid!obesity.!!Other!imaging9based!methods!of!fibrosis!assessment!include!computed!tomography!(CT)!and!magnetic!resonance!(MR)!imaging.! !Both!are! relatively!expensive!and,! in! the! case!of!CT,! associated!with! risks!of! radiation!exposure!(169).! !Accuracy!in!detecting!and!grading!fibrosis!is!still!relatively!poor!and! at! present! not! used! in! routine! practice.! In! a! recent! study! of! 113! patients!undergoing!contrast!enhanced!MRI!to!detect!fibrosis,!Jang!et+al!report!a!sensitivity!of! only! 50%! for! F2! fibrosis,! and! 83%! for! F4! fibrosis,! although! respective!specificities!were!>90%!(170).! !MR!elastography! is! a!more!promising! technique,!with!a!pooled!sensitivity!of!92%!(95%!CI!85996%)!and!specificity!of!96%!(95%CI!91998%)! in! distinguishing! F1/F2! fibrosis! from! F3/F4! in! a! meta9analysis! of! 5!studies!(171).!!














































































































2.5.1$Ischaemia-reperfusion$injury$Disruption!of!the!blood!supply!to!the!solid!organs,!either!through!direct!pressure!on! the! organ! itself! or! by! occlusion! of! the! arterial! blood! flow,! causes! ischaemia.!!This!ischaemia!may!occur!deliberately,!such!as!part!of!a!surgical!procedure!where!the! arterial! supply! is! clamped,! or! inadvertently! as! a! secondary! effect! of! another!action,! such! as! creation! of! a! surgical! pneumoperitoneum! or! application! of! a!retractor!(as!discussed!in!this!thesis,!see!Chapter!3).!!Ischaemia!leads!to!depletion!in! intracellular! oxygen! and! adenosine! triphosphate! (ATP),! the! basic! currency! of!cellular!energy!transfer!(176).!The!resulting!metabolic!changes,!including!a!switch!to!glycogen!consumption!and!anaerobic!respiration,!leads!to!disruption!of!the!cell!membrane! and! intracellular! oedema,! sodium! accumulation! and! derangement! of!intracellular! calcium,! with! production! of! reactive! oxygen! species! (ROS)! and!inflammatory!cytokines!(177).!!!!Within!the!liver,!a!type!of!macrophage!called!Kupffer!cells!line!the!sinusoids!(178).!!These! immune! cells! are! part! of! the!mononuclear! phagocyte! lineage.! ! As!well! as!scavenging! red! blood! cells,! they! are! involved! in! the! response! to! gutKderived!microbes! and! circulating! toxins.! ! Ischaemia! leads! to! aberrant! Kupffer! cell!activation,! with! production! of! cytokines,! vasoactive! compounds! and!chemoattractants,! in! turn! producing! a! neutrophil! response! and! platelet!aggregation.! ! This! in! turns! triggers! activation! of! both! the! humoral! and! nonKhumoral! immune! response,! including! complement! activation! (as! depicted! in!Figure!2.4)!(179).!!!Continued! ischaemia! would! of! course! lead! to! death,! at! cellular,! organ! and!subsequently!organismKlevel.!!However,!nonKlethal!transient!ischaemia!is!followed!by!reperfusion!of! the!organ,!usually!upon!release!of! the!obstruction! to! the!blood!supply.! ! In! the! liver,! restoration!of! the!blood!supply! leads! to!exacerbation!of! the!above!effects.! !Increases!in!proKinflammatory!cytokines,!damage!to!the!sinusoidal!endothelium! and! increased! expression! of! cellular! adhesion!molecules! all! lead! to!neutrophil!and!platelet!aggregation.! ! In!some!smaller!capillaries,!blood! flow!may!be! completely! occluded,! worsening! the! ischaemic! damage! to! the! cells!
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Humoral( factors,( including( complement,( reactive( oxygen( species( (ROS)( and(
proinflammatory( cytokines,( lead( to(activation(of( immune(cells( as(well( as(direct( toxic(
damage( to( hepatocytes( and( sinusoidal( endothelial( cells( (SECs).( ( This( diagram( is( a(
simplification( because( the( interplay( is( not( as( linear( as( depicted.( ( Activated( immune(
cells( also( produce( many( of( the( humoral( factors( themselves( and( go( on( to( damage(
hepatocytes(and(SECs.(NKT(–(natural(killer(T(cells(!The!main!mediators!of!ischaemiaKreperfusion!injury!(IRI)!within!the!liver!are!ROS,!cytokines!and!complement.!!ROS!are!produced!during!aerobic!metabolism,!and!are!neutralised! by! various! cellular! antioxidant! defense! mechanisms.! ! In! IRI,! the!antioxidant!capacity!may!be!overwhelmed,!leading!to!oxidative!stress!and!further!cellular!damage.!!Cytokines!implicated!in!IRI!include!interleukins!(IL)!1!and!6!and!tumour!necrosis! factor! (TNF)!α.! !Complement!activation! leads! to!direct! injury! to!the! liver! by! deposition! of! membrane! attack! complexes,! the! final! element! in! the!
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complement!pathway,!and!also!stimulates!further!cytokine!release!and!production!of!neutrophil!chemoattractants!(process!summarised!in!Figure!2.5).!!!Hepatocyte!damage!may!have!various!consequences,!depending!on!severity.!!NonKlethal!injury!may!lead!to!changes!in!gene!expression!and!intracellular!metabolism!in!a!way!that!may!obviate!the!damage!and!allow!the!cell!to!repair!itself.!!Cytokine!activation,! especially! TNFα,! may! trigger! apoptosis! and! cell! death.! ! A! more!damaging!mode!of!cell!death!is!through!necrosis,!which!is!an!uncontrolled!process!leading! to! a! potential! release! of!more! proinflammatory! stimuli! and! toxins.! ! The!extent!of!necrosis!will!depend!not!only!on!the!severity!of!the!initial!insult!but!also!the!underlying!condition!of!the!liver,!with!steatosis!and!other!chronic!underlying!conditions!associated!with!increased!necrosis!and!worse!outcomes.!!
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2.5.2$Fatty$livers$are$more$vulnerable$to$injury$Fatty! liver!has!a!number!of! structural! and!metabolic!differences! to!nonKsteatotic!liver!(181).! ! As! a! consequence,! tolerance! to! ischaemia! is! reduced.! ! In! a! study! of!lean!and!obese!rats!subjected!to!hepatic! ischaemia!and!reperfusion,!Selzner!et#al!demonstrated!that!obese!rats!were!unable!to!survive!an!experimental!insult!of!60!minutes! of! total! hepatic! ischaemia,! whereas! all! lean! animals! survived.!!Furthermore,!they!demonstrated!that!the!number!of!apoptotic!cells!in!the!liver!rise!with!increasing!periods!of!ischaemia,!but!the!relative!increase!in!apoptosis!is!much!smaller! in! obese! rats,!with! a! larger! amount! of! necrosis,!when! compared! to! lean!rats.! !PostKIRI!apoptosis! is!mediated!by! the!caspase!cascade.! !Selzner!et#al! found!that!administration!of!a!caspase!inhibitor!reduced!AST!levels!in!lean!rats!but!had!no!effect!on!obese!rats.!!!Taking!their!findings!together,!they!were!able!to!conclude!that!the!mode!of!cellular!damage!and!death!differs!from!nonKsteatotic!liver,!with!a!greater! degree! of! necrosis! rather! than! apoptosis! in! steatotic! livers!(182).! ! ! In! a!comparative! study! using! wildKtype! rats! and! a! rat! model! with! hepatic! steatosis,!evaluating!the!effect!of!administration!of!methylprednisolone!prior!to!induction!of!liver! ischaemia! by! clamping! the! inflow,! Saidi! et# al! demonstrated! reduced!inflammatory! response! and!histological! evidence! of! IRI! in! treated!wildKtype! rats!compared! with! controls.! ! The! beneficial! effect! of! steroids! was! not! seen! in! the!steatotic! rats,! indicating! that! different! mechanisms! governing! the! inflammatory!response! and! cellular! damage/death! were! present! in! lean! and! steatotic!livers!(183).!!Investigation!of!the!effects!of!steatosis!on!hepatocyte!function!has!been!extensive!and!revealed!a!number!of!metabolic!and!structural! changes! that! leave! fatty! liver!vulnerable! to! ischaemic! insults.! ! Intracellular! accumulation! of! lipid! leads! to!displacement!of!the!nucleus!to!the!edge!of!the!cell!and!ballooning.! !Seifalian!et#al!used! Doppler! flowmetry! and! intravital! microscopy! to! demonstrate! that!parenchymal!perfusion! is! reduced! in! fatty! livers! compared!with!healthy,! both! in!human!donor!livers!and!a!rabbit!model!(184).!!Reduced!flow!is!also!seen!in!fibrotic!rat! livers! and! can! be! improved! mechanically! with! increased! portal! perfusion!pressures!(185).!!These!changes!lead!to!narrowing!of!the!sinusoidal!capillaries!and!the! sluggish! flow! leads! to! trapping! of! white! blood! cells,! with! concomitant!
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2.5.3$Cellular$mechanisms$of$injury$in$steatotic$livers$An!analysis!of!all!of!the!exact!cellular!mechanisms!of!this!process!are!beyond!the!scope!of!this!review.!!The!main!mechanisms!are!discussed!here!and!a!fuller!review!is! provided! by! Tashiro! et# al!(181).! ! Much! interest! is! centred! on! the! role! of!mitochondrial!uncoupling!proteinK2!(UCPK2).!!UCP!is!usually!only!found!in!Kuppfer!cells!and!is!involved!in!the!uncoupling!of!oxidation!of!energy!substrates!from!the!production!of!ATP!(187).!!In!fatty!liver,!UCPK2!is!expressed!in!hepatocytes!as!well!as!Kuppfer!cells!(188).! ! In!an!obese!mouse!model,!Fulop!et#al!demonstrated!that!
! 67!
FasKinduced!liver!injury!in!UCPK2!deficient!mice!is!reduced!compared!with!UCPK2!competent! animals!(189).! ! When! compared! with! the! UCPK2! competent! animals,!liver! ATP! level! in! the! UCPK2! deficient! mice! was! significantly! reduced.!!Malondialdehyde! (MDA)! levels! were! used! as! a! measure! of! oxidative! stress! and!MDA!was!not!different!between!groups,!indicating!that!oxidative!stress!was!not!a!major! factor! in! causing! FasKmediated! liver! necrosis.! ! Interestingly,! UCPK2!expression! was! decreased! in! Kupffer! cells! and! the! authors! speculate! that! its!relative! absence! lead! to! increased! production! of! reactive! oxygen! species! from!Kupffer! cells.! ! The! inference! is! that! normal! UCPK2! expression! in! Kupffer! cells!means! that,! in! conditions! of! increased! oxidative! stress,! Kupffer! cell! ATP!metabolism! is! reduced! by! the! uncoupling! action! of! UCPK2,!which! is! a! protective!mechanism!(187).!!In!hepatocytes,!UCPK2!has!the!opposite!effect,!and!its!abundant!expression!in!fatty!liver!has!a!pathological!effect,!meaning!that!the!cells!are!more!vulnerable!to!liver!injury!(181).!!Peroxisome! proliferatorKactivated! receptors! (PPARs)! are! a! family! of! nuclear!hormone! receptors! that! are! implicated! in! the! pathogenesis! of! NAFLD! and! the!impairment! of! the! response! to! IRI.! ! The! balance! of! two! of! the! main! isoforms,!PPARα! and! PPARγ,! is! reversed! in! fatty! liver!(126).! ! PPARα! is! involved! in! the!inflammatory!response.!!Teoh!et#al!showed!that!administration!of!a!PPARα!agonist!in!mice!with! steatosis! leads! to! reduction! in! liver! lipid! content.! ! Furthermore,! in!their! IRI!model,! preKtreatment!with!PPARα!agonist!was! associated!with! reduced!hepatocyte! necrosis,! which! correlated! with! reduced! levels! of! inflammatory!cytokines! including! TNFα! and! ILK6! and! reduced! levels! of! adhesion!molecules!(190).!!These!changes!were!associated!with!increased!NFKκβ!activation.!!As!discussed!above,!NFKκβ!plays!a!complex!role!both! in!mediating! ! inflammatory!response!to!IRI!and!the!recovery!phase!(191).! ! !MassipKSalcedo!et#al!showed!that!the! effect! of! an! PPARα! agonist! on! a! rat! model! of! IRI! is! similar! to! the! effect! of!preconditioning,!with!the!effect!of!preconditioning!negated!by!administration!of!a!PPARα!antagonist!(192).!!! $
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2.5.4$Adiponectin$–linking$between$obesity,$steatosis$and$liver$injury$Adiponectin!may!also!play!an!important!role!in!IRI!in!steatotic!livers.! !Circulating!adiponectin! is! reduced! in! obese! subjects,!which! is! thought! to! have! a! deleterious!effect! on! health,! as! adiponectin! has! antiKinflammatory! effects!(193).! ! Conversely!adiponectin! is! found! in! higher! levels! in! steatotic! liver! compared! with! healthy!liver!(192).! ! MassipKSalcedo! et# al! found! that! adiponectin! mRNA! expression!increased!more! in! steatotic! livers! after! IRI! compared!with!normal! liver! controls.!Confusingly,! they! also! showed! that! by!blocking! the! effect! of! adiponectin!with! an!inhibitor! RNA,! IRIKinduced! hepatocellular! damage! and! oxidative! stress! was!reduced!in!steatotic! livers!but!not!in!normal! livers!(192).! !Man!et#al!showed!that!addition!of! exogenous!adiponectin! in!a! rat! liver! transplantation!model! improved!outcomes! in! otherwise! smallKforKsize! transplants!(194).! ! They! concluded! that!adiponectin’s! antiKinflammatory! effects! may! reduce! IRIKinduced! injury! and! may!also! exert! an! antiKobesity! effect! by! clearing! intracellular! lipid,! improving! the!function!of! the!graft.! !Adiponectin! is!now!known!to!mediate!several! intracellular!processes!involved!in!glucose!metabolism,!insulin!sensitivity,!lipid!clearance,!nitric!oxide!production!and!cytokine!expression,!as!well!as!exerting!an!effect!on!cellular!energy!metabolism! by! increasing! fatty! acid! oxidation!(193).! ! Although! its! exact!role! in! IRI! is! unclear,! it! is! apparent! that! obesity! and! steatosis! are! closely! linked!with!circulating!and!intrahepatic!adiponectin!expression!(195).!!The!same!authors!have!recently!shown!in!a!rat!model!that!transplanted!steatotic!livers!downregulate!adiponectin! and! resistin! production! and! that! increasing! their! levels! in! the! graft!reduces!evidence!of!hepatocellular!injury!after!transplantation!(196).!! $
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2.6$Clinical$Consequences$of$IRI$





























































































2.6.2$Ischaemia-Reperfusion$Injury$in$hepatic$resection$In! a! non(transplant! setting,! the! discrete! role! that! IRI! plays! in! post(operative!complications!is!more!difficult!to!discern.!!Although!there!is!a!rise!in!inflammatory!markers! following! liver! surgery,! the! rise! is! similar! to! that! after! other! major!abdominal!surgery!and!is!not!correlated!with!deranged!liver!function!(201).! !IL(6!and!IL(10!increase!after!major!liver!surgery!and!correlate!with!operating!time!and!are!predictors!of!post(operative!complications!and!liver!dysfunction!(202).!!Clinical! pre(operative! predictors! of! complications! and! increased! inflammatory!response! are! the! same! factors! associated! with! IRI!(203).! ! Thus,! markers! of!inflammatory! response! (including! cytokines,! CRP)! may! be! taken! as! surrogate!indicators!of!IRI!in!this!group.! !van!de!Poll!et#al!measured!markers!of!liver!injury!and! inflammation! after! liver! resection! with! and! without! occlusion! of! the! liver!inflow!blood!supply! (Pringle!manoeuvre)!and!showed! that! liver! injury!occurs!on!manipulation!of!the!liver!and!inflow!occlusion!does!not!have!a!significant!additive!effect!on!liver!injury!(204).!!This!study!does!not!account!for!the!inherent!delays!in!cytokine! expression! and! no! comparisons! in! post(operative! period! are! given.!Nonetheless,!IRI!and!the!measured!inflammatory!response!are!not!the!only!major!predictor! of! complications,! as! other! patient! and! technical! factors,! such! as! pre(existing! cardiovascular! disease,! long! operating! times,! high! blood! loss! and!development!of!complications!like!bile!leak,!are!more!important!(205).!!Despite! these! limitations,! there! has! been! much! interest! in! manipulation! of! the!inflammatory! response!(206)! in! an! attempt! to! improve! outcomes.! ! Steroid!administration! has! been! the! most! effective! method! of! reducing! IRI.! ! A! meta(analysis!of! six!studies! including!396!patients!showed! that!steroid!administration!was! associated! with! lower! post(operative! day! 1! IL(6! and! day! 3! CRP,! with! a!significantly! lower!rate!of!morbidity!in!the!steroid!group!(relative!risk!0.76,!95%!confidence!interval!0.57!to!0.99),!p=0.047)!(207).!!Interestingly,!pooled!analysis!of!ALT!levels!were!similar!in!steroid!and!control!groups.!!!!Ischaemic!preconditioning!(IPC)!is!another!attempt!to!ameliorate!the!effects!of!IRI!by!subjecting! the! liver! to!a! short!period!of! ischaemia!and!reperfusion!before! the!
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main!operative!insult!occurs.!!A!number!of!animal!models!and!varying!techniques!have!been!shown!to!produce!a!favourable!response.!!The!underlying!mechanism!is!questioned,!but!is!thought!to!involve!an!increase!in!nitric!oxide!(208),!associated!with! increased! tolerance! to! the! effects! of! oxygen! depletion! within! the!mitochondria!with!preservation!of!ATP!metabolism!(209).!!Within!the!field!of!liver!resection,!a!short!period!of!inflow!occlusion!is!performed!without!liver!resection!in!an! effort! to! precondition! the! liver! for! longer! periods! of! inflow! occlusion,! which!allows!parenchymal!transection!to!proceed!with! less!blood!loss.! !A!meta(analysis!of! 11! trials! including! 669! patients! showed! no! difference! in! clinical! outcomes,!including!mortality! and!morbidity.! ! In! subgroup! analysis,! four! trials! showed! no!significant!differences!in!ALT!levels!and!five!studies!showed!no!differences!in!AST!between! IPC! and! control! groups.! ! In! their! trial! of! 84! patients! undergoing! liver!resection,!Arkadopoulos!et#al!report!reduced!IL(6,!IL(8,!AST!and!malondialdehyde!levels!in!the!IPC!group,!with!fewer!numbers!of!cells!showing!signs!of!apoptosis!by!terminal!dUTP!nick(labelling!(TUNEL)!assay!(210).!!
2.7$Fatty$Liver$and$Ischaemia-Reperfusion$Injury$With! the! increasing! prevalence! of! obesity,! fatty! liver! disease!may! be! present! in!around!a!third!of!the!population,!and!in!20(25%!of!patients!undergoing!major!liver!surgery!(211).! ! Steatotic! liver! grafts! have! a! higher! incidence! of! primary! non(function!(212).! ! A! meta(analysis! of! 1000! patients! undergoing! hepatectomy!showed!an!increased!risk!of!postoperative!complications!(RR!1.53,!95%CI!1.27!to!1.85)! and! death! (RR! 2.79,! 95%CI! 1.19! to! 6.51)! in! patients! with! at! least! 30%!steatosis!compared!with!no!steatosis!(213).! !Given!that!NAFLD!is!a!marker!of!the!metabolic! syndrome,! patients! with! steatosis! may! have! a! higher! incidence! of!obesity,!cardiopulmonary!disease!and!diabetes!(214).!!These!pre(operative!factors!are! all! known! risk! factors! of! post(operative! complications!(215).! ! Despite! this,!Kooby! et# al! report! in! their! analysis! of! 485! patients,! steatosis! is! an! independent!predictor!of!complications,!and!remains!a!significant!independent!factor!even!in!a!multivariate!prediction!model!that!includes!co(morbidities!(216).!!!!
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2.8$Bariatric$Surgery$and$NAFLD/NASH$Following!bariatric!surgery,!weight!loss!leads!to!reduction!in!volume!of!fat!depots.!!The! reduction! in! visceral! fat! and! high! circulating! lipid! levels! leads! to! decreased!free!fatty!acid!flux!in!the!liver!(217).! ! !Thus,! intracellular!lipid!in!the!hepatocytes!can! be! metabolised! or! released,! leading! to! reduction! or! resolution! of! steatosis.!!Decrease! in! insulin! resistance! correlates!with! both!weight! loss! and! reduction! in!steatosis!(218).!!At!the!same!time,!reduction!in!fat!depots!are!also!associated!with!reduced!production!of! pro(inflammatory! cytokines!(217).! ! In! theory,! this! should!lead! to! a! reversal! of! the! process! of! progression! from! simple! steatosis! to! NASH.!!Fibrosis! however! is! a! non(reversible! process,! as! it! involves! deposition! of!collagenous!scar!tissue!within!the!liver!parenchyma.!!In!the!longer!term,!there!are!case!reports!of!acute!liver!failure!occurring!following!bariatric!surgery,!in!patients!with!NASH!!(219)!and!cirrhosis!!(220).!!!!In!a!meta(analysis!of!15!studies! including!766!paired! liver!biopsies,!91.6%!(95%!confidence! interval! 82.4–97.6%)! of! patients! showed! reduction! in! steatosis! after!surgery!(221).!!Similarly,!NASH!was!present!in!53%!of!biopsies,!and!improvement!in! histological! evidence! of! NASH! occurred! in! 81.3%! (95%! CI,! 61.9%–94.9%).!!Although!65%!of!biopsies!had!evidence!of!fibrosis,!only!121!paired!biopsies!were!systematically! scored! for! fibrosis! by! a! histopathologist.! ! Even! so,! 65%! (95%CI!38.2(88.1%)!showed!improvement.!!!!!In! a! large!prospective! study!of!381!patients!undergoing!various! forms!of!weight!loss! surgery,!Mathurin!et#al!were!able! to! compare!267!paired! liver!biopsies!at!1!year!and!211!at!5!years! following!surgery.! ! ! !Of!190!patients!with!a!NAS! fibrosis!score! of! F0! at! baseline,! 39! had! a! score! of! F1! at! 1! year! and! 41/166! at! 5! years.!!Although! NAS,! %! steatosis! and! ballooning! all! reduced! at! 1! and! 5! years,!inflammation! scores! and!extent!of! fibrosis! increased.! ! In!99!patients!with!NASH,!mean!NAS!score!reduced!from!3.71!±!SEM!0.86,!to!2.13!±!1.48!at!1!year!and!1.92!±!1.56! at! 5! years,! with! significant! reductions! in! steatosis! and! ballooning,! but! no!significant!fall!in!scores!of!inflammation!or!fibrosis!(222).!!In!terms!of!non(invasive!markers,! there!are!no!studies!where!markers!are!cross(validated!with!follow!up!liver!biopsy.!!Diab!et#al!studied!cytokeratin(18!levels!and!
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found!in!34!patients,!3!(8.8%)!had!an!increase!in!CK(18!levels!and!31!(91.2%)!had!a! decrease! over! 6! months.! ! Median! decrease! in! CK(18! was! 44%! (range! 13! to!88%)!(223).!!These!decreases!correlated!with!the!fall!in!BMI!and!ALT.!!Kahraman!




3.1$Introduction$In!Chapters!1!and!2,!the!role!of!bariatric!surgery!has!been!discussed,!including!its!beneficial! effect! on! reducing! inflammation! and! oxidative! stress! in! the! morbidly!obese.!!Steatotic!livers!are!particularly!vulnerable!to!ischaemia,!infection!and!other!toxic!insults.!!The!majority!of!patients!undergoing!bariatric!surgery!have!fatty!liver!disease.! ! There! is! little!work! on! post(operative! inflammatory! response! and! liver!injury!in!this!group!of!patients.!!This!chapter!aims!to!review!the!existing!literature,!which!focuses!on!the!inflammatory!response!following!laparoscopic!surgery.!!This!review!will! give! further! context! to! the! original! work! in! this! thesis! presented! in!subsequent!chapters.!!!
3.2$Liver$injury$during$bariatric$surgery$During! laparoscopic! bariatric! surgery,! the! left! lobe! of! the! liver! is! retracted! to!expose! the! stomach.! ! Obese! patients! have! large! livers! secondary! to! fatty!infiltration.! ! Liver! retraction! is! often! performed!with! a! fixed!metal! bar,! called! a!Nathanson! retractor.! ! The! shear! forces!may! tear! the! liver! or! cause!bleeding! and!haematoma!(226).! ! The! compression! may! even! cause! liver! infarction,!characterised!by!pain,!elevation!of!liver!enzymes!and!can!even!lead!to!multi(organ!failure!and!death!(227).!!After!gastric!bypass,!Yu!et#al!identified!three!patients!out!of!72!with!asymptomatic!left!lobe!infarction!on!computed!tomography!(CT)!(228).!!More!commonly,! liver!retraction!merely!squeezes!the!blood!supply,!which!causes!the!liver!to!be!partially!starved!of!oxygen!(ischaemia).!!Figure!3.1!shows!a!typical!intra(operative!finding!of!an!ischaemic(looking!purplish!left!lateral!liver!segment.!When!the!retractor! is! released!at! the!end!of!surgery,! the!restoration!of!a!normal!oxygenated! blood! supply! can! also! cause! tissue! damage! (ischaemia(reperfusion!injury).!!The!combination!of!mechanical!trauma!and!reperfusion!injury!is!sufficient!to!cause!derangement!of!post(operative!liver!transaminases.!!In!gastric!bypass,!this!may!be!up! to! a! six(fold! rise! in! aspartate! transaminase!and!alanine! transaminase!
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from!baseline!levels!(229).!!Serum!liver!enzyme!levels!return!to!baseline!within!72!hours.!!!!Morris(Stiff!et#al!demonstrated!that!laparoscopic!antireflux!surgery!was!associated!with!a!much!greater!rise!in!liver!enzymes!than!laparoscopic!cholecystectomy!(LC),!because!of!the!additional!effect!of!a!Nathanson!retractor,!which!is!not!required!in!LC!(230).! !The!phenomenon! is!not!unique! to! laparoscopic! surgery!and!deranged!liver!function!is!seen!after!open!upper!abdominal!surgery!as!well!(229,$231).! ! In!operations!where!liver!retraction!is!not!required,!the!pneumoperitoneum!still!has!a! significant! effect! on! the! intraabdominal! organs.! ! Since! the! inception! of!
laparoscopic! surgery,! there! has! been! much! interest! in! the! possible! deleterious!effects!of! the!pneumoperitoneum!on! liver! function,! oxidative! stress! and! immune!function.!!The!literature!pertaining!to!this!is!reviewed!herein.!
Figure' 3.1' Purplish' ischaemic' appearance' of' left' lateral' segment' of' liver' following'
placement'of'Nathanson' liver' retractor'during' laparoscopic' surgery' (intraoperative'
image'kindly'provided'by'Mr'Ameet'Patel)'
3.3$Pneumoperitoneum$causes$liver$injury$Studies!of!the!direct!effects!on!liver!tissue!in!humans!are!more!difficult!to!perform,!given! the! practical! and! ethical! difficulties! of! obtaining! tissue! in! patients! where!liver!biopsy! is!not! clinically! indicated.! !Three!pig!models!however!do!shed!some!light! on! the!matter.! ! Alexakis! et# al! performed! sequential! liver! biopsies! over! the!course! of! a! 2! hour! pneumoperitoneum! in! 14! pigs!(232).! ! They! quantified! 11!
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histological!hallmarks!of!liver!injury!as!a!score!of!0!to!3.!!They!found!that!amongst!others,!scores!for!intralobular!and!portal!inflammation,!oedema,!hyperemia,!focal!necrosis! all! increased! significantly! over! time,! mostly! as! changes! between! pre(operative! values! and! biopsies! taken! at! 2! hours! or! after! desufflation.! ! The!major!drawback! of! the! study! is! the! lack! of! validation! of! the! scores! either! internally! or!externally,!with!only!one!pathologist!used.! !All!of!the!mean!score!values!were!<1,!suggesting! that!most! of! the! 11!measured! parameters!were! scored! either! 0! or! 1.!!Yoshida! et# al! saw! an! (unquantified)! increase! in! hepatocyte! ballooning! and! lytic!change! around! the! central! vein,! with! sinusoidal! dilatation! and! congestion.!!Evidence! of! apoptosis,! though! TUNEL(staining! of! hepatocytes,! was! seen! in! the!pneumoperitoneum!group!(233).!!Hoekstra!et#al!in!a!smaller!study!of!8!pigs!found!similar! histological! findings! at! post(mortem! liver! biopsy,! but! no! pre(operative!comparisons! were! taken!(234).! ! Given! the! conflicting! evidence,! the! effects! of!pneumoperitoneum!on!the!splanchnic!circulation!and!liver!blood!flow!may!not!be!the!main!cause!of!damage.! !The!changes!may!be!due!to!direct!pressure!effects!on!the!liver.!!!Leister!et#al!performed!intravital!video!microscopy!on!the!left!liver!lobe!in! a! rat! model! of! pneumoperitoneum!(235).! ! They! found! that! an! 8mmHg!pneumoperitoneum! causes! significant! decreases! in! sinusoidal! perfusion! to! 70(80%! of! baseline,! with! an! 8! fold! increase! in! the! numbers! of! stagnant! leucocytes!within!the!sinusoids.!!Andrei! et# al! reviewed! 270! patients! undergoing! LC! and! 64! having! open!cholecystectomy.! !They!found!that!ALT!was!deranged!in!34%!after!LC,!compared!with! only! 15%! after! open! surgery! (p=0.004),! concluding! that! the!pneumoperitoneum! was! the! main! distinguishing! factor! between! groups!(236).!!Giraudo!et#al!studied!63!patients!undergoing!LC!in!3!groups!–!a!gasless!group!using!an! abdominal! wall! lifting! device,! a! 10mmHg! pneumoperitoneum! group! and! a!20mmHg!pneumoperitoneum!group.!!They!found!that!the!rise!in!ALT!after!surgery!was! higher! in! the! pneumoperitoneum! groups! than! the! gasless! group! and! was!proportional!to!both!the!length!of!surgery!and!the!pressure!used!(237).!!Similarly!Gupta!et#al!showed!that!a!lower!pressure!pneumoperitoneum!decreases!the!extent!of!elevation!of!post(operative!liver!enzymes!(238).! !At! least!16!published!studies!have! established! that! ALT! and! AST! rises! significantly! after! LC!(239).! ! Although!liver! enzymes! may! undergo! between! a! two! and! six(fold! rise! after! laparoscopic!
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surgery,!this!is!not!thought!to!have!clinically!significant!effects!on!the!majority!of!healthy!non(obese!patients! undergoing! routine! surgery!(240).! ! Despite! attempts!to!mitigate!the!extent!of!liver!injury!using!abdominal!lift!devices!(241)!rather!than!insufflation! or! pneumoperitoneum! using! other! inert! (but! more! expensive)!gases!(242),!only!the!application!of!intermittent!calf!pressure!pumps!have!become!standard!practice!(243).! !Similarly!there!is!no!clear!evidence!to!favour!the!use!of!low! pressure! pneumoperitoneum! over! standard! pressures!(244),! although!most!surgeons!will!keep!the!pressure!as!low!as!technically!feasible!(245).!!!!
3.4$Physiological$effects$of$pneumoperitoneum$during$surgery$Insufflation! of! the! abdominal! cavity! with! carbon! dioxide! (CO2)! is! required! to!perform!laparoscopic!surgery.! !For!patients!with!good!cardiorespiratory!function!and! no! other! signs! of! organ! dysfunction,! pneumoperitoneum! has! only! minor!clinically!relevant!effects.!!Some!CO2!will!dissolve!across!the!peritoneal!lining!and!dissolve! in! the!blood!stream,! forming!bicarbonate!and!hydrogen! ions.! !These!are!excreted! via! lung! ventilation.! ! Therefore! anaesthetists! monitor! end! tidal! CO2!concentration!and!arterial!blood!pH!and!can!increase!minute!ventilation!volumes!if!CO2!levels!are!too!high!(246).!!Increased!intraabdominal!pressure!causes!splinting!of!the!diaphragm,!reducing!ventilation!of!the!lung!bases!and!adversely!affecting!the!mechanics!of!breathing,!requiring!higher!ventilation!pressures.! !These!effects!are!exacerbated!in!obese!patients!given!the!additional!weight!of!their!abdominal!walls!with!attached!fat!aprons!(247).!!!!!In!bariatric!surgery,!patients!are!operated!on!in!a!steep!head(up!position.!!This!has!an!additive!effect!with!the!increased!intraabdominal!pressure!on!venous!return!to!the!heart,! causing!a!decrease! in! cardiac!output.! ! Lower!CO2!pressures! are!better!tolerated!(248).!!Renal!blood!flow!is!also!reduced!by!pneumoperitoneum!and!may!result! in!a! fall! in!urine!output!and!transient!deterioration!in!renal! function.! !This!usually! recovers! within! hours! of! surgery! and! the! effects! can! be! reduced! by!adequate!hydration!(249).!!!!
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3.5$Other$pathophysiological$effects$of$pneumoperitoneum$during$surgery$
3.5.1$Splanchnic$Hypoperfusion$Both! animal! and! human! studies! have! shown! that! pneumoperitoneum! can! cause!reduced! splanchnic! perfusion!(250).! ! The! main! importance! of! splanchnic!hypoperfusion!is!the!potential! for!a!reperfusion!phenomenon!to!occur!on!release!of!peritoneum!(251).!A! combination! of! decreased! cardiac! output,! increased! vascular! resistance! and!direct! compression! of! intra(abdominal! vessels! is! thought! to! result! in! reduced!blood! flow!(252).! ! Ishizaki! et# al! studied! blood! flow! in! the! superior! mesenteric!artery! in! dogs! and! demonstrated! a! reduction! in! perfusion! with! a!pneumoperitoneum!of!!16mmHg!(253).!!!In!a!pig!model,!Agusti!et#al!demonstrated!a!20(30%!reduction! in!splanchnic!blood! flow!measured!by!ultrasonic! flow!probe!after! induction! of! a! 15mmHg! pneumoperitoneum!(254).! ! They! also! showed!reduction! in! intestinal! intramucosal!perfusion,!measured!by! laser!Doppler!probe.!!This!was! improved! by! administration! of! dobutamine! to! increase! cardiac! output,!although! blood! flow! was! unaltered.! ! Schilling! et# al! demonstrated! dramatic!reductions! of! intraabdominal! blood! flow! after! elevation! of! pneumoperitoneum!pressure!from!10!to!15mmHg:!stomach!>40%,!jejunum!32%,!liver!39%!(255).!!The!liver!has!a!dual!blood!supply!from!the!hepatic!artery!and!portal!vein.! !Portal!vein!blood!pressure!is!5(10mmHg!(256)!and!supplies!the!majority!of!blood!to!the!liver.!!Therefore!routinely!used!pneumoperitoneum!pressures!of!12(15mmHg!have!a!significant! impact!on!hepatic!perfusion!(257).! ! !Clearance!of!a! luminescent!dye!indocyanine!green!(ICG)!from!the!plasma!by!the!liver!can!be!used!as!a!non(invasive!measure! of! hepatic! blood! flow.! ! ! Eryilmaz! et# al! measured! ICG! clearance! in! 42!patients! before! and! after! LC! in! two! groups! with! 10mmHg! and! 14mmHg!pneumoperitoneum.! !Whilst! a! 10mmHg!pneumoperitoneum!had!minimal! impact!on! ICG! clearance! before! and! after! surgery,! the! 14mmHg! group! demonstrated! a!significant! 25%! reduction!(258).! ! There! was! a! corresponding! significant! rise! in!ALT! and! AST! post(operatively.! ! Eleftheriadis! et# al! inserted! single! fibre! laser!Doppler! probes! into! the! liver! parenchyma! to! measure! hepatic! perfusion! and!demonstrated!a!significant! fall!during! laparoscopy!which!resolved!as!soon!as! the!pneumoperitoneum! was! released!(259).! ! Indirect! measurement! of! hepatic!
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perfusion!can!be!made!by!measuring!hepatic!vein!blood!flow!via!transoesophageal!echocardiography.! ! Meierheinrich! et# al! showed! that! hepatic! vein! blood! flow!increased! during! pneumoperitoneum! of! 12mmHg,! which! conflicts! with! other!data!(260).! ! This! may! suggest! that! this! is! a! poor! technique! of! assessing! liver!perfusion!or!may!reflect!that!understanding!of!the!dynamics!of!liver!blood!flow!is!still! limited.! !The! results!of!Goitein!et#al! further! cloud! the! issue.! ! In!a!pig!model,!which!may!be!more!representative!of!humans!than!small!animal!models!given!the!larger! size! and! similar! morphology! of! the! abdominal! cavity,! they! measured!intestinal! flow! using! coloured! microspheres! at! various! time! points! during!pneumoperitoneum.! ! Perfusion! was! measured! as! a! function! of! microsphere!concentration!within!the! intestinal!mucosa.! !They!found!that!perfusion! increased!slightly! after! insufflation! and! then! returned! to! near! baseline! levels,! suggesting! a!degree! of! autoregulation! and! concluded! that! 15mmHg! pneumoperitoneum! has!little!effect!on!splanchnic!perfusion!(261).! ! !Helium!had!no!significantly!different!effects!compared!with!CO2.!!A! number! of! measures! have! been! tried! to! reduce! the! effects! of! the! reduced!perfusion.! !Abdominal!wall! lifting!devices!are!associated!with! less!disturbance!to!mean!arterial!pressure,!gastric!and!intestinal!mucosal!pH,!and!urine!output!(260).!!!Schimazutsu! et# al! found! pneumoperitoneum! reduced! splanchnic! blood! flow! in! a!pig!model.!!They!determined!that!this!correlated!with!reduced!nitric!oxide!(NO),!a!potent! vasodilator,! and! that! splanchnic! blood! flow! could! be! increased! back! to!baseline! levels! by! administration! of! ethyl! nitrite,! a! NO! donor!(262).! ! Ali! et# al!conducted! a! similar! experiment! in! pigs! using! ethyl! nitrite,! measuring! perfusion!using! laser! Doppler.! ! They! found! that! ethyl! nitrite! corrected! hepatic! blood! to!baseline! but! had! minimal! impact! on! renal! flow,! which! was! not! reduced! during!pneumoperitoneum!(263).! !Preconditioning!(PC)!by!application!of!a!short!period!of!pneumoperitoneum,!followed!by!release,!then!reapplication!has!been!studied!in!a!rat!model.!!Yilmaz!et#al!showed!that!markers!of!liver!injury!and!oxidative!stress!were!reduced!by!ten!minutes!of!PC!(251).! !Perhaps!the!most!clinically!useful!and!relevant! manoeuvre! to! improve! perfusion! is! application! of! intermittent! calf!compression!pumps!during!surgery.!!Bickel!et#al!measured!hepatic!and!renal!blood!flow! using! a! laparosopic! ultrasound! Doppler! probe! during! LC.! ! Application! of!intermittent! calf! compression! reversed! the! fall! in! cardiac! output! induced! by!
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pneumoperitoneum! and! increased! renal! and! hepatic! blood! flows! significantly!compared!to!controls!(264).! !Urine!output!also!increased!in!the!calf!pump!group.!!This! manoeuvre! has! the! added! benefit! of! reducing! risk! of! venous!thromboembolism! and! is! recommended! routinely! for! patients! undergoing!laparoscopic!surgery!(243).!!!!
3.5.2$Peritoneal$surface$changes$The!peritoneum!comprises!a!metabolically!active!layer!of!secretory!cells!forming!a!continuous!layer!lining!the!intraabdominal!organs!(265).! !The!flow!of!CO2!during!insufflation!and!maintenance!of!peritoneum!causes!dessication!and!damage!to!the!cells,!altering!both!structure!(266)!and!metabolic! function.! !Dissolution!of!CO2!to!form!a!weak!carbonic!acid!causes!acidosis!within!the!peritoneum.!!In!addition,!the!increased!intraabdominal!pressure!reduces!perfusion!and!oxygenation!of!the!cells,!exacerbating! the! acidosis!(265).! ! Acidosis! is! likely! to! provoke! an! inflammatory!response,!with!increased!production!of!cytokines!(267)!and!induction!of!oxidative!stress! within! the! tissues!(255).! ! There! was! much! interest! in! the! potential!suppression! of! macrophages! and! induction! of! immune! dysfunction! by! CO2!pneumoperitoneum,!although!much!of!the!data!is!conflicting!(265,$267).!!It!is!clear!that! the!stress!response! following! laparoscopic!surgery! is!smaller! than!that!after!open!surgery!(268),!which!overall! is! likely! to!have!metabolic!and! immunological!advantages!(269).! ! The! suppression! of! the! immune! response! was! postulated! to!have!a!potential! impact!on!outcomes!after!cancer!surgery!(267)!but! this!has!not!been!borne!out!in!longer!term!clinical!studies!(270,$271).!!
3.6$Pneumoperitoneum$and$oxidative$stress$As!discussed!above,!oxidative!stress!occurs!during! laparoscopic!surgery!due! to!a!combination! of! reduced! splanchnic! blood! flow! causing! end(organ! ischaemia,!acidosis!within!the!peritoneum!due!to!dissolution!of!CO2!and!following!evocation!of! an! inflammatory! response!(272).! ! The! difficulties! in! accurately! measuring!oxidative!stress!are!discussed! in!Chapter!4!and! it! is! important! to!emphasise! that!the!available!measures!have!particular! limitations!and!caveats!when!interpreting!the!results.!
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dysfunction$Obesity! is! associated! with! many! complications,! including! diabetes! mellitus,!hypertension,! dyslipidemia,! cardiovascular! disease,! gallstones! and! cholecystitis,!sleep! apnea! and! other! respiratory! dysfunction,! and! the! increased! incidence! of!certain! cancers!(279,$ 280).! ! Morbidly! obese! patients! have! a! higher! rate! and!severity! of! complications! after! all! types! of! surgery!(281).! Over! 80%! of! patients!undergoing! bariatric! surgery! have! fatty! liver! disease!(282).! ! Fatty! liver! is!more!vulnerable!to!damage!by!toxins,! ischaemia!and! infections,! triggering! further! liver!injury!or!precipitating! liver! failure.! !Obesity! and! fatty! liver! are! independent! risk!factors! for! the! development! of! complications! after! liver! resection!(283).! ! Fatty!liver!disease!is!the!fastest!growing!indication!for!specialist!hepatology!referral! in!the!UK!(284).!!Bariatric! surgery! is! the! most! effective! treatment! for! morbid! obesity!(35).!!However,! the! liver! is! subjected! to! further! stress! during! surgery! that! may!complicate!the!post(operative!recovery.!Retraction!of!the!liver!during!surgery!and!subsequent!release!causes!ischaemia!and!then!ischaemia(reperfusion!injury!(IRI),!indicated!by!derangement!of!post(operative! liver! function! tests,!with!up! to!a!six(fold! rise! from! baseline! levels! lasting! for! up! to! 72! hours!(229).! ! In! addition,! the!pneumoperitoneum!created!to!facilitate!laparoscopy!also!causes!a!degree!of!injury!to! the! intra(abdominal! viscera.! ! This! injury! contributes! to! the! systemic!inflammatory! response! and!may! jeopardise! the! recovery! of! the! patient.! ! Clinical!outcomes! may! include! post(operative! fever,! renal! failure,! respiratory! distress,!hypotension!and!liver!failure!(285).! !Up!to!10%!of!bariatric!surgery!patients!may!have! clinically! significant! post(operative! complications,! increasing! hospital!stay!(35).! Upto! 18%!of! patients!with! pre(existing! liver! disease! have! progressive!hepatic! dysfunction! following! bariatric! surgery,! with! severity! ranging! from!transient! elevation! of! liver! transaminases!(229)! to! organ! dysfunction!(286)! and!rarely!liver!failure!causing!death.!(219)!!In!our!own!unit,!120!patients!underwent!weight! loss! operations! in! 2006(7.! Their! average! hospital! stay! was! 7! days,! with!complications! affecting! 8%! of! patients.! ! Over! 80%! had! deranged! liver! function!
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tests! for! at! least! 72! hours! post(operatively! and! 7%! suffered! infectious!complications!(unpublished!data).!
4.2.2$N-acetylcysteine$N(acetylcysteine! (NAC)! is! a! pharmacological! agent,! approved! for! use! in! the!prevention!of! radiological!contrast! induced!nephropathy!and! the!management!of!paracetamol!overdose.! ! It! is!a!derivative!of! the!amino!acid!cysteine!and!acts!as!a!precursor! to! glutathione,! an! important! antioxidant! !(287).! ! Glutathione! (GSH)! is!the!most!abundant!intracellular!buffer!and!mitochondrial!antioxidant!and!made!of!the! amino! acids! glycine,! glutamic! acid! and! cysteine.! ! Upon! contact! with! ROS,!oxidised! glutathione! (GSSH)! is! produced.! ! This! can! then! be! regenerated! in! a!reducing! reaction! which! consumes! NADPH! by! glutathione! reductase! (shown! in!Figure!4.1)!(288).! !Hypoxia! can! induce!GSH! synthesis,! although! the! rate! limiting!step! is! the! availability! of! cysteine! and! synthesis! is! an! energy(dependent!process!(289).!!!NAC!is!a!highly!soluble!cysteine!precursor!which!can!easily!diffuse!into!cells,!boosting!GSH!levels!rapidly!(289).!!
!
Figure' 4.1' The' Glutathione' Antioxidant' System' (after' Sastre' et# al,' 1996,' adapted'
from'Rahman'et#al,'1999)'(290)'!!NAC! also! acts! directly! as! a! free! radical! scavenger,! reacting! with! hydrogen!peroxide!!!(291).!It!is!used!widely!as!a!treatment!for!paracetamol!poisoning,!where!intracellular! glutathione! is! depleted,! leading! to! hepatocellular! necrosis! and! liver!failure.! !Its!effects!as!an!anti(oxidant!have!been!established!in#vitro!and!in!animal!studies!!(291)!!!
!86!
There!have!been!a!number!of! studies! looking!at! the! effect! of!N(acetylcysteine! in!critical!care!settings,!including!randomised!controlled!trials!in!severe!sepsis!(292),!coronary! artery!bypass! grafting!(293)! and! acute!pancreatitis!(294,$295).! ! These!studies!have!not!shown!a!significant!beneficial! clinical!effect,!although!one!study!demonstrated! an! increase! in! hepato(splanchnic! blood! flow!(296).! ! Koca! et# al!compared!the!effect!of!NAC!and!ischaemic!preconditioning!on!markers!of!oxidative!stress! in! patients! undergoing! arthroscopic! knee! surgery! under! tourniquet!control!(297).! ! They! found! that! both! treatments! were! effective! in! significantly!reducing!oxidative!stress,!with!lower!MDA!levels,!increased!superoxide!dismutase!and! glutathione! peroxidase! levels! and! an! increase! in! total! antioxidant! capacity!compared!with!control!group.!!!
4.2.3$NAC$in$Liver$Surgery$$$$$A!number!of!animal!models!of!ischaemia(reperfusion!injury!(IRI)!have!investigated!the!efficacy!of!NAC!in!reducing!hepatocellular!injury.!!These!studies!have!variously!shown! a! number! of! beneficial! effects! including! increased! bile! flow,! improved!sinusoidal!blood! flow,!decreased!post(operative! liver! transaminases!and!reduced!evidence! of! injury! on! liver! histopathology!(298).! ! ! Studies! in! pig! models! have!shown!a!reduction!in!post(IRI!inflammatory!markers!and!free!radical!production,!whilst! isolated! porcine! liver! perfusion! studies! have! shown! better! Kupffer! cell!function! following! NAC! administration!(299).! ! In! nine! clinical! trials! in! human!orthotopic! liver! transplantation,! NAC! was! administered! either! to! donors! before!organ!retrieval!or!to!recipients!before!graft!revascularisation.!!Three!trials!showed!a! statistically! significant! reduction! in! post(operative! liver! enzymes,! although! the!clinical! significance! in! terms! of! complications! and! graft! survival! could! not! be!evaluated!in!these!small!studies!(299).!!Two!studies!of!NAC!in!liver!resection!have!been!performed,!including!a!total!of!119!patients!(299,$300).!!Robinson!et#al!found!no!differences!in!clinical!outcomes!between!groups,!though!day!3!ALT!levels!were!lower!in!the!treatment!group!(Controls!308!(range!91–1599!versus!NAC!223!(74–764);!p#<!0.01)!(300).! !Worryingly! the!NAC!group!had!a!prolonged!prothrombin!time! on! post(operative! day! three,! although! this! was! of! doubtful! clinical!significance.!!!!
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All!of!these!reported!studies!have!reported!on!small!numbers!of!patients!and!were!underpowered!to!detect!effects!on!clinical!outcomes.! !However,!these!small!trials!have! not! been! performed! specifically! in! an! obese! population.! No! sub! analyses!looking!specifically!at!obese!patients!have!been!possible.!!Nevertheless,!a!number!of! liver! surgery! centres! continue! to! champion! the! use! of! NAC! based! on! the!experimental!evidence.!!
4.2.4$NAC$in$fatty$liver$disease$Progression! of! fatty! liver! disease! to! steatohepatitis! and! fibrosis! occurs! due! to!oxidative!stress!and!chronic! inflammation!(125).! !Steatotic!hepatocytes!are!more!vulnerable! to! toxic! insults! and! hypoxia,! being! less! able! to! tolerate! the!accompanying! mitochondrial! dysfunction! and! buffer! the! increased! oxidative!stress!(181).!!Thus,!potential!antioxidant!and!anti(inflammatory!effects!of!NAC!are!an!attractive!treatment!for!patients!with!NAFLD!(301).!!!!In!a!rat!model!of!NASH,!an!oral!formulation!of!NAC!given!in!feeds!was!associated!with! a! 34%! reduction! in! the! area! of! collagen! deposition! seen! on! liver!histopathology! compared! with! the! control! group!(302).! ! This! reduction! was!accompanied! by! a! corresponding! changes! in! expression! of! genes! involved! in!fibrogenesis,! including! matrix! metalloproteinases,! and! downregulation! of! heat(shock!proteins.!!NAC!fed!to!rats!decreased!body!fat!percentage!and!lowered!serum!triglycerides! and! leptin,! compared! to! controls! and! lowered! hepatic! stearoyl(coenzyme! desaturase(1! (SCD1),! a! key! enzyme! of! fatty! acid! and! energy!metabolism!(303).! ! In! rats! fed! with! a! hepatotoxic! compound! known! to! cause!oxidative!stress!and!hepatic!steatosis,!NAC!supplementation!decreased!hepatocyte!lipid! accumulation,! as! assessed! on! microscopy!(304).! ! In! a! rat! model! where!overfeeding! polyunsaturated! fats! leads! to! NASH,! NAC! supplementation! was!associated!with!lower!liver!pathology!scores,!reduced!markers!of!oxidative!stress!within!the!liver!and!decreased!hepatic!TNFα!mRNA!expression!(305).!!In!an!obese!ob/ob!mouse!model,! administration!of!NAC! for!60!days!decreased! the!degree!of!steatosis! and! lipid! peroxidation! in! the! group! fed! a! methionine(choline! deficient!diet,! which! induces! NASH,! and! a! high(fat! diet,! which! induces! steatosis!(306).!!Similar!results!were!seen!in!another!high(fat!diet!rat!model!of!NASH,!where!NAC!
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supplementation! reduced! steatosis! and! necroinflammatory! scores,! along! with!increased!tissue!GSH!levels!(307).!!In!a!partial!hepatectomy!model!in!rats!with!NAFLD,!pre(operative!administration!of! NAC! was! associated! with! lower! levels! of! malondialdehyde,! a! marker! of! lipid!peroxidation!and!higher!mitotic!indices!and!proliferating!cell!antigen!levels!in!the!remnant! liver! after! 48! hours,! suggesting! NAC! may! improve! liver!regeneration!(308).! ! In! an! ischaemia(reperfusion! rabbit! model! with! steatosis,!administration! of! NAC! before! reperfusion! was! associated! with! decreased! ALT!levels,!used!as!a!marker!of!liver!injury,!and!improved!hepatic!microcirculation,!as!evaluated!by! laser!Doppler! flow!(309).! ! In! a! rat!model!of! ischaemia(reperfusion,!the!effect!of!NAC!was!compared!in!steatotic!and!normal!livers.! !Administration!of!NAC! in! the! normal! liver! rats! had! no! effect! on! markers! of! oxidative! stress! and!histopathological!evidence!of!liver!injury.!!However,!in!the!steatotic!rats,!there!was!a! significant! reduction! in! hepatic! MDA,! lung! myeloperoxidase! and! liver! injury!scores!(310).! !NAC!was!given! in! combination!with!other!drugs! in!a! rat!model!of!IRI,!which! had! a! significant! effect! on! reducing! post(IRI! transaminases,!MDA! and!inflammatory!response!(311).!!!Human! studies! of! NAC! in! the! context! of! NAFLD/NASH! are! less! encouraging.!!Pamuk!et#al!gave!18!patients!with!NASH!daily!oral!NAC!supplements!for!4!weeks!and! noted! a! reduction! in! ALT! and! AST,! although! their! control! group! also! had! a!similar!reduction!in!transaminases!over!the!same!time!period!(312).!!!Khoshbaten!
et# al! randomised! 30! patients! with! NAFLD! to! receive! NAC! or! Vitamin! C! for! 3!months!(313).! ! Serum! ALT! fell! significantly! in! the! NAC! group! from! 77! to! 51.7!(p=0.014).! ! However,! ALT! in! the! Vitamin! C! group! was! significantly! lower! at!baseline.! ! The! study! also! showed!a! statistically! significant!5mm!reduction! in! the!size!of!the!spleen!in!the!NAC!group,!which!the!authors!interpret!as!a!possible!sign!of!reduction!in!steatosis.!!In!our!unit,!NAC!has!been!shown!to!improve!the!metabolic!function!of!hepatocytes!when! given! as! an! infusion! in! fatty! livers! rejected! for! orthotopic!transplantation!(314).! ! Comparing! the! effect! of!NAC! added! to! a! perfusion!buffer!used!to! isolate!hepatocytes!from!steatotic! livers!to!the!standard!buffer!(n=!5!and!
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5),!cells!from!the!NAC!group!had!a!significantly!higher!mean!viability!(81.1!±!1.7%!vs.!66.0!±!4.7%;!p!=!0.003).!!The!quality!of!isolated!hepatocytes!was!assessed!using!a! cell! attachment! assay,! a! protein! synthesis! assay! and! measurement! of!mitochondrial! dehydrogenase! activity,! which!were! all! significantly! higher! in! the!NAC!group.!Although!the!mechanism!by!which!NAC!had!a!beneficial!effect!was!not!elucidated,!other!cell!models!have!shown!that!NAC!reduces!inducible!nitric!oxide!synthase!(iNOS),!perhaps!by!inhibiting!cytokine(stimulated!iNOS!expression!(315,$
316).!!
4.2.5$Why$perform$this$randomised$trial?$The! consensus! is! that! bariatric! surgery! can! improve! fatty! liver! disease! !(282).!!However,! it! is!possible! that! liver!damage!may!worsen! transiently!when! the! liver!suffers! ischaemia! intra(operatively.! ! This! injury! can! trigger! a! systemic!inflammatory! response! and! jeopardise! the! recovery! of! the! patient.! ! The! directly!attributable! clinical! effect! of! intraoperative! hepatocellular! damage! on! post(bariatric!surgery!outcomes!has!not!been!quantified.!!Although!usually!self(limiting,!a! larger! post(operative! inflammatory! response! may! predispose! the! patient! to! a!worse!response! to! further! insults,! such!as!anastomotic! leakage!or!post(operative!infection!–! a! so(called! “second!hit”! !(317).! ! ! Clinical!outcomes!may! include!post(operative!pyrexia,!and!rarely!to!more!serious!problems,!such!as!renal!failure,!acute!respiratory!distress! syndrome!and!hypotension.! !Up! to!10%!of! bariatric! surgery!patients!may!have!clinically!significant!post(operative!complications!!(35),!leading!to! additional! allocation! of! health! resources! and! an! increase! in! hospital! stay.!!Obesity! and! steatosis! are! independent! risk! factors! for! the! development! of!complications!after!liver!resection!(283)!and!transplantation!!(318).!!In!the!longer!term,! there! are! case! reports! of! acute! liver! failure! occurring! following! bariatric!surgery,! in! patients! with! NASH! !(219)! and! cirrhosis! !(220).! ! Follow(up! studies!with!post(operative!liver!biopsies!have!confirmed!resolution!of!steatosis,!but!with!varying!changes!in!the!degree!of!inflammation!and!fibrosis!!(282).!!!No!study!has!specifically! looked!at!the!role!of!perioperative!N(acetylcysteine!in!a!morbidly! obese! population.! ! These! patients! have! a! propensity! to! develop! an!exaggerated! inflammatory! response! to! surgical! trauma!(285)! and! are! more!
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vulnerable! to! oxidative! stress!(129).! With! an! increasing! proportion! of! the!population! being! obese,! the! prevalence! of! obesity(related! post(operative!complications! will! escalate.! ! N(acetylcysteine’s! role! as! an! anti(oxidant! and! free!radical!scavenger!may!have!a!protective!effect!within!this!population,!ameliorating!the!intra(operative!insult!to!the!fatty!liver.!!In#vitro!data!demonstrate!a!significant!benefit! from!N(acetylcysteine! for!hepatocytes!derived! from!fatty! livers!(314).! ! In#
vivo,! the! effect! of! NAC!may! reduce! immediate! post(operative! complications! and!also!prevent!further!deterioration!long!term!in!the!subset!of!patients!with!NASH.!!The!use!of!NAC!may!be!extended!to!other!obese!patients!undergoing!liver!surgery,!reducing!the!burden!of!post(operative!complications!on!the!health!service.!!
4.3$Aims$and$Outcome$Measures$This!study!aims!to!answer!the!following!question:!
• Does! administration! of! NAC! reduce! the! surgical! insult,! especially! signs! of!hepatocellular!injury?!
#The! following! outcome!measures! are! used! to! quantify! the! decrease! in! extent! of!hepatocellular! damage! and! its! clinical! effect! of! NAC! on! the! treatment! group! as!measured!by:!!!





4.4.1$Trial$Design$and$Patients$Recruitment$This!was!a!prospective!randomised!controlled!trial! investigating!the!effects!of!N(acetylcysteine,!performed!between!July!2009!and!August!2012.!!Full!review!by!the!Local! Reseach! Ethics! Committee! at! King’s! College! Hospital! and! approval! by! the!MHRA!(UK)!was!sought!and!obtained!before!commencement!of! recruitment! (see!Appendix!2,!Section!B1.1!for!Sponsor!details).!There!are!two!study!groups:!!1. Treatment!Arm!–!NAC!group!2. Control!Arm!Patients!were!seen!in!the!Multidisciplinary!Morbid!Obesity!Clinic!or!Pre(operative!Assessment!Clinic!at!King’s!College!Hospital,!who!were!referred!for!morbid!obesity!surgery.!!!Fully!informed,!written!consent!obtained!prior!to!enrolment!into!this!study.!!
Inclusion)criteria)were:0)Male!or!Female!Age!range!18!to!75!years!inclusive!Patients!must!meet!the!criteria!set!out!by!NICE!for!morbid!obesity!surgery,!that!is!they!must!have!BMI!>40kg/m2!or!>35kg/m2!with!obesity(related!complications,!and!are!undergoing!either!Laparoscopic!Adjustable!Gastric!Banding!or!Roux(en(Y!Gastric!Bypass!or!Laparoscopic!Sleeve!Gastrectomy!!
Exclusion)criteria)were:0)Patients!undergoing!Duodenal!Switch!!Patients!undergoing!OPEN!bariatric!surgery!!(a!small!minority!of!total!patients)!Pregnancy!History! of! chronic! liver! disease,! including! viral! hepatitis,! haemochromatosis,!alcoholic! liver! disease! or! known! alcohol! intake! 28! units! per!week! (and! a! set! of!normal! tests! of! liver! disease! screening! including! negative! hepatitis! serology! and!normal!autoantibody!screen)!Previous!liver!surgery,!eg!resection,!orthotopic!transplantation!
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History!of!active!psychiatric!illness,!including!severe!depression,!bipolar!disorder,!schizophrenia!and!eating!disorders!Bleeding!tendency!or!anticoagulant!medications!Known!allergies!to!N(acetylcysteine!or!related!compounds!!
4.4.2$$Randomisation$and$Blinding$Participants! were! allocated! to! NAC! or! Control! groups! using! a! sequential! sealed!envelope!method.!The!research! team!opened!the!allocation!envelope!a!minimum!of!2!hours!before!surgery!to!allow!time!for!Pharmacy!to!dispense!the!NAC!infusion.!!The! operating! surgeon! and! anaesthetist!were! aware! if! the! patient! receives! NAC!infusion!as!it!is!easily!distinguished!due!to!its!bright!colour!and!pungent!odour.!The!patients!were!blinded!to!the!intervention.!!
4.4.3$Trial$interventions:$
4.4.3.1$Intervention$Group$-$NAC$Subjects! randomised! to! the! intervention! received!N(acetyl! cysteine! infusion,! at! a!standard! 150mg/kg! in! 200ml! 5%! dextrose! over! 15mins! at! induction! of!anaesthesia!followed!by!an!infusion!of!50mg/kg!in!500mls!of!5%!dextrose!during!surgical! retraction! of! liver! for! a! maximum! of! 4! hours,! together! with! standard!anaesthetic!medications.!The!maximum!dose!was! limited! to! 16.5g! for! loading! dose! and! 5.5g! for! infusion,!making!a!maximum!total!dose!of!22g!per!study!participant.!!The!Investigational!Medicinal!Product!(IMP),!N(acetylcysteine!was!sourced!as!Acetylcysteine! 200mg/ml! and! supplied! from! Aurum! Pharmaceuticals! Ltd,!Bampton! Road,! Harold! Hill,! Romford,! Essex! RM3! 8UG! Product! License/! UK!Marketing!Authorisation:!12064/0026.!IMP! was! handled! according! to! the! Medicines! for! Human! Use! (Clinical! Trial)!Regulations!2004!and!amended!in!2006.!!
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The! control! subjects! received! standard! anaesthetic! medications! alone.!!Anaesthesia!was!provided!by! two!bariatric! anaesthetists,! using!a! combination!of!propofol! and! sevofluorane! for! anaesthesia,! with! remifentanil! and! fentanyl! for!analgesia.!
4.4.3.2$Standard$Treatment$of$patients$Patients! were! treated! as! per! routine! practice.! ! Although! the! inclusion! criteria!included! adjustable! gastric! banding! and! Roux(en(Y! gastric! bypass,! only! patients!undergoing! Laparoscopic! Sleeve! Gastrectomy!were! included! in! this! study.! ! This!was! because! a! concurrent! study! in! the! unit! was! recruiting! patients! undergoing!gastric!bypass,!so!none!could!be!recruited!before!the!closure!of!the!study.!!The!LSG!was!performed!by!a!single!experienced!surgeon!(Ameet!Patel,!CI)!for!all!patients.!!Six!trocars!were!utilised!and!LSG!was!performed!with!standard!techniques!using!a!38(Fr!bougie.!!A!12mmHg!carbon!dioxide!pneumoperitoneum!was!created.!!A!liver!biopsy!from!the!left!lateral!section!of!the!liver!was!taken!using!a!Tru(Cut!cannula,!taking!2!or!3!passes!in!order!to!obtain!cores!of!liver!tissue!at!a!minimum!of!1cm!in!length.!!A!fixed!Nathanson!liver!retractor!was!placed!under!the!left!lateral!section!of!the!liver!to!facilitate!clear!visualisation!of!the!hiatus.!!After!devascularisation!of!the! greater! curvature! using! an! ultrasonic! coagulating! dissector,! the! LSG!commenced! 4–6! cm! proximal! to! the! pylorus! on! the! greater! curvature! and!continued!towards!the!angle!of!His.!!The!completed!staple!line!was!reinforced!with!absorbable!sutures.! !A!further!liver!biopsy!from!the!left! lateral!section!was!taken!before! release! of! pneumoperitoneum.! ! Haemostasis! was! ensured! before! the!operation! was! completed.! ! Blood! loss! was! recorded! by! measuring! volume! of!effluent! in! the! suction! lavage! apparatus.! ! Post! operatively,! all! patients! received!anticoagulation!therapy!with!low!molecular!weight!heparin!and!wore!compression!stockings!for!embolism!prophylaxis.!Gastrograffin! meal! contrast! radiography! was! performed! for! all! patients! and!methylene!blue!dye!tests!were!completed!on!patients!with!post(operative!drains!in!situ! to! detect! gastric! leak.! ! ! Qualified! dieticians! provided! post(operative! dietary!education.! ! Post(operative! diet! consisted! of! fluids! only! for! 4! weeks,! puréed!consistency!foods!for!a!further!2–4!weeks,!followed!by!soft!foods!for!an!additional!4!weeks,!then!the!gradual!return!to!normal!foods!in!reduced!portions.!
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4.4.4$Sample$Collection$All! of! the! study! samples! were! stored! in! a! secure! freezer! within! the! Institute! of!Liver!Studies,!according!to!the!guidelines!set!out!in!the!Human!Tissue!Act!(2004).!
4.4.4.1$Serum$and$Plasma$Serial!fasting!serum!and!plasma!samples!were!taken:(!!(i) before!surgery!(ii) at!end!of!surgery!(iii) on!post(operative!days!1,!2,!3!and!4!(iv) !at!outpatient!follow!up!6!months!after!surgery!(see!Chapter!4).!! !Blood!samples!were!taken!routinely!at!these!time!points!for!standard!biochemical!and! haematological! testing.! The! following! equipment! is! needed! to! take! the!samples:!non(sterile!gloves,!2!purple!top!EDTA!containing!bottles,!1!gold!top!bottle!containing! separator! gel,! 1! plain! brown! top! bottle,! standard! venesection!equipment,! including! tourniquet,! alcohol! sterile!wipes,! green! needles! and! 20mls!syringe.! !Blood! samples!were! sent! as!per! standard! clinical! practice! to! the!King’s!College! Hospital! Haematology! and! Biochemistry! Laboratories! for! evaluation! of!routine!blood!counts!and!biochemistry!analysis.!!!!A!further!10!mls!of!blood!was!taken!as!part!of!the!study!protocol.!!The!blood!was!divided! equally,! with! 5mls! put! into! an! ice(chilled! purple(top! bottle,! containing!EDTA,!and!5mls! in!a!yellow(top!bottle!containing!gel!separator.!The!bottles!were!gently!shaken!for!10!seconds.! ! !The!yellow(top!bottle!was! left!on!ice!to!allow!the!blood!to!clot.!!In!the!meantime,!the!purple(top!bottle!was!centrifuged!at!2000g!for!15mins! and! the! supernatant! was! transferred! to! labelled! cryotubes! in! 0.5ml!aliquots! and!placed! immediately! into! the! freezer! at! (80°C.! !As! soon!as! the!blood!had!clotted,!the!yellow(top!bottles!were!centrifuged!at!1500g!for!15min.!!Again,!the!serum! supernatant!was! transferred! to! cryotubes! in!0.5ml! aliquots! and!placed! in!the!(80°C!freezer.!!All!samples!were!clearly!marked!with! identifiers!and!stored! in! the!(80°C! freezer,!which!was!securely!locked!and!was!situated!within!the!laboratories!of!the!Institute!of!Liver!Studies!for!future!analysis.!!
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The!above!were!performed!by! laboratory! staff! according! to! standard! techniques!by! the!King’s!College!Hospital!Biochemistry!Department,!on!an!automated!multi(analyser,!the!Advia!2400!(Siemens!Healthcare!Diagnostics,!Camberley,!Surrey,!UK).!The!most! important!markers!of!hepatocellular!damage!and! inflammatory!change!included!ALT,!AST,!CRP,!White!cell!count!and!platelet!count.! !These!outcomes!are!analysed!herein.!!Changes!in!insulin!resistance,!measured!by!HOMA!index,!are!also!described!in!Chapter!4.!!Other!elements!of!liver!function,!such!as!bilirubin,!albumin!and! INR,!were!not! analysed! in! this! study! as! they!were!not! appropriate! outcome!measures!in!this!study.!!Insulin! resistance! is! calculated! using! the! Homeostasis! Model! of! Assessment!
(HOMA)(IR!index:! !(319).!
4.4.5.3.2$Liver$Tissue$
• Histopathology!!! NAFLD!score!Each! liver! biopsy! specimen! was! individually! marked! with! an! anonymised!identification! code.! ! Sections! were! paraffin! fixed,! embedded! and! stained! with!haematoxylin!and!eosin,! reticulin,!Orcein!and!Perl's! stains!by! the!Histopathology!Department!at!Institute!of!Liver!Studies,!King’s!College!Hospital.!!Dr! Alberto! Quaglia,! Consultant! Liver! Histopathology! at! King’s! College! Hospital,!performed!the!histopathological!assessments,!blinded!to!patient!identities,!clinical!details!or!timing!of!biopsies.!!
4.4.5.3.2.1)Histopathology)!A! diagnosis! of! NAFLD! was! made! by! a! hepato(histopathologist! on! the! basis! of!typical! histological! findings! in! the! appropriate! clinical! setting! and! following!exclusion! of! other! liver! disease.! The! pathologist! also! classified! the! biopsy! as!consistent!with!NASH!or!as!NAFLD!without!evidence!of!NASH.!NAFLD! Activity! Scoring! was! undertaken,! according! to! the! criteria! set! out! by!Kleiner!and!Brunt!(162),!defined!as!the!unweighted!sum!of!the!scores!for!steatosis!(0(3),! lobular! inflammation!(0(3),!and!ballooning!(0(2);!thus!ranging!from!0!to!8.!!
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Scores!≥5!are!compatible!with!a!diagnosis!of!steatohepatitis.!!Fibrosis!was!scored!0(4!according!to!the!Kleiner(Brunt!definitions!(162).!!
4.4.5.3.2.2)Liver)Injury)Score)!In!order!to!quantify!the!extent!of!hepatocellular!injury,!a!local!scoring!system!was!formulated!and!used.!!There!are!no!validated!scoring!systems!to!look!at!acute!liver!injury! in!human! livers! in! this!context.! !Published!scoring!systems!used! in!animal!models!of! ischaemia(reperfusion! injury! include!the!Suzuki!score,!a!score!used!by!Alexakis!et#al!to!grade!pneumoperitoneum(induced!liver!injury!in!a!pig!model!and!a! score! developed! in! a! multi(centre! international! study! originally! to! look! at!chemotherapy(induced! liver! injury.! ! The! Suzuki! score! is! the! sum! of! histological!changes! that!are!scored!0(4!on! the!degree!of! cytoplasmic!vacuolation,! sinusoidal!congestion! and! necrosis! of! parenchymal! cells!(320).! ! ! Alexakis! et# al! scored! the!following! 11! features! 0(3: portal! inflammation,! intralobular! inflammation,!eosinophilic! infiltration,! edema,! sinusoidal! dilatation,! sinusoidal! hyperemia,!centrilobular! dilation,! centrilobular! hyperemia,! pericentrilobular! ischemia,! focal!lytic!necrosis,!and!confluent!necrosis!(232).!Rubbia(Brandt! graded! the! following! features:! steatosis,! sinusoidal! dilation,!nodular! regeneration,! centrilobular!or!portal! vein! lesions,! centrilobular! vein! and!perisinusoidal! fibrosis,! peliosis,! perisinusoidal! haemorrhage! and! hepatocellular!changes!(321).!A!local!Liver!Injury!Score!was!developed!for!this!study,!based!on!the!NASH!Clinical!Research!Network!Scoring!System!Definitions!set!out!by!Kleiner!et#al!(162),!with!some!modifications!to!include!other!potentially!pertinent!histological!changes!(see!Table!4.1).!!!! !
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Table'4.1'Parameters'assessed'in'liver'biopsy'
!NAFLD!Activity!Score! (1)!+!(2)!+!(3)!Liver!Injury!Score! ! (3)!+!Sum![(5)!to!(16)]!
Item Description Score 
















Few balloon cells 








<2 foci /200X field 
2-4 foci /200X field 











Perisinusoidal or periportal 








5. Portal Inflammation 
 
None to minimal 
Greater than minimal 
0 
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Occasional, after scrupulous search  
Scattered, easily seen 
Scattered in most lobules 


















Occasional, after scrupulous search  
Scattered, easily seen 
Scattered in most lobules 



















Present (look in 10 high power fields) 
0 
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4.4.6$Safety$Variables$One!of! two!experienced!Consultant!Anaesthetists! looked!after!participants! intra(operatively! for! the! duration! of! their! general! anaesthetic.! ! They! had! continuous!monitoring! of! vital! signs,! including! cardiorespiratory! parameters,! together! with!the! clinical! status! of! the! patient.! ! Medications! used! for! general! anaesthesia!included! remifentanil,! sevofluorane,! fentanyl! and! morphine,! rocuronium,!glycopyrrolate!and!propofol.!!!!Post(operatively,! participants!were! nursed! on! either! a! High(dependency! Unit! or!General! Surgery!Ward! by! an! experienced! medical! and! nursing! team,! under! the!supervision!of!a!Consultant!General!Surgeon!in!King’s!College!Hospital.!!There!was!round(the(clock! full! access! to! a! range! of! support! services,! including! radiologists!and!critical!care!physicians.!!The!ward!nursing!and!medical!teams!continuously!supervised!patients’!recovery.!!Daily! morning! ward! rounds! were! conducted,! as! well! as! ad(hoc! reviews! as!appropriate.! ! Daily! monitoring! of! renal! and! liver! function! and! haematological!indices!was!performed!as!part!of!standard!care.!!Where! adverse! events! occurred,! the! supervising! Consultant! Surgeon! was! made!aware!of!any!problems!and!directly!involved!in!the!response!to!these!issues,!as!and!when!they!arose.!!Adverse!events!were!defined!in!advance!in!the!protocol!and!are!listed!in!Appendix!2.!!!!! $
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4.4.7$Adverse$events$$N(acetylcysteine! has! a! good! safety! profile.! ! Hypersensitivity! reactions,! including!transient! rash! and! bronchospasm,! are! recognised.! ! Participants! in! the! treatment!will!be!under!general!anaesthetic!when!they!receive!N(acetylcysteine!infusion.!!Weight! loss! surgery! carries! a! risk! of! complications! (approximately! 10%).! ! The!commonest! complications! include! post(operative! chest! infection,! wound! site!infection,!haemorrhage!and!anastomotic!leak.!!See!Appendix!B1.3!for!full!list.!!!These!were!recorded!as!Adverse!Events.! !They!were!not!reported!as!SAEs!unless!they!fulfilled!the!criteria!for!SAEs.!
4.4.7.1$Treatment$Stopping$Rules$Individual! participants! who! developed! a! serious! adverse! reaction! to! N(acetylcysteine!during!the! infusion,!had!the! infusion!terminated.! !This!occurred!in!one!patient,!whose!demographic!data! is! included! in!the! final!analysis!of! the!trial,!but!whose!other!laboratory!data!is!not!included!as!she!did!not!undergo!any!of!the!other!interventions.!!
4.4.8$Data$Quality$Assurance$Outcome! measures! were! recorded! where! appropriate! in! the! case! report! forms.!!Laboratory! values! of! biomarkers! and! other! measures! were! recorded! on! Excel!Spreadsheets! using! anonymised! patient! identification! numbers! and! timepoints.!!All!recordings!were!made!contemporaneously.!!Cross!checking!of!data!points!with!the!original!machine!outputs!in!the!laboratory!was!performed!in!conjunction!with!laboratory! colleagues.! ! No! external! auditing! process! or! data! verification! was!undertaken! as! it! was! felt! that! the! overall! volume! of! data! was! of! a! small! and!manageable!scale.! ! In!any!case,! there!was!no! funding!source! for!such! third!party!involvement.!! $
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4.4.9$Data$Handling$and$Storage$Data!was!stored!on!a!Microsoft!Excel!Spreadsheet.!!Personal!data!was!stored!securely!on!password(protected!workstations!within!the!office! of! the! Principal! Investigator! at! King’s! College! Hospital! and! was! only!accessible!to!the!research!team.!!All!data!were!anonymised!before!analysis.!!!Patients’!samples!were!stored!in!a!coded,!anonymised!form!within!the!Institute!of!Liver!Studies,!according!to!the!guidelines!set!out!by!the!Human!Tissue!Act!(2004).!
4.4.10$Sample$size$calculation$In! a! previous! study,! the! AST! increased! significantly! from! baseline! (24±6)! and!peaked!at!24!hours!after!laparoscopic!(152!SD±!102!U/L)!and!open!(231!SD±!518!U/L)! RYGB! but! there!was! no! significant! difference! in! AST! levels! between! study!groups[Nguyen!et#al,!2003!(229)].!!!In!order!to!conduct!a!study!with!80%!power!to!detect!a!50%!reduction!in!the!post(operative! rise! in! AST! in! relation! to! placebo! in! the! population! of! laparoscopy!patients,! assuming! an! increase! in! AST! level! of! 128! U/L! and! a! pooled! standard!deviation! of! 100! U/L,! the! 50%! reduction! corresponds! to! an! effect! of! size! 0.64!which! yields! a! sample! size! of! 40! patients! in! each! of! the! two! groups,! that! is! 40!patients!in!control!and!40!NAC(infused!patients.!! !
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4.4.11$Statistical$Analysis$Statistical!analyses!were!performed!using!SPSS!20!(SPSS,!USA).!A!planned!interim!analysis!was!performed!after!2!years,!at!which!point!it!became!apparent!that!various!methodological!flaws!in!the!design!of!the!trial!meant!that!a!meaningful! result! would! be! unlikely,! even! if! more! patients! were! enrolled.! ! The!reasons!for!this!conclusion!are!discussed!below.!!Demographic!data!and! intra(operative!variables!were!compared!between!groups!using!independent!samples!t(test!for!normally!distributed!data!and!Fisher’s!exact!test! for! dichotomous! categorical! variables.! ! Complications! between! groups!were!compared!using!Pearson(Chi!square!test.!!The!assumption!of!normality!was!tested! for!ALT,!AST,!WCC,!Platelets!and!CRP!at!baseline!using!the!Shapiro(Wilk’s!test!(p>0.05).!!These!parameters!were!normally!distributed! at! baseline.! ! Outliers!were! also! found! in!many! of! the! parameters,! as!assessed!by! inspection!of! a!boxplot.! ! These!outliers!were! left! in! the! comparison.!!Two(way!ANOVA!using!time!and!treatment!group!as!fixed!factors!was!not!possible!as! the! variances!were!unequal.! ! Thus,! independent! samples! t(tests!were!used! to!compare!values!between!groups!at!the!various!timepoints,!with!significance!set!at!p<0.05.! !A! secondary!analysis!of! changes! in!parameters!over! time!within!groups!was!performed!using!repeated!measures!ANOVA.!!Post(hoc!comparisons!between!different!timepoints!were!performed!after!applying!a!Bonferroni!correction.!!Area! under! curve! (AUC)! for! each! parameter!was! also! calculated! to! give! a!more!general! measure! of! the! post(operative! change.! ! AUC! was! estimated! using! the!trapezoid!rule,!dividing!each!timepoint!into!a!series!of!strips,!calculating!the!area!of!the!strips!(average!height!X!width,!which!was!set!at!1),!and!calculating!the!sum!of!the!areas!(322).! !The!assumption!of!normality!was!satisfied!using!the!Shapiro(Wilk’s!test!and!the!independent!samples!t(test!was!employed!to!assess!differences!between!groups.!!For! completeness,! a! sensitivity! analysis!was! employed! by! comparing! the! groups!using!non(parametric!Mann(Whitney(U!tests,!and!independent!samples!t(test!with!and!without! the! removal! of! outliers.! ! The! results!were! similar! to! the!parametric!
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Allocated to control group (n= 10) 
♦!Received allocated intervention (n= 
10)!
♦!Did not receive allocated intervention 
(n=0)!
Excluded  (n= 0) 
♦!!!Not meeting inclusion criteria 
(n=0) 
♦!!!Declined to participate (n= 0) 
♦!!!Other reasons (n=0) 
Analysed  (n= 9) 
♦!Excluded from analysis (n= 1) 
       Only demographic data available 
 
  
Allocated to intervention (n= 10) 
♦!Received allocated intervention (n= 9)!
♦!Did not receive allocated intervention  
due to anaesthetic problems (n=1)!
 
Analysed  (n= 10) 





Lost to follow-up (n= 0) 
Discontinued intervention (n=0) 
 
Lost to follow-up  (n= 1) 
Went another hospital after 4   
months 
Discontinued intervention (n= 0) 
Assessed for eligibility (n= 20 ) 
Follow2Up)
Randomized (n= 20) 
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 Control (n=10) Mean (n=9) 
Liver Retraction Time (min) 94.6 ±12.6 86.1 ±8.4 
Operation Time (min) 134.3 ±17.2 121.9 ±8.8 
Blood Loss (ml) 165 ±40.2 216.7 ±35.4 
Length of Hospital Stay (days) 7.1 ±0.7 7.0 ±1.0 !
!109!
4.5.2.2$Serious$Adverse$Events$
Complications are classified and tabulated according to the Clavien-Dindo grading in 
Table 4.5  (324).  Of 20 patients, 10 patients had significant complications, meeting 
criteria for Serious Adverse Events.  1 patient had a post-operative haemorrhage 
requiring further surgery on the evening of LSG, followed by readmission and further 
surgery for a staple line failure on post-operative day 13.  He was treated in-hospital for 
a further 8 weeks to allow the leakage and intra-abdominal infection to resolve. 1 
patient required a 2-unit blood transfusion post-operatively, after a fall in haemoglobin 
on the evening after surgery. 1 patient was treated in with non-invasive ventilator 
support on the high dependency unit for post-operative respiratory difficulties.  This 
was predicted pre-operatively given the patient’s history of obesity hypoventilation 
syndrome and severe sleep apnoea and resolved within 48 hours without significant 
sequelae.   4 more patients were readmitted within 30 days of discharge.  1 patient 
became dehydrated following an episode of diarrhoeal infection and was readmitted for 
rehydration.  2 patients were also readmitted over concerns about poor oral intake and 
were rehydrated intravenously.  1 patient fainted on post-operative day 22 and was 
readmitted as a precaution.  Pre-operatively, that patient had been taking three 
antihypertensive medications and these were stopped following readmission.   
1 patient was readmitted 3 months following surgery with poor oral intake.  Following a 
period of rehydration, she was discharged but was subsequently admitted two weeks 
later to a hospital elsewhere with confusion and leg weakness and was diagnosed with 
Wernicke’s encephalopathy, brought on by poor nutritional intake. 
 
2 further patients were reported as Serious Adverse Events, although they did not suffer 
complications per se. 1 patient was admitted to a different hospital to have an ovarian 
cystectomy 4 months post LSG.  Another patient fell pregnant 5 months post LSG and 
went on to have an uncomplicated pregnancy and gave birth to a healthy baby. 
 
1 patient in the treatment group developed respiratory difficulties after intubation, with 
evidence of high airway pressures and possible laryngospasm.  A decision was taken to 
terminate the procedure immediately and she recovered with sequel and left hospital the 
same evening.  This was reported as an Adverse Drug Reaction as such respiratory 
complications might occur after NAC infusion, although the attending anaesthetic team 
was not completely convinced this was due to NAC.  The patient underwent LSG 
(outside of the study) 6 months afterwards without complication. 
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4.5.2.3$Adverse$Events$
As expected in a group of morbidly obese patients undergoing major abdominal 
surgery, there was a high rate of adverse events without any lasting clinical significance.  
Most patients had post-operative pain and nausea, along with transient episodes of 
tachycardia, pyrexia and signs of basal atelectasis.  Although these were classified as 
adverse events for the purpose of trial reporting, they are not termed as such in this 
evaluation. 
1 patient developed meralgia paraesthetica diagnosed following discharge.  It is likely 
that compression of the lateral cutaneous nerves of the thigh occurred whilst recumbent 
during the initial post-operative recovery period.  The patient required treatment with 
neuromodulating analgesia and recovered over the next few months.  A full list of 
adverse events for each patient is given in Appendix B1.6 (Table B.1). 
 
Lengths of stay were similar, although 1 patient from each group did have prolonged 
readmissions within the reporting period, as detailed above. !!!! !
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Table'4.5'30'day'Complications'by'ClavienMDindo'Classification'(324)'
Qualitative!makeCup! of! each! group!was! compared! by! ChiCsquare! test.! No! significant!























































































































Grade&5:&Death&of&the&patient& & 0& 0&!
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Curve! (AUC)! values! from! baseline! to! the! fourth! day! were! calculated! using! the!
trapezoidal! rule.! ! Fold! change! values!were! calculated! as! ratio! of! timepoint/baseline!
value.!Fold!changes!were!not!normally!distributed!(ShapiroCWilks!test,!p<0.05).!!MannC
WhitneyCU! test! was! used! to! compare! treatment! groups.! ! All! comparisons! were!
statistically!nonCsignificant!(p>0.05).!!!
Normal! ranges! of! values:! Alanine! aminotransferase! (ALT)! 5! –! 55! IU/L;! Aspartate!
Transaminase!(AST)!10!–!50!IU/L;!White!Blood!Cell!Count!(WCC)!4.0!–!11.0!x109/L;!CC
reactive!protein!(CRP)!<5!mg/L;!Platelet!count!(PLT)!150!–!450!x109/L!!! $
! Parameter! Control!(n=10)! NAC!(n=9)!
! Mean!±!SEM!
Pre7operative!values! ! !
! ALT!(IU/L)! 33!±4! 30!±5!
! AST!(IU/L)! 28!±2! 26!±3!
! WCC!(x109/L)! 8.6!±0.7! 10.3!±1.3!
! CRP!(mg/L)! 15.6!±3.1! 17.5!±4.8!
! PLT!(x109/L! 341!±32! 301!±17!
Area!under!curve! ! !
! AUC!ALT! 4058!±1099! 3034!±662!
! AUC!AST! 2869!±690! 2125!±350!
! AUC!WCC! 224!±16! 237!±32!
! AUC!CRP! 1302!±249! 1513!±399!
! AUC!PLT! 6060!±595! 5155!±243!
Fold!changes! ! !
! ALT!FC!at!1hour! 5.66!±0.9! 5.36!±0.7!
! ALT!FC!at!24!hours! 7.78!±1.8! 6.55!±0.9!
! WCC!FC!at!1!hour! 1.88!±0.1! 1.58!±0.1!
! Peak!CRP!FC! 11.59!±2.8! 9.04!±2.4!!
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4.5.3.1$ALT$
There were no significant differences at baseline (p=0.575).  Following surgery, ALT 
rose, peaking at postoperative day 1.  The rise in ALT at the end of surgery and on post-
operative day 1 was significant (p<0.001). However there were no significant 
differences between treatment groups (see Figure 4.4).  There was a wide variation 
between subjects in both groups in the extent of the ALT rise post-operatively and the 
standard deviations and confidence intervals are correspondingly large. AUC ALT was 
calculated to give a more general measure of the post-operative rise in ALT and values 
were not significantly different between treatment groups.   !
!
Figure'4.4'Change'in'postMoperative'ALT'over'first'four'postMoperative'days.'
Values!given!as!mean!ALT! (95%!confidence! intervals)! IU/L.!No! significant!differences!
between!timepoints!(p>0.05).!! $
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4.5.3.2$AST,$WCC,$Platelets,$CRP$Data! are! also! presented! for! changes! in! AST,!WCC,! CRP! and! Platelets! (see! Figure!4.5).! ! Again,! these! demonstrate! a! lack! of! any! significant! differences! between!groups.! ! There! is! a! significant! rise! in! AST! and! WCC! between! baseline,! end! of!surgery!and!day!1!(p<0.001).!!CRP!lags!behind!and!rises!significantly!on!days!1!and!2!(p<0.001),!when!it!then!reaches!a!plateau,!before!falling!off!more!slowly.!!Platelet!account!appears!to!be!depressed!on!day!1!and!day2!from!baseline!(p<0.01).!
!
Figure'4.5'Changes'in'AST,'WCC,'CRP'and'Platelets'over'4'postMoperative'days.'














































BMI'' 0.441' 0.269' @0.035' 0.312' @0.44' @0.086' .551*'
Blood'Loss' 0.063' 0.122' .534*' .515*' 0.323' .682**' @0.011'
Liver'retraction'time' 0.262' 0.378' .499*' .463*' 0.353' .841**' 0.132'
NAS'at'start' .637**' .586**' 0.243' 0.244' @0.194' @0.075' 0.099'
Fibrosis'score'at'start' 0.307' 0.248' 0.379' 0.135' @0.135' @0.054' 0.118'
Difference'in'Start'
and'End'Injury'Scores' 0.301' 0.442' @0.082' @0.069' @0.143' 0.18' @0.205'!
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4.6.1$The$effect$of$NAC$on$liver$function$and$liver$histology$During!laparoscopic!bariatric!surgery,!the!combination!of!pneumoperitoneum!and!mechanical! liver! retraction! causes! hepatocellular! injury.! ! These! results!demonstrate! that! by! the! end! of! surgery,! a! five(fold! increase! in!ALT!occurs.! ! The!injury! peaks! by! the! first! post(operative! day.! ! The! elevation! is! associated!with! a!concomitant! elevation! in! WCC,! whilst! CRP! takes! longer! to! rise,! peaking! by! the!second! post(operative! day.! ! There! is! great! patient(to(patient! variation! in! the!degree!of!post(operative!elevation.!!This! is!the!first!report!of!the!use!of!NAC!or!any!other!antioxidant!as!a!method!of!attenuating!intra(operative!liver!injury!in!morbidly!obese!patients.! !The!rationale!for!this!study!was!based!on!evidence!in!our!unit!that!NAC!lead!to!improvement!in!measures!of!quality!and!metabolic!function!of!hepatocytes!isolated!from!steatotic!livers.! ! The! administration! of! NAC! in! the! perioperative! period! did! not! have! a!significant! effect! on! post(operative! parameters.! ! There! were! no! significant!differences!between!treatment!groups!in!ALT,!AST,!WCC,!CRP!and!platelet!counts.!!!!The!locally!developed!liver!injury!score!was!used!to!demonstrate!that!histological!changes!did!occur!during!surgery,!and!the!change!in!injury!scores!due!to!surgery!was!statistically!significant,!although!the!rise!in!score!was!only!on!average!1!point.!!Junnarkar! et# al! used! bucillamine! in! a! rat! model! of! liver! ischaemia(reperfusion!injury!(325).!Buccilamine!is!also!a!thiol!donor!like!NAC!and!acts!as!an!antioxidant!by! increasing! intracellular! levels! of! glutathione.! ! They! employed! the! previously!published! Suzuki! score! of! histopathological! changes! of! necrosis,! vacuolation! and!ballooning!to!assess!liver!injury!(326).!!We!incorporated!these!features!in!a!more!comprehensive! score,! although! congestion! and! vacuolation! were! the! most!important! determinants! of! injury! score! in! our! study! population.! ! To! the! best! of!one’s!knowledge,!there!are!no!other!reports!of!serial!intraoperative!liver!biopsies!in! humans! and! these! results.! ! Although! the! left! liver! lobe! looks! discoloured! and!blueish! after! the! removal! of! the! liver! retractor,! these! results! demonstrate! that!histopathological!changes!at!that!point!are!limited.!!These!results!corroborate!the!findings!by!Alexakis!et#al,!who!found!in!their!11(parameter!score!that!the!majority!
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of!individual!scores!were!0!or!at!most!1/3,!with!mean!scores<1!(232).!!These!data!show!that!histological! changes!due! to!pneumoperitoneum!are!subtle.! !Given! that!markers!of!liver!injury!and!inflammation!continue!to!rise!on!post(operative!days!1!and!2,!it!is!likely!that!further!histopathological!changes!may!become!discernible!at!later!timepoints.!!Of!course,!it!would!neither!be!safe!or!ethical!to!obtain!liver!tissue!after! the! patient! leaves! the! operating! theatre! in! a! clinical! setting.! ! Therefore,!circulating!markers!of!liver!injury!are!more!useful!in!this!context.!!NAS! score! correlated! strongly! with! the! AUC! of! ALT! and! AST,! confirming! that!patients!with!higher!grades!of!NAFLD/NASH!are!vulnerable!to!more!hepatocellular!damage!(181,$211).!!However!operating!and!liver!retraction!times!did!not!directly!correlate! with! ALT! or! AST! levels! but! there! was! a! correlation! between! Log10!transformed!operating!time!and!the!24!hour!ALT!fold!change,!which!is!in!keeping!with! other! published! findings!(27,$ 272).! ! Liver! retraction! times! correlated!with!AUC(CRP,!indicating!that!inflammatory!response!is!associated!with!liver!injury.!!
4.6.2$Clinical$outcomes$of$NAC$Trial$The!trial!was!not!powered!to!detect!differences!in!clinical!outcomes.!!In!general,!a!BMI! >60kg/m2! is! associated! with! higher! risk! of! complications! following!gastrointestinal!surgery.! ! !Although!the!rate!of!life(threatening!complications!was!low,! there! were! a! number! of! complications.! One! out! of! 19! (5%)! patients! had! a!staple! line! leakage.! ! Published! rates! of! leakage! are! between! 1! and! 7%,! with! a!recent! large! series! reporting!a! rate!of!2.8%! !(327).!One!other!patient! required!a!post(operative!blood!transfusion.!!The!long!staple!line!needed!when!resecting!the!stomach! is! a! risk! factor! for! both! bleeding! and! leakage! in! LSG.! ! ! Other! recorded!complications!were! not! directly! related! to! surgery! itself.! ! Readmission! rate!was!high! (4/20),! and! may! reflect! the! high(risk! nature! of! the! super(obese! cohort! of!study!participants.! !Only!one!patient!had!a!complication!possibly!related! to!NAC,!and!this!complication!was!short(lived!and!self(limiting.!!NAC!has!been!widely!used!in!different!patient!populations! and!has! a! good! safety!profile.! ! This! is! part! of! its!attraction!as!a!potential!treatment.!!!!
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The! study! groups! were! well! matched,! with! similar! demographic! parameters,!although!there!was!a!higher!incidence!of!NASH!in!the!NAC!group.!!There!was!a!high!incidence!of!other!obesity(related!complications,!especially!diabetes,!hypertension,!hypercholesterolemia! and! obstructive! sleep! apnoea.! ! Operating! times! and!intraoperative!blood! loss!were!also!not! significantly!different.! !Baseline!outcome!measures!were!also!similar!between!groups,!except!for!platelet!count,!which!was!non(significantly! but! persistently! higher! in! the! NAC! group.! ! Given! that! the!difference!was!present!at!baseline,!it!is!likely!this!is!a!chance!finding.!!!!
4.6.3$Limitations$of$study$A!major! drawback! of! the! study!was! a! lack! of! a! standardised,! reproducible! toxic!insult! to! the! liver! during! intraoperative! liver! retraction.! ! The! Nathanson! liver!retractor!was!placed!during!surgery!to!allow!adequate!visualisation!of! the!hiatus!for!surgery!to!proceed!safely.!!The!pressure!applied!to!liver!varied!from!patient!to!patient!depending!on!their!body!habitus,!intraabdominal!dimensions!and!size!and!texture! of! the! liver.! ! There! are! no! routine! clinical! methods! of! measuring! tissue!oxygen!tension!or!pressure!within!the!liver.!!Some!experimental!methods!do!exist,!including! insertion! of!microdialysis! catheters! to! allow! continuous!monitoring! of!metabolites,!such!as!lactate,!or!of!tissue!pO2!and!pCO2.!!It!is!also!possible!to!use!a!surface!oxygen!saturation!probe!(328),! although! this!does!not!have!approval! for!routine! clinical! use! and!would! itself! have! required!new!MHRA(UK)! approval! for!use! as! a! medical! device.! ! Other! authors! have! used! laser! Doppler! imaging! to!measure! end(organ! perfusion! but! there! are! no! approved! devices! for! clinical! use!and!the!only!published!studies!are!in!animal!studies!or!isolated!perfusion!models.!!In! terms! of! commonly! used! measures! of! liver! perfusion,! measurement! of!indocyanine! green! (ICG)! clearance!using! a! transcutaneous! external! probe! allows!determination!of!plasma!disappearance! rate!of! ICG!and! the! retention! rate!of! ICG!after! 15minutes!(329).! ! These! parameters! estimate! liver! perfusion! and! liver!excretory! capacity,! giving!a! functional!measure!of! global! liver! function.! !There! is!one!human! study!measuring! liver!perfusion! at! two!different!pneumoperitoneum!pressures! during! laparoscopic! cholecystectomy!(258).! ! A! 14mmHg!pneumoperitoneum! is! associated! with! a! statistically! significant! decrease! in! ICG!plasma!disappearance!rate!by!the!end!of!the!operation.!!However,!the!significance!
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of!this! is!questionable,!and!in!contrast!Hoekstra!et#al!showed!in!a!pig!model!that!ICG! clearance! increases! during! pneumoperitoneum,! suggesting! a! compensatory!increase!in!global!liver!perfusion!(234).!!Therefore,!it!is!open!to!question!whether!ICG! clearance! would! be! a! useful! method! of! quantifying! liver! ischaemia! in! the!present!study.!!!!There!were!a!number!of!other!limitations!in!the!methodology.!!The!trial!design!was!deliberately!pragmatic!and!therefore!patients!were!not!stratified!by!their!other!co(morbidities! and!allowed! to! continue! their! regular!medications.! !Eleven! (58%)!of!patients! completing! the! study! were! taking! cholesterol(lowering! medications,!including! various! statins! and! fenofibrate.! ! These! drugs! are! known! to! cause! liver!dysfunction!(330),! although! it! should!be!noted! that!all!patients!had!normal! liver!function!at!baseline.!!Similarly!inhalational!anaesthesia!may!have!an!effect!on!post(operative! liver! function,! due! to! their!metabolism! in! the! liver! and! their! effect! on!hepatic! blood! flow!(331).! ! The! dosage! of! anaesthetic! drugs! used! varies! from!patient! to! patient! and! between! anaesthetists,! creating! another! confounding!variable.! ! Conversely,! sevofluorane! may! offer! a! protective! effect,! as! a!pharmacological!postconditioning!agent!as!demonstrated!in!a!randomised!trial!of!patients!undergoing!liver!resection!(332).!!Beyaz!et#al!investigated!the!use!of!NAC!in! patients! undergoing! laparoscopic! gynaecological! surgery! under! isofluorane!anaesthesia.! ! Contrary! to! their! rather! misleading! conclusions,! they! noted! no!significant! differences! in! post(operative! liver! function! tests! between! groups! and!indeed! both! groups! had! lower!ALT! and!AST! levels! after! surgery! compared!with!baseline.! ! Simvastatin! may! protect! the! liver! and! suppress! caspase(mediated!apoptosis!(333).! ! The! study! participants! were! all! in! the! super(morbidly! obese!category!and!at!greater!risk!of!peripheral!skeletal!muscle! injury,!which!may!also!contribute! to! some! of! the! transaminase! rises! although! no! patients! had! clinical!evidence! of! rhabdomyolysis!(334).! ! ! Post(operative! oral! administration! of!methylene! blue,! as! a! method! of! diagnosing! a! staple! line! leak,! may! also! have!affected!the!results!as!methylene!blue!has!well!known!anti(oxidant!effects!!(335).!!In!this!study,!the!timing!of!the!injury!to!the!liver!was!intraoperative.! ! !Taking!the!results!presented!here!which!show!peak!transaminase!rise!on!post(operative!day!1!together!with!other!evidence!from!the!ischaemia(reperfusion!injury!literature,!it!is!
!123!
likely!that!the!effects!of!liver!retraction,!due!to!compression!and!ischaemia,!might!persist!for!up!to!12!and!perhaps!more!than!24!hours!after!surgery!(179).!!It!could!be! argued! that! a! one(off! infusion! of!NAC! is! insufficient! to! counteract! this! injury.!!Many!animal!models!investigating!NAC!and!IRI,!infusion!continued!for!more!than!6!hours!(309).! ! In! other! trials! investigating! NAC! in! an! acute! setting,! infusion!was!continued! for! much! longer:! 24! hours! after! aortic! aneurysm! surgery!(336),! 48!hours! for! critical! care! patients! who! were! hypotensive!(337)! and! for! 7! days! in!patients!with!severe!acute!pancreatitis!(294)! and!acute! liver! failure!(338).! ! !The!volume! of! carbon! dioxide! gas! or! the! actual! measured! intraoperative!pneumoperitoneum!pressures!(as!opposed!to!merely!the!setting!on!the!insufflator!machine)!were!not!recorded!in!this!study!and!variations!in!flow!and!pressure!may!have! differentially! affected! hepatic! blood! flow!(339).! ! ! Measurement! of!intraoperative!and!post(operative!lactate!levels!may!have!been!a!useful!marker!of!overall!acid(base!balance!and!end(organ!tissue!perfusion!.!!
4.6.4$Potential$sources$of$bias$in$this$trial$The! method! of! allocation! to! study! groups,! using! sealed! envelopes! and! block!randomisation,! can! be! criticised! and! presents! a! higher! risk! of! bias! than! other!potential!methods!(340).! ! ! The!difficulties!of!minimising!bias! in! surgical! trials! is!well! known!(341).! It! was! not! possible! to! use! a! third! party! for! control! of!randomisation!due!to!lack!of!funds.!!Nevertheless,!the!primary!outcome!measures!are!objective!laboratory!assays!that!are!at!low!risk!of!bias.!!In!this!study,!it!was!not!feasible!to!use!a!placebo!infusion!for!NAC!due!to!lack!of!access!to!such!an!infusion.!!More! importantly,! NAC! is! administered! after! dilution! in! 1! litre! of! 5%! dextrose!solution! and! a! plain! dextrose! infusion!was! not! given! to! the! control! group.! ! This!may! have! been! another! confounding! factor.! ! Dandona! et# al! found! that! glucose!infusion! in! patients! with! diabetes! induced! oxidative! stress! within! 6! hours! of!administration!(342).!!!!The!most!important!factor!in!the!interpretation!of!the!results!is!the!small!sample!size!and!premature!closure!of!the!trial.!!The!trial!was!stopped!early!after!a!planned!interim! analysis! due! to! a! number! of! factors.! ! Rate! of! recruitment! over! the! two!years!was! low.! !Following! initiation!of! the! trial,!other!studies! in! the!surgical!unit!
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were! recruiting! patients! specifically! for! Roux(en(Y! gastric! bypass.! Laparoscopic!AGB! was! increasingly! performed! as! day(case! procedures,! which! meant! that!potential! participants! could! not! complete! the! other! study(specific! interventions.!This!meant!these!two!groups!of!patients!were!no!longer!available!for!recruitment.!!At!the!ongoing!rate!of!accrual!to!the!trial,! it!may!have!taken!many!more!years!to!reach!the!stipulated!sample!size.!!Analysis!of!the!primary!outcome!measures,!especially!ALT!and!AST,!along!with!the!cytokines!and!markers!of!oxidative!stress,!showed!a!large!variation!in!values.!!This!is! likely! to!be!multi(factorial.! !Reasons! for! the!variation! include! the!variability!of!the!degree!of!compression!and! ischaemia! induced!by! liver!retraction,! the!groups!were! not! stratified! by! liver! pathology! or! other! co(morbidities! and! the! inherent!unpredictability! in! the!variation!of! the! inflammatory! insult! for!each!patient.! !For!example,!Nguyen!et#al!also!reported!very!large!variation!in!the!peak!post(operative!ALT!after!RYGB!(mean!152!SD±!102!U/L)!(229).! !In!a!larger!sample!size,!the!bias!introduced!by!this!variability!would!have!been!offset!by!the!randomisation!to!each!study!group.!!However,!taking!into!account!the!other!issues!discussed,!the!opinion!of! the! trial! steering!committee!was! that! these! limitations!could!not!be!overcome!within! the! framework! of! the! existing! trial! design! and! that! further! recruitment!would!likely!be!futile.!!As!a!result!of!early!stoppage,!the!study!is!underpowered!and!there!is!a!risk!that!this!negative!result!is!a!Type!II!statistical!error!(inferring!NAC!was!ineffective!in!reducing!hepatocellular!injury!when!it!is!in!fact!effective).!!Given!that! there! were! more! Grade! 3! complications! in! the! NAC! group,! it! may! also! be!possible! that! administration! of! NAC! lead! to! worse! clinical! outcomes.! ! Again,! a!larger!trial!would!have!addressed!this!question!more!robustly.!!!! $
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5.1$Introduction$The!pathophysiologies!of!obesity(induced!inflammation!and!oxidative!stress!have!been!discussed!in!Chapter!1!and!2,!along!with!the!particular!concerns!about!fatty!liver! disease.! Chapter! 3! covers! the! pathophysiological! effects! of!pneumoperitoneum! and! the! potential! effects! of! liver! retraction! in! triggering! an!ischaemia(reperfusion!injury.!!The!clinical!outcomes!of!the!NAC!trial!are!detailed!in!Chapter!4.!!This!chapter!includes!the!secondary!non(clinical!measures!evaluated!in!the! context! of! the! NAC! trial.! ! More! detail! is! given! of! the! particular! cytokines,!biomarkers! and! other! assays! used! in! evaluating! the! inflammatory! and! oxidative!stress! response!after! surgery.! !These!markers!have!been!discussed!previously! in!the! context! of! the! various! pathophysiological!mechanisms! of! disease! previously.!!The! laboratory! methods! described! in! this! chapter! will! also! pertain! to! the!longitudinal!studies!described!in!subsequent!chapters.!
5.2$Background$
5.2.1$Assessment$of$liver$injury$Ischaemia! and! ischaemia(reperfusion! injury! mediate! their! effects! through! the!production!of!reactive!oxygen!species,!leading!to!direct!cellular!damage,!oxidative!stress!and!production!of!pro(inflammatory!stimuli!!(343).!!In!turn,!this!can!trigger!the! systemic! inflammatory! response.! ! Hepatocellular! injury! leads! to! a! local!response! as! well,! creating! a! pro(inflammatory,! pro(fibrogenic! environment! (see!Figure!5.1).!!Both!systemic!and!local!changes!can!be!detected!in!the!serum!(344),!using! biomarkers! for! inflammation! (including! interleukins! 6! and! 10,! tumour!necrosis! factor! alpha,!C(reactive!protein),! fibrosis! (for! example,!hyaluronic! acid),!oxidative! stress! (including! lipid! peroxidation! status,! glutathione! enzymes)! and!apoptosis!(for!example!cytokeratin!18,!Fas!ligand).!!The!expression!of!genes!within!
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the!liver!controlling!these!processes!of!inflammation,!fibrosis,!oxidative!stress!and!apoptosis! can! be! analysed! using! molecular! biology! techniques,! including!quantitative! real(time! polymerase! chain! reaction! and! microarray!technology!!(345).!
$$
Figure' 5.1' Summary' of' the' cellular' processes' involved' in' liver' injury' that' leads' to'
nonMalcoholic'steatohepatitis'(adapted'from'Wieckowska'et#al,'2007)''(344).'''
Hepatocyte! steatosis! is! a! prerequisite! for! the! subsequent! events! that! lead! to! liver!
injury!and!fibrosis.!!
$Obviously,! it! would! be! impractical! (and! unaffordable)! to! measure! all! potential!markers!used!in!the!literature.!!When!designing!these!studies,!a!range!of!markers!has! been! selected! to! exemplify! and! account! for! the!main! processes! in! question:!inflammation,!oxidative! stress!and!hepatocyte!apoptosis.! ! Fibrogenesis! is! a!more!chronic! process! and! hyaluronic! acid! has! been!measured! over! longer! timepoints,!and! this! is! described! in! Chapter! 6.! ! It! was! also! not! possible! to! perform!comprehensive!molecular!biology!studies!of!the!samples!taken!in!the!NAC!trial!as!part! of! this! thesis! but! a! ‘proteomic(style’! approach!was! adopted! in!measuring! a!range!of!apoptosis(related!proteins,!as!described!below.!
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5.2.3.1$TNFα$$This! is! the! classic! obesity! associated! pro(inflammatory! cytokine! and! was! first!associated! with! obesity! and! insulin! resistance! more! than! 20! years! ago!(348).!!Evidence! for! its! effects! comes! from! various! knockout!mouse!models! and! cross(sectional! clinical! studies! of! obese! subjects!(346).! ! TNFα! is! present! in! low!
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concentrations! in! normal! weight! subjects! and! is! increased! in! both! T2DM! and!NAFLD!(139).! ! It! is! secreted!by!macrophages!and!other! immune!cells!within! the!adipose! tissue! and! liver!(90).! ! Its! mechanism! of! action! is! through! two! TNFα! –receptors.!!Three!different!intracellular!pathways!are!associated!with!TNFα!(349).!!The! chronic! metabolic! effects! are! effected! through! phosphorylation! of! mitogen(activated!protein!kinases.!!A!series!of!further!processes!leads!to!phosphorylation!of!the!insulin!receptor,! leading!to!insulin!resistance.! !Activation!of!nuclear!factor(κβ!(NF(κβ),!a!nuclear!transcription!factor,!leads!to!phosphorylation!and!transcription!of! a! number! of! nuclear! proteins! involved! in! cell! survival! and! proliferation,!inflammatory!response!and!anti(apoptosis!mechanisms.! !Finally,!TNFα!has!a!role!in!death!receptor!activation,!activating!caspase(mediated!apoptosis.! !The!balance!of!the!various!pathways!and!effects!is!not!fully!understood!but!can!be!affected!by!levels!of!other!cytokines!and!ROS.! !Clinically,! its!effects! include!stimulating!fever,!promoting! chemoattraction! to! neutrophils,! increasing! neutrophil! migration! into!tissue! by! increasing! expression! of! adhesion! molecules! on! endothelial! cells,!stimulating!macrophage!phagocytosis,!and!increasing!liver!production!of!CRP!and!other! acute! phase! response! proteins!(349).! ! ! TNFα! expression! is! stimulated! by!toxic! and! inflammatory! stimuli,! including! bacterial! endotoxins,! and! other!cytokines.!
$
5.2.3.2$Interleukin$6$IL(6! is!another!pro(inflammatory!cytokine! involved! in! the! immune!response!and!implicated!in!the!obesity(related!pathogenesis!of!insulin!resistance!and!NAFLD,!as!well! as! other! auto(immune! and! chronic! inflammatory! diseases!(346).! ! It! is!released! by! immune! cells! and! increased! levels! in! adipose! tissue! are! found! in!obesity!(347).! ! It! is! an! important! mediator! of! the! inflammatory! response,! and!stimulates! fever!and!production!of!CRP!by! the! liver.! !CRP! is! involved! in!humoral!immunity,! binding! to! dead! cells! and! bacteria! and! activating! the! complement!system!(90).! !Elevated! IL(6! is!associated!with!a!number!of!chronic! inflammatory!and!auto(immune!diseases,!including!systemic!lupus,!rheumatoid!arthritis,!chronic!lung!disease,!Castleman’s!disease!and!inflammatory!bowel!diseases!(350).!!!
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5.2.3.3$Interleukin$10$IL(10!is!traditionally!classed!as!an!anti(inflammatory!cytokine,!although!it!is!more!accurately! described! as! an! immunoregulator! as! it! can! stimulate! some! aspects! of!the! inflammatory! response!(351).! Low! IL(10! levels! are! associated! with! obesity,!insulin(resistance! and! hepatic! steatosis!(348).! ! Exogenous! IL(10! administration!and! knockout! models! suggest! that! inhibition! of! IL(10! production! plays! an!important! role! in! development! of! NAFLD! and! insulin! resistance!(352).! It! is!released!by!macrophages!and!other! immune!cells! in!response!to!bacterial! toxins,!catecholamine!release!and!pro(inflammatory!cytokines,! including!TNFα!(352).! !A!NF(κβ! pathway! controls! transcription! and! IL(10! itself! has! a! negative! feedback!effect! on! the! expression! of! other! pro(inflammatory! cytokines.! ! The! anti(inflammatory!hypothesis!was!supported!by!IL(10!knockout!mice!models!that!had!lethal!sequelae!of! increased! inflammatory!bowel!pathology,!and!down(regulation!of! colitis! by! administration! of! exogenous! IL(10!(353).! ! Low! IL(10! levels! are!associated! with! metabolic! syndrome! and! obesity!(347).! ! IL(10! expression! on!macrophages!in!adipose!tissue!was!increased!after!RYGB(induced!weight!loss!and!this!was!associated!with!a!decrease!in!pro(inflammatory!cytokine!and!cell!surface!marker!expression!(93).!!The!authors!of!this!study!postulate!that!changes!in!IL(10!in! adipose! tissue! reduce! macrophage! infiltration,! which! is! thought! to! be! a! key!event! in! creating! a! pro(inflammatory! state! in! obesity.! ! ! However,! there! is!increasingly! contradictory! evidence! about! the! true! role! of! IL(10,! and! it! may! be!simplistic! to! deem! it! a! purely! anti(inflammatory! cytokine.! ! Elevated! IL(10! is!associated! with! lymphoma!(352)! and! a! poorer! prognosis! after! acute! coronary!syndrome!(354).!!!!!
5.2.4$Adipocytokines$Collectively!more!than!50!cytokines!have!been!isolated!from!adipose!tissue!and!are!implicated! in! obesity! related! diseases!(355).! ! The! cytokines! that! are!predominantly!or!only!secreted!by!adipose!cells!have!been!termed!the!adipokines.!!Leptin!and!adiponectin!are!probably!the!best!known!and!most!widely!researched!and! there! is! increasing! interest! in! the! role! of! resistin! in! development! of! insulin!resistance.! ! I! will! discuss! these! in! detail.! ! There! has! been! increasing! interest! in!
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adipocytokines! in! other! acute! settings!(356).! ! Adipocytokines! may! be! useful! in!predicting!severity!and!need!for!intervention!in!acute!pancreatitis!(357).!!!
5.2.4.1$Leptin$Leptin! was! initially! seen! as! a! modulator! of! energy! homeostasis! and! thought! to!exert! its! effects! mainly! as! an! endocrine! signal!(358).! ! Leptin! levels! are!proportional!to!adipose!tissue!mass!and!therefore!very!high!in!the!morbidly!obese.!!Lately!its!role!in!the!immune!response!is!increasingly!recognised,!in!the!setting!of!acute! sepsis! and! in! chronic! inflammatory!diseases!(359).! ! Leptin! is! increased!by!other! inflammatory! stimuli,! including! pro(inflammatory! cytokines! like! IL(6! and!TNFα!and!levels!fall!after!weight!loss.!!As!well!as!centrally!regulating!appetite!and!energy!homeostasis,!leptin!has!peripheral!effects!on!the!immune!system,!including!macrophage! activation,! neutrophil! chemotaxis! and! modulation! of! T(helper! cell!differentiation.! ! Bariatric! surgery! is! associated! with! dramatic! falls! in! leptin,!potentially!because!of!loss!of!fat!depots!following!weight!loss!(59,$87,$101).!!!!
5.2.4.2$Adiponectin$Adiponectin!changes!negatively!correlate!with!weight!loss!and!are!associated!with!improved! insulin! sensitivity!(346).! ! Its! secretion! by! adipocytes! is! inhibited! by!TNFα! and! IL(6!(355).! ! It! acts! on! the! liver! to! increase! fatty! acid! oxidation! and!reduce!gluconeogenesis!and!exogenous!adiponectin!may!stimulate!lipid!clearance!from! steatotic! liver!(195).! ! Adiponectin! appears! to! exert! opposite! effects! on!immune! cells! to! pro(inflammatory! mediators,! reducing! cell! adhesion! molecule!expression,! inhibiting! production! of! TNFα! and! inactivation! of! NF(κβ! pathways.!!There! is!much! interest! in! its! anti(atherogenic! effects! and! low! adiponectin! levels!are! associated! with! vascular! complications! of! diabetes! and! the! metabolic!syndrome!(360).! ! Bariatric! surgery! is! associated! with! an! increase! in! circulating!adiponectin!levels!(361).!!!!
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5.2.4.3$Resistin$Resistin! has! been! isolated! from! adipocytes,! macrophages! and! its! expression! is!increased! in! experimental! models! of! asthma! and! inflammatory! bowel!disease!(355).! ! Resistin! levels! correlate! positively! with! BMI! and! adipose! tissue!mass! and! insulin! resistance,! although! there! are! many! conflicting! reports! of! the!exact! nature! of! this! association!(362).! ! Resistin! is! also! associated! with! a! pro(inflammatory!response,!inducing!TNFα!and!IL(6!secretion!by!activation!of!NF(κβ!in!mononuclear! cells!(355).! ! High! resistin! mRNA! expression! with! liver! tissue!correlates! with! increasing! NAFLD! activity! score! (NAS)!(363).! ! The! effect! of!bariatric!surgery!on!resistin! levels! is!not!yet!clear,!with!conflicting!results!(364).!!Post(prandial! resistin! levels! are! higher! after! LSG! than! RYGB,! suggesting! that! its!release!may!be!mediated!by!gut!hormones!and!affected!by!bypassing!the!proximal!small!bowel!(365).!!!
5.2.5$Oxidative$Stress$Markers$The! concept! of! oxidative! stress! has! been! described! earlier! and! refers! to! an!overload! of! cellular! antioxidant!mechanisms! so! that! ROS(mediated! tissue! injury!can!occur.!!Quantification!of!oxidative!stress!is!directed!at!measurement!of!known!antioxidant! compounds,! such! as! vitamins! E! and! C,! assessment! of! antioxidant!enzymatic! activity! such! as! SOD! and! GPX,! and! detection! of! byproducts! of! tissue!injury,! caused! by! lipid! peroxidation,! protein! oxidation! and! DNA! oxidation!(summarised! in! Figure!5.3)!(366).! ! Oxidative! stress!markers! are! by! their! nature!often!unstable!and!prone!to!producing!artefactual!results!due!to!inconsistencies!in!sample!procurement,!storage!and!processing.!!Thus,!there!are!significant!variation!between! studies! and!no! standardised! reference! ranges!have!been!established,! in!contrast! to!routine!clinical!parameters,!such!as!renal!and! liver! function!tests!and!full! blood! count! indices!(272).! ! In! general,! determination! of! oxidative! stress!markers! using! more! complex! methods,! such! as! high(pressure! liquid!chromatography! (HPLC)! or! mass! spectrometry! (MS),! is! more! accurate! than!enzymatic! methods.! ! Some! enzyme(linked! immunosorbent! assays! (ELISA)! have!been! developed! but! in! general,! the! byproducts! are! small! molecules! that! do! not!elicit!specific!antibody!production!(366).!!!
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Figure'5.3'Summary'of'the'effects'of'oxidative'stress'and'potential'methods'of'
measurement'(adapted'from'Grune'and'Berger,'2007)''(366)'Taking! into! account! feasibility! and! availability! in! the! unit’s! laboratories,! the!following! assays! to! measure! oxidative! stress! in! this! study:! ! thiobarbituric! acid!reactant!substances!(TBARS)!as!a!measure!of!lipid!peroxidation;!protein!carbonyls!as!a!measure!of!protein!oxidation;!SOD!and!GPX,!both!antioxidant!enzymes.!
5.2.5.1$TBARS$Following!the!production!of!excess!reactive!oxygen!species!and!other!free!radicals!due!to!oxidative!stress,!enzymatic!damage!to!cell!constituents,!including!lipids!and!protein! occurs.! ! Enzymes! such! as! myeloperoxidase! produce! toxic! acidic!compounds! including! hypochlorous! acid,! leading! to! peroxidation! of! lipids.!!Measuring!lipid!hydroperoxides!directly! is!technically!difficult.! !The!TBARS!assay!quantifies! the! concentration! of! malondialdehyde! (MDA),! the! most! abundant!product!of! lipid!peroxidase,!by!way!of! an!enzymatic! reaction!with! thiobarbituric!acid! (TBA),! producing! a! fluorescent! product! that! can! be! measured! with! a!spectrophotometer.! ! MDA! is! not! the! sole! product! of! lipid! peroxidation! and! the!TBARS! assay! is! merely! an! approximation! of! a! much! more! complex! process.!!Nevertheless,!it!remains!one!of!the!most!widely!used!measures!of!oxidative!stress.!!The! assay! is! standardised! and! reproducible.! ! A! number! of! studies! have!demonstrated! increasing! TBARS/MDA! levels! after! laparoscopic! surgery!(272).!!Bariatric!surgery!is!associated!with!significant!reductions!in!lipid!peroxidation,!as!a!consequence!of!weight!loss!and!improved!glycaemic!control!(108,$110).!!
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5.2.5.2$Superoxide$Dismutase$Superoxide!Dismutase!(SOD)!is!a!metalloprotein(based!family!of!enzymes!found!in!all!cells.! !SOD!catalyses!the!(dismutation)!reaction!of!potentially!toxic!superoxide!anion! radicals! (O2()! into! less! dangerous! oxygen! and! hydrogen! peroxide,! which!itself! is! broken! down! further.! ! Both! of! these! ROS! can! cause! lipid! and! protein!damage!(367).!!SOD!is!mainly!present!in!the!cytosol!and!its!expression!is!induced!by! oxidative! stress! and! pro(inflammatory! cytokines,! such! as! interleukin(1! and!TNFα!(368).! ! An! increase! in! SOD! levels! is! a! protective!mechanism! and! there! is!much! interest! in! therapeutic! inducement! of! SOD! expression! by! plant!extracts!(368).!!Mutations!in!SOD!genes!are!associated!with!genetic!diseases,!such!as! motor! neuron! disease,! and! reduction! in! SOD! activity! is! associated! with!development! of! various! chronic! diseases,! including! asthma! and!hypertension!(367).! !Bariatric!surgery!is!associated!with!a!reduction!in!SOD!after!6(12! months,! which! is! taken! as! a! beneficial! indicator! of! reduced! oxidative!stress!(110).! ! In! a! cross(sectional! study! of! oxidative! stress! markers! after!cholecystectomy,!SOD!activity!was!higher!at!the!end!of!laparoscopic!surgery!than!in!non(operated!controls!(369).!!!
5.2.5.3$Protein$Carbonyls$The!production!of!reactive!oxygen!and!nitrogen!species!during!periods!of!oxidative!stress!can! lead! to!damage! to!cellular!proteins.! !These!reactions!often! involve! the!oxidation! of! protein! side! chains,! forming! aldehydes! and! ketones.! ! These! are!together! referred! to! as! carbonyls,! owing! to! the! Carbon(Oxygen! groups! on! these!side!chains.! !Protein!Carbonyls!(PC)!are!very!stable!and!therefore!provide!a!good!global!measure!of!oxidative!stress.!!In!an!acute!setting,!PC!are!increased!following!laparoscopic! cholecystectomy,! with! greater! pneumoperitoneum! pressures! of!15mmHg!associated!with!larger!rises!in!PC!levels!(370).!!Morbidly!obese!patients!have!elevated!PC!compared!with!normal!weight!controls!and!fell!by!approximately!30%!6months!after!weight!loss!surgery!(371,$372).!!
5.2.5.4$Glutathione$Peroxidase$Glutathione! Peroxidases! (GPX)! are! a! family! of! cytosolic! enzymes! which! act! as!scavengers!of!hydrogen!peroxide,!converting!H2O2!to!water!by!reducing!oxidised!
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glutathione.! ! Hydrogen! Peroxide! is! a! by(product! of! SOD! and! is! produced! after!dismutation! of! reactive! oxygen! species,!which! are! generated!by! oxidative! stress.!!GPX(1! expression! in! the! livers! of! obese! patients! undergoing! bariatric! surgery!correlates!with!the!severity!of!NAFLD!Activity!Score!(NAS)!(373).!!!!
















Inducer! Of! Apoptosis,! FADD! C! FasCAssociated! protein! with! Death! Domain,! IAP! C!
Inhibitors!of!Apoptosis!!! $
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5.2.6.1$Cytokeratin$18$fragments$CK(18! is! an! intracellular! protein! expressed! in! high! levels! in! cells! of! epithelial!origin.! !Fragments!of!CK(18!are! released! into! the!circulation! following!cell!death!and! can! be! used! as! a! biomarker.! ! CK(18! is! cleaved! by! caspases! into! smaller!fragments!during!apoptosis.!!CK(18!M65!Assay!measures!the!total!level!of!CK(18!in!the!serum,!giving!a!measure!of!total!cell!death,!by!any!cause,!including!necrosis!or!apoptosis.! ! CK(18!M30! is! a! caspase(cleaved! fragment! and! the! assay! allows!us! to!measure!the!extent!of!cell!death!by!apoptosis.!!Combination!of!M65!and!M30!Assay!results! allows! a! determination! of! the! approximate! contribution! of! apoptosis! in!measuring!cell!death,!although!precise!quantification!of!this!contribution!may!not!be!possible.! !Cytokeratin(18!(CK(18)!has!been!validated!for!use!as!a!non(invasive!diagnostic!marker! of! NASH/NAFLD!(175),! although! its! clinical! utilisation! is! still!not!widespread.! ! There! is! also!much! interest! in! its! use! as! a! tumour!marker! for!various! cancers!(378)! and! as! a! prognostic! indicator! in! sepsis!(379).! ! In! liver!disease,! there! is! increasing! recognition! of! its! value! as! a! marker! of! severity! and!survival!in!acute!liver!failure!(380)!and!paracetamol(induced!liver!injury!(381).!!!!
5.2.6.2$TRAIL$Tumour!Necrosis!Factor(!Related!Apoptosis(Inducing!Ligand! (TRAIL)! is! a!widely!expressed!protein!that!is!thought!to!induce!apoptosis!in!a!variety!of!cells.!!There!is!much!interest!in!its!role!in!liver!diseases.!!Changes!in!the!balance!between!TRAIL!and!various!TRAIL!decoy!receptor!ligands!are!thought!to!affect!the!extent!to!which!TRAIL! induces! apoptosis.! ! TRAIL(TRAIL! Receptor! binding! is! an! important!upstream! part! of! the! apoptosis! pathway! leading! to! caspase(induced! protein!cleavage.!!Having!established!with!the!CK(18!M30!assay!that!a!degree!of!apoptosis(induced!cell!damage!occurs!after!surgery,!we!have!assayed!TRAIL!concentration!in!serum!to!ascertain!possible!modes!of!apoptosis.! ! .! !TRAIL!has!been! implicated! in!the! development! of! hepatic! steatosis!(382)! and! steatotic! hepatocytes! are! more!susceptible!to!TRAIL(mediated!apoptosis!(383,$384).!!!!
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5.3$Aims$and$Outcomes$Following!on!from!the!clinical!results!of!the!NAC!trial!detailed!in!Chapter!4,!the!aim!of! this! study! is! to! determine! if! administration! of! NAC! reduces! post(operative!oxidative! stress,! inflammatory! mediators! and! biomarkers! of! liver! injury! after!bariatric! surgery.! ! By! understanding! the! changes! in! these! markers,! it! may! be!possible!to!elucidate!the!main!mechanism!of!action!of!NAC!in!this!clinical!setting.!!These!results!are!the!first!time!this!combination!and!breadth!of!biomarkers!have!been!studied!in!the!first!days!after!bariatric!surgery.!!The!outcome!measures!used!in!this!study!are:!!





5.4.1$Patients$and$Interventions$Patients! were! recruited! as! part! of! the! NAC! Trial.! ! Protocol! details! are! given! in!
Section$4.41.!!Serial!serum!and!plasma!samples!were! taken:(!before!surgery,!at!end!of!surgery,!and!on!post(operative!days!1,!2,!3!and!4.! !Liver!tissue!samples!were!taken!at!the!beginning!and!end!of!surgery.!!Details!are!given!in!Section$4.4.4.!!




o Oxidative!stress:!TBARS,!SOD,!GPX,!protein!carbonyls!!These!markers!were!measured!using!commercially!available!assays,!according!to!the!manufacturer’s! instructions.! ! All! samples! assayed!were! run! in! duplicate! and!their! concentrations! were! determined,! with! the! aide! of! the! manufacturer’s!standards,!provided!with!each!kit.!!!! $
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5.5$Detailed$Laboratory$methods$The! laboratory! methods! are! divided! into! three! separate! sections:! Markers! of!Oxidative! Stress,! Cytokines! and! Markers! of! Liver! injury.! ! Please! note! that! all!materials! and!disposable! laboratory! equipment! (for! example,! sample! tubes)!was!sourced!from!Sigma(Aldrich!(Sigma(Aldrich!Company!Ltd,!Poole,!UK).!!
5.5.1$Markers$of$Oxidative$Stress$Markers! measured! included! a! marker! of! Lipid! Peroxidation! TBARS,! Superoxide!Dismutase,!Protein!Carbonyls!and!Glutathione!Peroxidase.!!










50!μl!of!sample!solution!(see!4.6.7)!was!added!to!each!well,!along!with!50!μl!SDS!solution.!!The!solutions!were!mixed!by!swirling.!!1.25mls!TBA/Buffer!Reagent!was!added!forcefully!into!each!well.!!The!plate!was!incubated!at!95°C!for!60minutes.!!At!the!end!of! this!period,! the!plate!was! cooled! to! room! temperature! in! an! ice!bath.!!The!plates!were!centrifuged!at!3000rpm!for!15minutes.! !300!μl!supernatant!was!removed!from!each!well!and!placed!in!a!fresh!96(well!plate!for!analysis.!Each! sample! was! assayed! in! duplicate.! ! Five! standards! from! 0! to! 100nmol/ml!concentrations!were!also!assayed!in!duplicate!on!each!plate.!Absorbance!was! read! using! a! spectrophotometer! at! 532nm! (Dynex!MRX,! Dynex!technologies!Ltd.!Worthing,!UK).!!A!standard!curve!was!created.!!Curve!fitting!settings!included!Lin/Lin!axes!scaling!and! Linear! regression! with! data! extrapolation! was! performed.! ! Values! of!absorbance!were!interpolated!from!the!generated!standard!curve.!An!example!of!the!standard!curve!is!given!below.!!The!R(squared!value!was!≥0.996!for!each!plate.!!!
5.5.1.2$Superoxide$Dismutase$ELISA$SOD!measurement!was!performed!using!a!commercially!available!kit:!Cu/Zn!SOD!Platinum!Enzyme!Linked!Immunosorbent!Assay!(ELISA)!from!Alexis!Biochemicals!(purchased! from! Enzo! Life! Sciences! UK,! Ltd,! Exeter,! UK).! ! This! is! a! quantitative!sandwich! enzyme! immunoassay! technique.! ! An! anti(human! Cu/ZnSOD! antibody!coating! is! adsorbed! onto! microwells.! ! The! manufacturer! states! that! the! normal!range!is!0.226!mg/L!(range!not!detectable!–!0.352).!!!!Sample!timepoints!used!for!SOD!ELISA!were!Pre(operative,!end!of!surgery,!day!1,!and!day!3.!!!
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5.5.1.2.1$Reagents$and$Standards$used$in$ELISA$
Manufacturer’s! 96(well! microwell! plate! with! monoclonal! antibody! to! human!Cu/ZnSOD!HRP(Conjugate!anti(human!Cu/ZnSOD!monoclonal!antibody!Human!Cu/ZnSOD!Standard!solution!–!5ng/ml!Assay!Buffer!(PBS!with!1%Tween20!and!10%!BSA)!Phosphate!Buffered!Saline!Wash!Buffer!(PBS!with!1%!Tween20)!Substrate!solution!of!tetramethyl(benzidine!Stop!solution!(Phosphoric!acid!1M)!Deionized!Water!!
5.5.1.2.2$Reagents,$Standards$and$Sample$Preparation$
Wash!buffer!and!Assay!Buffer!concentrates!were!diluted!to!working!volume!with!deionized!water!to!produce!a!final!volume!of!1000mls!of!Wash!Buffer!and!100mls!of!Assay!Buffer.!HRP(Conjugate!was!diluted!1:5!by!adding!20!μl!to!80!μl!of!Assay!Buffer.!A!further!1:100!dilution!was!made!by!adding!0.06mls!of! above! to!a! further!5.94mls!Assay!Buffer.!Standards!were!prepared!by!serial!1:2!dilutions!with!addition!of!100!μl!PBS!to!100!μl! of! each! successive!dilution!of! 5ng/ml! Standard! solution,! leaving!7! standards:(!5ng/ml,!2.50ng/ml,!1.25ng/ml,!0.63ng/ml,!0.31ng/ml,!0.16ng/ml,!0.08ng/ml!and!a!blank!standard!of!PBS!alone.!!Sample! aliquots! were! thawed! and! kept! on! ice! until! it! was! time! to! perform! the!assay.!Subsequently!they!were!allowed!to!come!up!to!room!temperature.!!Samples!of!serum!were!diluted!1:20!with!PBS,!using!10!μl!of!sample!to!190!μl!of!PBS.!!
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5.5.1.2.3$Assay$Procedure$
The!microwell!plate!was!washed!twice!with!400!μl!of!Wash!Buffer!per!well,!with!thorough!and!careful!aspiration!of!the!microwell!contents!between!washes.! ! !The!Wash!Buffer!was!allowed!to!sit!in!the!wells!for!approximately!15!seconds!on!each!occasion.!!Excess!Wash!Buffer!was!removed!by!tapping!the!well!upside!down!on!an!absorbent!pad.!!!100!μl!PBS!was!added!in!duplicate!to!the!blank!wells.!!90!μl!PBS!was!added!to!all!other!wells.!10!μl!of!each!sample!and!standard!were!loaded!onto!the!96!well!pre(coated! microwell! plate! in! duplicate! according! to! a! predetermined! template,! for!ease!of!sample!identification.!50! μl! of! HRP(Conjugate!was! added! to! all!wells.! ! The! plate!was! covered!with! an!adhesive! film!and! incubated!on!a!microplate!shaker!set!at!100rpm,! for!1!hour!at!25°C.!At!the!end!of!this!period,!the!wells!were!emptied!and!washed!3!times!with!400!μl!Wash!Buffer!for!each!wash!as!before.!100! μl! of! Substrate! solution! was! pipetted! into! each! well.! ! Again! the! plate! was!incubated!for!10mins!at!room!temperature,!in!a!darkened!part!of!the!room.!Once!the!highest!standard!had!become!a!dark!blue!colour,!the!reaction!in!all!wells!was!stopped!by!adding!quickly!100!μl!of!Stop!Solution!to!each!well.!!Great!care!was!taken!to!perform!this!step!quickly!and!consistently.!Absorbance! of! each!well! was! read! by! a! spectrophotometer! using! 450nm! as! the!primary!wave!length!(Dynex!MRX,!Dynex!technologies!Ltd.!Worthing,!UK).!A! standard! curve! was! constructed! using! a! cubic! spline! technique! and! the!concentration!of! SOD! in! each!well!was! interpolated! from! the! standard! curve.!An!example!of! the! standard! curve! is! given!below.!The!R2! value!was!≥0.995! for! each!plate.!!
5.5.1.3$Protein$Carbonyl$ELISA$This!is!another!commercially!available!ELISA!!(purchased!from!Enzo!Life!Sciences!UK,!Ltd,!Exeter,!UK).! ! In!measuring!PC,! the!assumption! is!made!that! there!are!no!nucleic! acids! (and! therefore! no! nuclear! material)! within! the! sample,! as! these!would! give! falsely! elevated! readings.! ! PC! quantification! can! occur! by! various!
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2ml! of! EIA! Buffer!was! added! to! the! blocking! reagent! container,!mixed! and! then!diluted!in!a!larger!container!to!a!final!volume!of!75ml.!
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0.5ml!of!this!diluted!blocking!solution!was!added!to!the!Anti(DNP(biotic!antibody!microvial! and! mixed! well,! then! made! up! to! a! total! of! 20ml! with! more! diluted!blocking!solution.!0.5ml! of! diluted! blocking! solution!was! added! to! the! Streptavidin(HRP!microvial,!mixed!well!and!then!made!up!with!more!solution!to!a!total!of!20ml.!!!1ml!of!DNP!was!added!to!9ml!guanidine!hydrochloride.!The!oxidised!protein!standards!(1(6)!were!each!mixed!with!25!μl!deionised!water,!vortexed!and!then!kept!overnight!(for!13!hours!total)!at!37!°C.!!Before!use!on!the!morning!of!the!experiment,!they!were!revortexed!to!ensure!the!whole!sample!was!dissolved.!!5!μl!of!each!sample!was!added!to!a!1.5ml!reaction!tube!containing!200!μl!of!diluted!DNP!solution,!mixed!well!and!incubated!for!45minutes!at!room!temperature.!!5!μl!of! each! sample/diluted! DNP! mixture! was! then! added! to! another! reaction! tube,!containing!1ml!of!EIA!buffer.!200!μl!of! each! sample!was! loaded! into! the!96!well!ELISA!microplate! in!duplicate,! according! to! a!pre(assigned!plate!map.! !The!plate!was!left!overnight!(for!13!hours!in!total)!at!4!°C.!!!
5.5.1.3.3$Assay$Procedure$
The!plate!was!allowed!to!come!to!room!temperature!and!washed,!five!times!with!a!volume!of!300!μl!per!well!of!EIA!buffer.!!After!emptying!the!wells!by!tapping!on!a!piece!of!blotting!paper,!250!μl!of!diluted!blocking!solution!was!added!to!each!well.!!The! plate! was! incubated! for! 30! minutes! at! room! temperature.! ! The! plate! was!washed!again,!as!above.!!200!μl!of!diluted!anti(DNP(biotin!antibody!was!added!to!each!well!and!the!plate!was!incubated!for!1!hour!at!37!°C.!!The!plate!was!washed!again,! as! above.! ! 200μl! diluted! streptavidin(HRP! was! added! to! each! well! and!incubated!for!1!hour!at!room!temperature.!!Further!washings!occurred,!as!above.!200!μl!Chromatin!reagent!was!added!to!each!well!and!the!colour!development!in!the!wells!was!observed.!!The!plate!was!kept!at!room!temperature!and!absorbance!at!650nm!was!measured!repeatedly!with!the!spectrophotometer!every!1(2minutes!until,! at! approximately!13!minutes! after! adding!Chromatin,! the!highest! standard!had!an!absorbance!of!approximately!0.7.!!At!this!point!the!reaction!was!arrested!by!
!148!
adding!100!μl!of!Stopping!Reagent!to!each!well.!!Absorbances!were!read!at!450nm!(Dynex!MRX,!Dynex!technologies!Ltd.!Worthing,!UK).!A!standard!curve!was!constructed!by!the!software,!using!the!Lin/Lin!setting,!with!linear!regression.!!R2!was!0.92!for!plate!1!and!0.96!for!plate!2.!!PC!concentrations!were!interpolated!from!the!standard!curve.!!!








GPX!activity! is!a! function!of! the! fall! in!absorbance!of! the!reaction!mixture!over!a!period!of!15!minutes! (discussed! further!below).! !Therefore! the!plate! reader!was!set! up! to! perform! absorbance! measurements! every! minute! for! a! period! of!15minutes! (Dynex!MRX,!Dynex! technologies!Ltd.!Worthing,!UK).! !The!microplate!was!set(up!by!adding!140!μl!Assay!Buffer,!20!μl!of!the!Reaction!Mixture!and!20!μl!of!sample.! !Assays!were!performed! in!duplicate.! !The!reactions!were! initiated!by!adding! 20! μl! Cumene! Hydroperoxide! to! each! well! quickly! using! a! multichannel!pipettor.! ! Absorbance! was! measured! immediately! at! 1! minute! intervals! for! 15!minutes.! ! A! set! of! controls!were! loaded!where! a! further! 20! μl! Assay!Buffer!was!added! in!place!of! the!sample!volume.! !A!background!rate!of!decay! in!absorbance!was!provided!by!the!controls.!!Glutathione!Peroxidase!activity!was!determined!by!using!the!optical!plate!reader!software.! ! The! gradient! of! the! decay! slope! of! absorbance! at! 340nm! was!determined.! ! The! slope! of! the! controls! was! subtracted! from! this! to! give! a! net!change!in!absorbance!per!minute!(ΔA340/min).!!One!unit!of!GPX!is!defined!as!the!amount!of!enzyme!that!will!cause!the!oxidation!of!1!nmole!of!NADPH!to!NADP!per!minute!at!room!temperature.!!The!reaction!rate!could!then!be!determined!using!an!adjusted!extinction!coefficient!of!NADPH,!0.00379μM(1.!!GPX!activity!in!Units/ml!= !"!!"#$/!"#!.!!"#$%!!! ! !.!!"!"#!"!!where!volume!of!sample!in!each!well!was!180μl,!using!undiluted!samples.!!
5.5.2$Cytokines$This!section!is!divided!into!Luminex!Multiplex!Cytokine!Array,!which!was!used!to!measure! TNFα,! IL(6,! IL(10! and! the! adipocytokines! Leptin,! Resistin! and!Adiponectin,!and!TNFα!High!Sensitivity!ELISA.! !TNFα!was!measured!in!two!ways!due!to!problems!with!its!detection!within!the!study!samples.!
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Standard! Cocktail! was! reconstituted! with! Calibrator! Diluent! according! to! the!individual!instructions!in!each!assay!–!approximately!1ml!volume!total.!Using!7!polypropylene!mini(tubes!for!the!serial!dilution!of!the!Standard,!500!μl!of!reconstituted! Standard!was! pipetted! into! Standard! 1! tube.! ! 200! μl! of! Calibrator!Diluent!was!put!in!the!remaining!six!tubes.!!A!3(fold!dilution!series!was!produced!by! transferring!100!μl! from!Standard!1! into! Standard!2,!mixing! thoroughly! then!transferring! 100! μl! from! Standard! 2! to! Standard! 3! and! so! on.! ! Each! Standard!Cocktail!was!different!and!the!values!of!the!highest!Standard!were!recorded!on!a!card!for!each!plate.!!
5.5.2.1.3$Reagent$Preparation$
Wash!Buffer!was!reconstituted!with!deionised!water!1:25!to!create!500ml!of!Wash!Buffer.!Each!Microparticle! Concentrate! vial!was! centrifuged! for! 30! seconds! to! clear! any!particles!from!inside!the!cap!and!then!vortexed!to!resuspend!the!particles.!!50!μl!of!Microparticle!Concentrate!was!added!to!5.0!ml!Microparticle!Diluent.!!The!diluted!Microparticles!were!shielded!from!light!until!use.!As! above,! the! Biotin! Antibody! Concentrate! vials! were! centrifuged! and! vortexed!before!diluting!50!μl!in!5.25ml!Biotic!Antibody!Diluent.!Streptavidin(PE!vial!was!also!centrifuged!then!vortexed.! !A!100(fold!dilution!was!performed! by! adding! 55! μl! Streptavidin(PE! to! 5.5ml! Wash! Buffer.! ! The! diluted!solution!was!shielded!from!light!with!aluminium!foil.!
5.5.2.1.4$Sample$Preparation$
The! initial!plan!had!been! to! assay!all! six!of! the! target! cytokines!on!one!plate,! as!marketed!by!the!manufacturer.! !The!printed!protocol!advised!a!four(fold!dilution!of!each!sample!with!Calibrator!Diluent.! ! In! fact,! the!relative!abundances!of!TNFα,!IL(6,!IL(10,!Leptin,!Resistin!and!Adiponectin!differed!greatly,!and!it!was!noted!that!
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the!Standard!Cocktail!provided!with!each!plate!meant!that!individually!optimised!Standard! curves! could! not! be! produced! for! each! analyte.! ! Therefore! three!microplates! were! required! for! each! set! of! samples.! ! The! combinations! and!dilutions!are!given!as!follows:!TNFα,!IL(6!and!IL(10!–!a!1:1.5!dilution,!using!100!μl!sample!and!50!μl!Calibrator!Diluent;!Leptin!and!Resistin!–!a!1:5!dilution,!using!30!μl!sample!and!120!μl!Calibrator!Diluent;!Adiponectin!–!a!1:100!dilution,!using!10!μl!sample!and!190!μl!diluent.!!Diluted!Samples!were!stored!on!ice!until!ready!for!use.!!
5.5.2.1.5$Assay$procedure$
The! filter(bottomed!96(well!microplate!was! pre(wet!with! 100!μl! of!Wash!Buffer!and! the! liquid! removed! using! the! Vacuum! Manifold.! ! After! resuspending! the!Microparticle!mixture!by!vortexing,!50!μl!of!each!individual!analytes!Microparticle!Mixture!was!added!to!each!well.!50! μl! of! Standards! and! Diluted! Samples! were! added! in! duplicate! to! the! wells!according! to! a! predetermined! plate!map.! ! The!microplate!was! securely! covered!with! a! foil! plate! sealer! and! incubated! for! 3! hours! at! room! temperature! on! a!horizontal!orbital!plate!shaker!(0.12”!orbit)!set!at!500!rpm.!At!the!end!of!this!period,!the!microplate!was!emptied!using!the!Vacuum!Manifold!then!each!well!was!washed!with!190!μl!of!Wash!Buffer.! !The! liquid!was!emptied!again!using!the!Vacuum!Manifold.!!This!washing!procedure!was!performed!3!times!in!total.!!At!the!end,!complete!removal!of!the!liquid!was!checked!in!each!well.!50!μl!of!diluted!Biotic!Antibody!Cocktail!was!added! to!each!well.! !After! covering!with! a! foil! plate! sealer,! the! microplate! was! incubated! for! 1! hour! at! room!temperature!on!the!orbital!shaker.!Three!washes!were!performed!as!detailed!above.!50! μl! of! diluted! Streptavidin(PE! was! added! to! each! well.! ! The! microplate! was!covered!and!incubated!on!the!orbital!shaker!as!above!for!30!minutes.!Three!washed!were!performed!as!above.!The!microparticles!were!resuspended!by!adding!125!μl!Wash!Buffer!to!each!well!(an!increased!volume!to!avoid!damaging!the!needle!on!the!Luminex!Bioanalyser).!The!microplates!were!read!on!the!Bioanalyser.!!
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Standard! curves!were! generated! using! the! analyser! computer! software.! ! A! 5(PL!curve!fit!was!used!to!produce!the!curve!and!the!concentrations!of!analytes!in!each!sample!were!interpolated.!!The!final!results!were!corrected!for!the!dilution!factor.!!





Wash!buffer!was!reconstituted!with!deionised!water!to!create!1000ml!solution.!!Substrated!Solution!was!made!by!reconstituting!the!vial!of!lyophilised!Substrate!in!6ml!Substrate!Diluent.!!Similarly!lyophilised!Amplifier!was!diluted!in!6ml!Amplifier!Diluent.!!!!TNFα!Standard!was!reconstituted!with!Calibrator!Diluent,!making!a!32pg/ml!stock!solution.!!After!allowing!the!solution!to!sit!for!15minutes,!a!serial!1:2!dilution!was!performed.! !500!μl!Calibrator!Diluent!was!pipetted! into!6!marked!polypropylene!tubes.!!500!μl!TNFα!Standard!was!transferred!into!the!first!tube.!!The!solution!was!gently!mixed! and! a! further! 500! μl! was! transferred! to! the! next! tube,! and! so! on.!!Eight! standards! were! created:! 32pg/ml,! 16pg/ml,! 8pg/ml,! 4pg/ml,! 2pg/ml,!1pg/ml,!0.5pg/ml!and!plain!Calibrator!Diluent!served!as!the!zero!standard.!!Sample!serum!aliquots!were!thawed!on!ice!and!brought!to!room!temperature!just!before!use.!!They!were!added!to!the!reaction!mixture!undiluted.!
5.5.2.2.3$Assay$procedure$
The! whole! procedure! was! performed! with! facemask! and! gloves! to! avoid!contamination!with!saliva!and!respiratory!secretions,!which!are!rich!in!TNFα.!50! μl! Assay! Diluent! was! added! to! each! well,! after! vortexing! diluent! to! ensure!mixing.! !200!μl!of! Sample!and!Standards!were!added! in!duplicate!according! to!a!predetermined! plate! map.! ! The! microplate! was! covered! with! adhesive! film!incubated!for!3!hours!at!room!temperature.!!!After! this! period,! the! wells! were! aspirated! and! excess! liquid! was! removed! by!tapping!the!inverted!plate!vigorously!on!blotting!paper.!!Each!well!was!filled!with!400!μl!Wash!Buffer!using!an!automated!manifold!dispenser.!!The!wells!were!again!emptied!as!before.!!5!further!wash!steps!were!performed!as!above.!!After!the!sixth!occasion,!any!excess!liquid!was!removed!by!vigorous!inversion!onto!blotting!paper!as!above.!!!200!μl!TNFα!HS!Conjugate!was!added!to!each!well.!!The!plate!was!incubated!for!2!hours!at!room!temperature!on!the!benchtop.!!!6!Washes!were!performed!as!above.!
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50!μl!Substrate!Solution!was!added!to!each!well!and!the!plate!was!incubated!for!1!hour!as!above.!50! μl! Amplifier! Solution! was! added! to! each! well! and! a! further! 30! minute!incubation!took!place.!At!the!end!of!this!period,!50!μl!Stop!Solution!was!added!to!each!well.!!!Optical! density! of! each!well!was!measured! using! a!microplate! reader! at! 490nm,!with!λ!correction!at!650nm!(Dynex!MRX,!Dynex!technologies!Ltd.!Worthing,!UK).!!A!standard! curve!was! generated,! using! logarithmic! transformation! and! regression,!using!a!Spline!Smoothed!fitting!algorithm.!!TNFα!concentrations!were!interpolated!from!the!standard!curve.!Unfortunately,! >50%!of! the!wells! did! not! give! a! reading!within! the! range! of! the!standard!curve!and!therefore!these!results!were!not!used.! ! It!was!not!possible!to!repeat!the!ELISA!due!to!lack!of!samples.!!
5.5.3$Markers$of$Liver$Injury$This!section!is!divided!into!sections!for!Cytokeratin(18,!TRAIL!and!Fas(Ligand,!and!Apoptosis!Proteome!Profile!Tissue!Array.!!







25!μl!of!samples,!standards!and!controls!were!added!to!the!96(well!microplates!in!duplicate!according!to!a!predetermined!plate!map.!75!μl!of!diluted!HRP!Conjugate!solution!was!added!to!each!well.!M65! microplate! was! incubated! for! 2! hours! on! a! shaker! at! 600rpm! at! room!temperature;!M30!microplate!was!incubated!for!4!hours!on!a!shaker!at!600rpm.!At!the!end!of!the!incubation!period,!the!microplate!was!aspirated!and!then!washed!5!times!with!250ml!of!Wash!Buffer!per!well!each!time.!!!200! μl! of! TMB! was! added! to! each! well! and! the! microplate! was! incubated! in!darkness!for!20!minutes.!50!μl!Stop!Solution!was!added!to!each!well.!
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After! mixing! for! 10! seconds,! the! absorbance! for! each! plate! was! read! after! 5!minutes! at! 450nm!on! a!Microplate! reader! (Dynex!MRX,!Dynex! technologies! Ltd.!Worthing,!UK).!A! Standard! Curve!was! generated,! using! Lin/Lin! axes! scaling! and! a! Cubic! Spline!algorithm.! ! Concentrations! of! Ck(18! M65! and! M30! were! determined! by!interpolating!the!values!from!the!Standard!Curve.!!R2!was!1.000.!!!
5.5.3.2$TRAIL$and$FasLigand$ELISA$Both! ELISAs! are! sandwich! enzyme! immunoassay! based! on! a! horseradish!peroxidase!reaction,!which!leads!to!a!change!in!absorbance!of!the!reaction!mixture!proportional! to! the! concentration! of! TRAIL! or! FasL! in! the! sample.! ! The! assay!protocols!are!very!similar!and!therefore!are!included!together!below.!The!kits!used!were! Quantikine! ELISA! (R! &! D! Systems! Europe! Ltd,! Abingdon,! UK).! ! The!manufacturer!states!that!normal!range!of!TRAIL!in!serum!is!mean!76!pg/ml!(range!28(135)!and!of!Fas!Ligand!is!mean!85.2!±SEM!25.6!pg/ml!(range!39.8!–!145).!!!!Sample!timepoints!used!for!TRAIL!assay!were!Pre(operative,!end!of!surgery,!day!1,!day!2!and!day!4.!!
5.5.3.2.1$Reagents$used$in$the$assay$




All!reagents!were!brought! to!room!temperature!before!use.! !Wash!and!Cell!Lysis!buffer! concentrates! were! diluted! with! deionised! water.! ! All! procedures! were!performed! whilst! wearing! a! facemask! to! avoid! contamination! as! high! levels! of!TRAIL!are!found!in!saliva!and!respiratory!secretions.!!The!TMB(Substrate!solution!was!reconstituted!by!adding!12.5ml!of!TMB!to!12.5ml!hydrogen!peroxide!for!each!assay.!!Both! standards! were! reconstituted! with! 1ml! deionised! water.! ! This! produces! a!stock!solution!of!10,000pg/ml.! !The!standards!were!allowed!to!sit! for!15minutes!before!proceeding.!For!FasL,!seven!test! tubes! for!serial!dilution!were!used.! !The!first!was!filled!with!360!μl!Calibrator!Diluent!ED5K,!with!200!μl!Calibrator!Diluent!in!the!remaining!6!tubes.! !40!μl!of! the!stock!Standard!solution!was!put! in!the!first!tube,! forming!the!1000!pg/ml!standard!(highest).!!After!mixing,!200!μl!was!taken!from!this!tube!and!put! in! the! next! one.! ! The! procedure!was! repeated! for! the! next! 5! tubes! forming!standards! 500! pg/ml,! 250! pg/ml,! 125! pg/ml,! 62.5! pg/ml,! 31.5! pg/ml! and! 15.6!pg/ml.!!Plain!Calibrator!Diluent!served!as!the!zero!standard.!TRAIL!standards!were!created!in!the!same!manner,!except!the!first!tube!was!filled!with!900!μl!Calibrator!Diluent,!with!1000!μl!in!each!subsequent!tube.!!Then!100!μl!of! TRAIL! standard! stock! solution! was! transferred! to! the! first! tube! with! 500! μl!transferred! to! the! next! 6! tubes! serially.! ! The! concentrations! of! ! TRAIL! standard!were!1000!pg/ml,!500!pg/ml,!250!pg/ml,!125!pg/ml,!62.5!pg/ml,!31.5!pg/ml!and!15.6!pg/ml.!!Plain!Calibrator!Diluent!served!as!the!zero!standard.!!Serum!sample!aliquots!were!thawed!on!ice.!For!TRAIL!assay,!samples!were!diluted!2(fold!with!100!μl!sample!diluted!in!100!μl!Calibrator!diluent!in!a!separate!96(well!plate.!!They!were!then!transferred!to!the!ELISA!plates!in!duplicate,!according!to!a!predetermined!plate!map.!
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5.5.3.2.3$Assay$procedure$
100!μl!Assay!Diluent!RD1S!was!added!to!each!well.!!50!μl!of!sample!and!standard!was!added!to!each!well,!in!duplicate!according!to!a!plate!map.!(The!TRAIL!sample!had!been!diluted!two(fold).! !The!microplates!were!incubated!for!2!hours!at!room!temperature,!with!the!TRAIL!plate!placed!on!a!horizontal!shaker!set!at!500!rpm.!At!the!end!of!this!period,!the!wells!were!aspirated!and!washed!four!times,!with!a!volume!of!400!μl!Wash!Buffer!per!well!per!wash.! !After! the! last!wash,! the!plates!were! inverted! forcefully!onto!blotting!paper! to! ensure! all!Wash!Buffer!had!been!removed.! ! 200! μl! of! the! relevant! HRP(Conjugate! was! added! to! each! well.! ! The!plates!were!again!incubated!for!2!hours!at!room!temperature,!with!the!TRAIL!plate!placed!on!a!shaker!as!before.!!The!washing!step!was!repeated!as!above.!!200!μl!of!the! relevant! TMB(Substrate! solution!was! added! to! each!well.! ! Both! plates!were!mixed!gently!and!incubated!for!30!minutes!at!room!temperature!on!the!benchtop.!At!the!end!of!this!period,!50!μl!Stop!Solution!was!added!to!each!well!and!the!plates!were!gently!shaken!to!ensure!mixing.!The!absorbance!was!read!by!a!microplate!reader!at!450!nm!with!a!λ!correction!at!550!nm!(Dynex!MRX,!Dynex!technologies!Ltd.!Worthing,!UK).!The!standard!curves!were!generated!using!linear!regression!with!Log/Log!axes!scaling.!!R2!was!0.99!for!both! plates.! ! Concentrations! of! FasL! and! TRAIL! were! interpolated! from! the!standard!curves.!!!!
5.5.3.3$Apoptosis$Proteome$Profile$Tissue$Array$After! tissue! damage,! the! expression! of! various! apoptosis(associated! proteins!changes.! ! Analysing! these! expression! profiles! may! give! an! indication! of! the!mechanisms! involved! in! causing! the! tissue! damage! and! also! possible! target!proteins! affected! by! the! administration! of! N(Acetylcysteine.! ! This! Apoptosis!Proteome! Profile! Array! (Apoptosis! Array,! AA)! allows! rapid,! simultaneous!detection!of!35!apoptosis(related!proteins!in!one!assay!(Proteome!Profiler!Human!Apoptosis! Array! Kit,! R! &! D! Systems! Europe! Ltd,! Abingdon,! UK).! ! Relative!quantification! of! each! protein! gives! an! indication! of! the! intracellular! processes!occurring.! ! The! AA! contains! 35! spots! coated!with! specific! antibodies,!which! can!bind! the! target! proteins,! along!with! controls.! ! The! original! protocol!was! for! use!with!cell! lysates.! !Therefore!an! initial!modification!was!performed! to!allow!us! to!
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Wash! buffer! concentrate! was! diluted! by! adding! 40mls! of! buffer! concentrate! to!960ml!deionised!water.!!Array!Buffer!1!was!ready!for!use.!!2!ml!of!Array!Buffer!2!was!added!to!8ml!of!Array!Buffer!3.!Leupeptin! 25! μl,! Pepstatin! 5! μl! and! Aprotonin! 50! μl! were! added! to! 5ml! Lysis!Buffer(15!to!create!sufficient!Lysis!Buffer!!for!tissue!homogenisation.!
5.5.3.3.4$Sample$Preparation$
The!protocol!demanded!that!approximately!1!x!107!cells!would!be!solubilised!by!1ml!Lysis!Buffer.!!In!order!to!determine!how!much!liver!tissue!would!be!required!for! each! assay,! the! weight! HepG2! cells! was! used! as! a! guide.! ! HepG2! cells! were!resuspended! in! 1ml! of! EMEM!medium.! ! The! cell! count!was! 1.5! x! 107/ml.! ! After!pelleting! this!cell! solution,! the!estimated!weight!of!1!x!107! liver!cells!was!24mg.!!To! solubilise! these! cells,! approximately!42!μl! Lysis!Buffer!was! required! for! each!milligram!liver!tissue!(1000!μl!lysis!buffer!÷!24mg!tissue).!Each!piece!of! liver!biopsy!tissue!was!weighed!and!rinsed!with!PBS.! ! !42!μl/mg!of!Lysis!Buffer!was!added!along!with!Triton!X(100!(1%!of! the!total!volume!of!Lysis!Buffer!≈!1.5!(!2.0μl).!The!cells!were!solubilised,!then!centrifuged!at!10,000rpm!for!5!mins!at!room!temperature.! !The!supernatant!was!decanted!and!put!in!a!second!microtube.!!A!protein!assay!was!performed!modified!Lowry!method!!(388).!Initially! 5! μl! of! sample! was! diluted! with! 45! μl! of! PBS! (1:10)! but! a! further! x3!dilution! was! performed,! as! initial! protein! levels! were! recordable.! ! The! original!protocol! indicated! that! each! lysate! should! contain! between! 200! –! 500! μg! total!protein! in! a! volume! of! 250! μl.! ! After! determining! the! protein! content! of! each!sample! lysate,! the!volume!of! lysate! containing!350μg!protein!was!calculated!and!the! volume!was!made! up! to! 250! μl!with! Lysis! Buffer.! ! Each! sample!was! clearly!marked!and!kept!on!ice!until!required.!!!
5.5.3.3.5$Assay$procedure$
2ml! of! Array! Buffer! 1! was! placed! into! each! well! and! the! array! membrane! was!placed!in!the!well!facing!upward.!!The!well!was!incubated!on!a!rocking!shaker!for!1!hour,!with!the!well!arranged!so!that!the!rocking!occurred!end(to(end.!!The!sample!
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lysate! was! placed! in! a! separate! tube,! with! 1.25ml! Array! Buffer! 1.! ! The! total!quantity!of!diluted!lysate!was!1.5ml.!!The!well!was!emptied!of!Array!Buffer!1!and!the!diluted!lysate!was!added!to!the!well!containing!the!array!membrane.!!The!well!was!covered!and!incubated!overnight!at!4!°C!on!a!rocking!platform!shaker.!After! a! period! of! approximately! 18!hours,! the! array!was! removed! from! the!well!and! placed!within! an! individual! plastic! tube! container! containing! 20ml! of!Wash!Buffer.!!To!wash!the!array,!the!tube!was!placed!on!a!rocking!platform!shaker!for!10!minutes,!before!the!Wash!Buffer!was!exchanged!for!fresh!Wash!Buffer.!!Three!such!washes!were!performed.! !During!this!time,!the!well!was!washed!thoroughly!with!deionised!water!and!allowed!to!dry!completely.!After! 3! washes,! the! array! membrane! was! removed! from! its! washing! container,!shaken!dry! gently! and!placed! back! in! the!well.! ! 15! μl! of! reconstituted!Detection!Antibody!Cocktail!was!diluted!by!adding!it!to!1.5ml!of!Array!Buffer!2/3.!!1.5ml!of!this!diluted!Detection!Antibody!Cocktail!was!added!to!the!well!and! incubated!for!an!hour!at!room!temperature!on!a!rocking!platform!shaker.!At!the!end!of!this!period,!the!array!was!removed!from!the!well!and!washed!again!as!above!three!times.!Again! after! shaking! the! array! dry,! it! was! placed! back! in! the! well.! ! 1! μl! of!Streptavidin(HRP!was!diluted!in!2!ml!Array!Buffer!2/3!and!1.5ml!of!this!solution!was!added!to!the!well!with!the!array!membrane.!!The!array!was!incubated!for!30!minutes!on!a!rocking!platform!shaker!at!room!temperature.!As!above,!the!array!membrane!was!removed!and!washed!three!times.!Excess!Wash! Buffer! was! drained! off! the! membrane.! ! The! array! membrane! was!placed!on!a!plastic!sheet!protector!and!exposed! to!chemoluminescent!reagents!–!Lumigen,!according!to!the!manufacturers!protocol!and!transferred!to!a!dark!room.!In!the!dark!room,!the!wrapped(up!array!membrane!was!placed!on!a!photographic!plate!and!exposed!to!X(ray!film.!!After!initial!test!runs,!it!was!noted!that!3minutes!exposure!time!gave!the!best!results.!!The!developed!film!was!then!scanned!digitally.!!Using!ImageJ!software!(ImageJ,!U.!S.!National!Institutes!of!Health,!Bethesda,!Maryland;!http://imagej.nih.gov/ij/),!the!pixel! density! of! each! spot!was!measured,!with! the!background!value! subtracted.!!The!background!value!was!determined!by!measuring!the!pixel!density!within!the!
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negative! control! spots.! ! Each! protein! was! measured! in! duplicate! so! an! average!pixel!density!was!calculated.!!Each! pair! of! liver! biopsies! was! developed! on! the! same! film! so! that! processing!conditions! were! comparable.! ! The! fold! change! in! pixel! densities! could! be!determined.!!!! $
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5.5.5$Statistical$Analysis$Statistical!analyses!were!performed!using!SPSS!20!(SPSS,!USA).!!The!assumption!of!normality!was!tested!for!each!parameter!at!baseline!using!the!Shapiro(Wilk’s! test! (p>0.05).! ! All! parameters! were! normally! distributed! at!baseline.! ! Outliers! were! also! found! in! many! of! the! parameters,! as! assessed! by!inspection!of!a!boxplot.!!These!outliers!were!left!in!the!comparison.!!For!SOD,!two(way!ANOVA!using! time!and!treatment!group!as! fixed! factors!was!not!possible!as!the!variances!were!unequal! for.! !Thus,! independent!samples! t(tests!were!used!to!compare!values!between!groups!at!the!various!timepoints,!with!significance!set!at!p<0.05.! !A! secondary!analysis!of! changes! in!parameters!over! time!within!groups!was!performed!using!repeated!measures!ANOVA.!!Post(hoc!comparisons!between!different!timepoints!were!performed!after!applying!a!Bonferroni!correction.!!For! TBARS,! GPX,! PC! and! Adipocytokines,! it! was! possible! to! perform! Two(way!ANOVA,!using!timepoint!and!treatment!group!as!fixed!factors.!!IL(6,! IL(10!and!CK(18!fragment!results!were! found!to!have!unequal!variances,!so!therefore!two!sets!of!analyses!were!performed!as!above.!!TRAIL!and!FasL,!the!assumptions!for!Two(way!ANOVA!were!satisfied!and!this!test!was!used,!using!timepoint!and!treatment!group!as!fixed!factors.!!Correlations!were!performed!to!assess!the!interaction!between!demographic!and!intraoperative! factors! and! the! primary! outcome! measures! of! the! whole! cohort!grouped!together.!!Where!variables!were!non(normally!distributed,!they!were!log(10! transformed.! Linearity! between! co(factors! was! assessed! visually! using!scatterplots!and!Pearson’s!correlation!was!used.!!Clinical!significance!was!determined!if!P<0.05.!! $
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5.6$Results$$There!were!no!significant!differences!between!treatment!groups!at!baseline.!!Table!5.1! shows! the! values! in! each! group.! ! Biomarker! levels! were! comparable! to! the!published! literature.! ! Values! for! each! timepoint! are! presented! in! Appendix! B1.6!(Tables!B.5!and!B.6).!!!!
Table'5.1'Mean'baseline'values'of'biomarkers'in'treatment'groups'
No!significant!differences!between!treatment!groups!at!baseline!(p>0.05)!!
5.6.1$Markers$of$Oxidative$Stress$There! were! no! significant! differences! between! treatment! groups! in! oxidative!stress!markers.!!SOD!was!the!only!parameter!to!change!significantly!from!baseline!(p=0.001),!peaking!by!the!end!of!surgery.!!!!The! wide! variance! in! these! data,! with! large! confidence! intervals! and! standard!deviations!indicate!the!difficulties!in!accurately!assessing!oxidative!stress!changes!
! Parameter! Control!(n=10)! NAC!(n=9)!
! Mean!±!SEM!
Oxidative!Stress! ! !
! SOD!(mg/L)! 0.44!±0.04! 0.48!±0.06!
! TBARS!(nmol/ml)! 19.4!±3.9! 13.4!±4.3!
! GPX!(U/ml)! 7.37!±1.7! 9.77!±1.7!
! PC!(nmol/mg!prot)! 0.72!±0.4! 0.67!±!0.3!
Cytokines! ! !
! ILS6!(pg/ml)! 5.22!±0.7! 7.49!±1.5!
! ILS10!(pg/ml)! 0.98!±0.4! 0.74!±0.1!
! TNFα!!(pg/ml)! 5.28!±0.7! 7.77!±0.7!
! Leptin!(ng/ml)! 159!±32!! 196!±46!
! Resistin!(ng/ml)! 11.0!±2.0! 10!±1.3!
! Adiponectin!(ng/ml)! 12231!±2173! 10007!±2024!
Apoptosis! ! !
! CKS18!M65!(IU/L)! 315!±60! 378!±82!
! CKS18!M30!(IU/L)! 223!±49! 187!±22!
! TRAIL!(pg/ml)! 101!±9! 90!±11!
! Fas!Ligand!(pg/ml)! 91!±11! 93!±8!!
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Values!are!expressed!as! log2[fold! change],!where! fold! change! is! End/Start! corrected!
pixel! density.! ! Abbreviations:! cIAP! –! cellular! inhibitor! of! apoptosis,! TRAIL! R! –! TNF!
related!apoptosis!inducing!ligand!Receptor,!FADD!–!Fas!associated!death!domain,!HIF!–!
hypoxia! inducible! factor,! HO! –! haemoxygenase,! HSP! –! heat! shock! protein,! PON! –!















































































Log!OpTime! 0.098! 0.021! -0.093! 0.306! -0.108! .495*! 0.412! .556*! 0.207!
BMI!pre-op! -0.357! 0.053! -0.187! 0.107! 0.291! 0.148! 0.261! 0.31! -0.423!
HOMA!pre-op! -0.07! 0.158! 0.254! 0.089! 0.203! 0.249! -0.079! 0.086! 0.131!





































































Log!SOD!1hr!FC! 0.161! 00.167! 00.019! .566*! 0.127! 0.146! 00.132! 0.372!
Log!SOD!24hr!FC! 00.06! 0.19! 00.057! 0.4! 0.281! 0.059! 0.001! .522*!
Log!M30!24hr!FC! 0.025! 00.149! 00.285! 0.099! 0.417! 0.407! 00.071! .578*!
Log!M65!24hr!FC! 0.118! 00.064! 00.354! 0.011! 0.089! 0.256! 00.332! 0.483!
Log!PEAK!CRP!FC! 0.471*! 00.098! 0.334! .575*! 0.249! 0.634**! .787**! 0.012!!
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5.7$Discussion$Laparoscopic! bariatric! surgery! is! associated! with! beneficial! health! outcomes,!including! resolution! of! obesity(related! co(morbidities,! improved! health(related!quality! of! life! and! prolonged! life! expectancy.! ! Pneumoperitoneum! and!intraoperative!liver!retraction!is!associated!with!a!number!of!deleterious!findings,!inducing! an! inflammatory! response,! a! rise! in! transaminases! and! increased!oxidative! stress.! ! This! occurs! due! to! a! combination! of! pressure(related!microcirculatory! changes,! direct! barotrauma! to! the! liver! and! other! viscera! and!ischaemia(reperfusion!injury!after!the!end!of!surgery.!!In! chapter! 2,! the! clinical! outcomes! of! this! trial! were! presented,! including! a!significant!rise! in!ALT,!AST,!WCC!and!CRP!post(operatively.! !Liver! transaminases!and!WCC!rise!significantly!by!the!end!of!surgery,!with!a!peak! in!ALT!and!AST!on!day!1,! followed!by!a! return! to!baseline!within!3(4!post(operative!days.! !CRP!rise!lags!behind,!peaking!on!day!2.!!The!many!limitations!of!the!study!were!highlighted,!including! the!observation!of!wide!variations! in! the!extent!of!derangement!of! the!parameters!from!patient!to!patient.!!NAC!administration!did!not!have!a!significant!effect! on! these! clinical! parameters.! ! The! study! was! not! of! sufficient! power! to!comment!on!the!effect!of!NAC!on!outcomes,!including!complications.!!!!!In! this! chapter,! the! results! are! presented! of! a! number! of! interesting! laboratory!assays! undertaken! to! further! investigate! post(operative! events.! ! Again,! the! post(operative! changes! in! cytokines,! oxidative! stress! markers! and! Cytokeratin! 18!fragments! were! subject! to! a! large! inter(individual! variation.! The! study! has!demonstrated! that! NAC! had! no! statistically! significant! effect! on! each! of! the!parameters! and! did! not! ameliorate! hepatocellular! injury.! ! Even! so,! the! data!presented! here! is! novel! and! reveals! more! evidence! regarding! the! nature! of! the!post(operative!response!to!surgery.!!
5.7.1$The$effect$of$NAC$on$oxidative$stress$In! terms!of!oxidative!stress,! indicators!of! lipid!and!protein!oxidation,!TBARS!and!PC,! and! GPX,! part! of! the! glutathione! antioxidant! system,! did! not! change!significantly!after!surgery.! !GPX!catalases!the!conversion!of!hydrogen!peroxide!to!
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water.! ! Hydrogen! peroxide! is! one! of! the! most! abundant! byproducts! of! ROS!production!and!leads!to!lipid!and!protein!peroxidation.!!GPX!is!the!most!abundant!antioxidant! enzyme! within! eukaryotic! cells,! which! is! the! reason! this! test! was!selected! for! this! study!(389).! Ueda! et# al! showed! that! plasma! GPX! activity! had!increased!by!35%!by!1!week!after!RYGB,!accompanied!by!a!significant!decrease!in!adipose!tissue!levels!of!8(iso(Prostaglandin!F2α!(8(iso(PGF2α)!(390).!!8(iso(PGF2α!is! a! quantitative!marker! of! tissue! oxidative! stress,! derived! from! the! products! of!lipid! peroxidation.! ! An! increase! in! GPX! activity! may! be! interpreted! as! having! a!beneficial! effect! on! cell! metabolism! by! reducing! ROS(induced! damage! and!knockout!mice!models! corroborate! this!(389).! ! However! there! are! a! number! of!different!GPX! isoforms,!each!with!a!different!gene!whose!expression! is! regulated!individually!(389).! ! The! assay! used! in! this! study! measured! total! plasma! GPX!activity! and! it! is! possible! that! expression! of! the! various! GPX! enzymes! is!differentially!expressed!in!this!cohort.!!The!timescale!of!the!repeated!measures!of!GPX! only! covered! the! first! post(operative! day! and! induction! of! GPX! may! take!longer.!!In!myeloid!cell!lines,!Shen!et#al!measured!expression!of!cellular!GPX!mRNA!expression!and!protein! levels!and!supernatant!enzymatic!activity!after! induction!with! phorbol! ester! (a! known! stimulant! of! cell! differentiation! and! inducer! of!oxidative!stress)!and!demonstrated!that!increase!in!GPX!levels!and!activity!occurs!after!48!to!60!hours!(391).!!NAC!is!able!to!increase!intracellular!glutathione!levels!but!its!effect!on!GPX!induction!is!not!clear.!!In!a!comparison!between!non(diabetic!and!diabetic!rats,!Ribeiro!et#al!found!higher!levels!of!GPX!activity!in!the!kidney!and!liver!of!diabetic!rats,!but!that!NAC!administration!did!not!increase!GPX!activity!in!either! group,! although! NAC! was! associated! with! reduced! markers! of! lipid!peroxidation!(392).! ! This! suggests! that! GPX! expression! may! be! associated! with!diabetes!and!obesity!(111,$390)!but!that!its!expression!is!not!increased!in!an!acute!setting,!which!contradicts! the! finding! that!GPX!activity! increased!within!hours!of!laparoscopic!and!open!cholecystectomy!(369).!!!!Both!TBARS!and!PC!are!indicators!of!oxidative!stress(induced!cellular!damage!and!both! assays! are! straightforward! enzymatic!methods.! ! TBARS! is! the!most!widely!performed! measure! of! lipid! peroxidation.! ! Significant! reductions! in! both!parameters! have! been! demonstrated! in! the!medium! to! long(term! after! bariatric!surgery,!indicating!the!general!reduction!in!oxidative!stress!!(393).! !Conversely,!a!
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number! of! studies! have! shown! that! malondialdehyde! (MDA)! levels! increase!rapidly!following!surgery.!!Plasma!MDA!levels!rose!rapidly!in!patients!undergoing!laparoscopic!prostatectomy!under!general!anaesthesia!within!60!minutes!and!120!minutes! of! induction! of! pneumoperitoneum!(394).! ! The! authors! used! an! MDA!ELISA! rather! than! the! TBARS! enzymatic! method! used! in! this! study.! ! In! a!randomised! trial! of! NAC! in! patients! undergoing! laparoscopic! gynaecological!surgery,!Beyaz!et#al! found!that!MDA!levels!(measured!by!an!unspecified!method)!increased! significantly,! by! 22%,! at! 1! and! 24! hours! after! surgery! in! patients!receiving!NAC,!although!there!was!no!increase!seen!in!the!control!group!(395).!!In!patients! undergoing! laparoscopic! Nissen! fundoplication,! which! requires! liver!retraction,!TBARS! levels! rose! significantly!by! the!end!of! surgery!and!on! the! first!post(operative!day.! !No! rise!was! seen! in!patients!undergoing! laparoscopic! lower!abdominal! surgery,! such! as! colectomy!(396).! ! A! number! of! studies! have!demonstrated!rise!in!MDA/TBARS!after!laparoscopic!cholecystectomy.!!Polat!et#al!showed! that! both! TBARS! and! PC! were! increased! by! the! end! of! laparoscopic!cholecystectomy!(370).! ! ! Seven! et# al! found! a! rise! in!MDA! and! other!markers! of!oxidative! stress! after! both! open! and! laparoscopic! cholecystectomy!(369).! ! In! a!similar!study,!Bukan!et#al!showed!that!TBARS!levels!rise!by!more!than!50%!within!45!minutes!of! laparotomy! incision,!with!a! smaller! rise!of!12%!after! induction!of!pneumoperitoneum!(397).! ! ! Oddly,! they! found! that! MDA! levels! dropped! in! the!laparoscopy! group! on! the! first! operative! day! to! <50%! of! baseline! values,!which!they! conclude! is! a! beneficial! effect! of! laparoscopy.! ! Tissue! MDA! levels! in! small!patches! of! peritoneum! rose! after! both! laparoscopic! and! open! surgery!(398).!!Similarly,! a! number! of! small! animal! models! of! pneumoperitoneum! have!demonstrated! a! rise! in! liver! tissue!TBARS! and!PC!within! hours! of! surgery!(274,$
275,$ 399-401).! ! In! contrast,! McHoney! et# al! measured! plasma!MDA! using! high(performance!liquid!chromatography!in!children!undergoing!open!and!laparoscopic!Nissen! fundoplication! and! found! no! significant! changes! from! baseline! at! end! of!surgery! or! after! 4,! 24! and! 48! hours!(402).! ! ! Aran! et# al! measured! levels! of!ischaemia(modified!albumin!and!found!an!increase!in!circulating!levels!within!30!minutes!of!induction!of!laparoscopy!but!did!not!see!a!concomitant!increase!in!MDA!or!other!markers!of!oxidative!stress!at!the!same!timepoint!(403).!!These!results!do!show!very!wide!confidence!intervals,!especially!at!Day!2,!suggesting!either!a!very!heterogenous!insult!or!problems!with!sample!processing.!!!
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!SOD!levels!rose!by!a!factor!of!mean!4.8!(95%CI!2.7(6.9)!by!the!end!of!surgery.! !1!hour!SOD!fold!change!correlates!strongly!with!24!hour!fold!change!of!IL(6,!which!also! correlates! strongly! with! Peak! CRP! fold! change.! ! The! inference! is! that! SOD!expression!is!associated!with!the!inflammatory!response!(as!indicated!by!CRP!and!IL(6!rises)!but!that!an!increase!in!its!expression!occurs!much!sooner!than!the!other!parameters.! ! !Thus,!a!rapid!rise! in!SOD! levels!by! the!end!of!surgery!predates! the!other!markers!of!inflammatory!response.!!!Interestingly,!24!hour!SOD!fold!change!correlated! strongly! with! the! 24! hour! fold! change! of! ALT,! whereas! 1! hour! fold!changes!did!not.!!This!suggests!that!transaminase!rise!and!hepatocellular!damage!is! associated! with! a! more! prolonged! period! of! oxidative! stress,! and! patients! in!whom!SOD!levels!return!to!baseline!more!rapidly!have!less!hepatocellular!damage.!!!!
5.7.2$The$effect$of$NAC$on$cytokines$Interleukin(6!(IL(6)!levels!rose!significantly!and!peaked!by!the!end!of!surgery!and!began!to!return!to!baseline!on!post(operative!day!1.!!IL(6!is!the!prototypical!“pro(inflammatory!cytokine”!in!the!literature!on!post(operative!inflammatory!response.!Bariatric!surgery!is!associated!with!significant!falls!in!IL(6!over!6(24!months!(90).!!IL(6! rises! after! laparoscopic! and! open! surgery! but! the! magnitude! of! rise! after!laparoscopic! surgery! is! smaller!(404).! ! Jacobi! et# al! have! reviewed! studies! of!laparoscopic! versus! open! cholecystectomy! to! 2002! and! found! that! 7! studies!including! 286! patients! showed! that! post(operative! IL(6! rise! was! lower! in!laparoscopic! cholecystectomy! than! in! open,!whereas! only! 1! study! of! 12!patients!showed! no! difference!(404).! ! These! types! of! studies! were! cited! during! the!introduction! of! laparoscopic! surgery! as! objective! evidence! that! laparoscopic!surgery! had! certain! advantages! over! open! surgery! in! terms! of! being! a! lesser!immunological!and!inflammatory!insult!(405).! !IL(6!stimulates!production!of!CRP!by! the! liver!as!part!of! the! inflammatory!response!(91).! !This! study!confirms! this!relationship,!as!24!hour!fold!change!of!IL(6!correlated!strongly!with!peak!CRP!fold!change!from!baseline!(p=0.016).!!!!In!this!study,!IL(10!fold!change!after!surgery!was!mean!193!(95%CI!37(350).!!This!dramatic!increase!may!reflect!the!fact!that!most!of!the!patients!were!super(obese!
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(BMI>60kg/m2),!diabetic!and!had!NASH!–!all! factors!associated!with!elevated!IL(10!(406,$ 407).! IL(10! has! traditionally! been! viewed! as! an! anti(inflammatory!cytokine.! Rabelo! et# al! found! that! IL(10! levels! correlated! with! HOMA! index! and!reduced!in!patients!with!NASH!compared!with!simple!NAFLD!(407).!!Dalmas!et#al!have!conducted!the!largest!study!of!bariatric!patients!to!include!IL(10!(406).!!They!found!that!IL(10!was!undetectable!in!the!serum!of!normal!weight!individuals!and!was!higher! in!diabetic!obese!patients! than!non(diabetic!obese!patients.! !After!12!months,! IL(10! levels! fell! in! patients! undergoing! RYGB,! along! with! all! other!measured! cytokines,! including! IL(6! and! CRP!(406).! ! NAC! has! been! shown! to!increase!IL(10!levels!in!a!randomised!trial!of!liver!transplant!patients!(408).!!Although! there! was! a! statistically! significant! difference! in! TNFα! between!treatment!groups,!this!was!a!spurious!finding!as!is!clearly!demonstrated!in!Figure!5.6.!!Mean!baseline!TNFα!levels!were!different!in!NAC!and!control!groups!and!this!difference! was! maintained! across! all! timepoints.! ! On! day! 2,! TNFα! levels! were!significantly!lower!than!baseline!(approximately!50%).! !In!contrast,!other!studies!have!shown!significant!rises!in!TNFα!following!laparoscopic!surgery,!up!to!3!fold!in!gynaecological! surgery!(409),! and! in! multiple! animal! models! of!pneumoperitoneum!(410-412).! ! TNFα! rises! after! bariatric! surgery! have! been!smaller! but! statistically! significant! after! laparoscopic! gastric! banding!(413)! and!RYGB!(414).! ! Long! term! studies! evaluating! TNFα! after! bariatric! surgery! have!produced! conflicting! results! and! a! meta(analysis! showed! that! there! are! no!significant!changes!after!12!months!(90).!!In!one!of!few!studies!where!inflammatory!markers!were!measured!at!similar!time(points,!Abramo!et#al!compared!the!effects!of!different!types!of!general!anaesthesia,!xenon,! propofol! only! and! sevofluorane,! in! 33! patients! undergoing! RYGB!(414).!!They! found!that! the!rise! in! IL(6! levels!after!surgery!and!at!12!hours! in! the! three!groups!were!the!same!order!of!magnitude!as!this!study:!End!of!surgery!fold!change!from! baseline:! xenon! median! 4.9! (range! 1.9–11.7),! propofol! 4.95! (1.5–54.3),!sevofluorane!2.7!(−6!to!62.5);!12!hours!after!4.55!(2.6–16.5),!5.40!(0.9–61.2),!3.5!(−21.2! to! 26.5).! ! Relevant! to! this! study,! the! fold! changes! were! smallest! in! the!sevofluorane!group.!!Patients!in!this!study!were!all!given!sevofluorane!anaesthesia,!after!induction!with!propofol.!!They!found!that!IL(10!levels!also!rose!after!surgery,!
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but!the!mean!fold!changes!were!dramatically!smaller!than!I!have!described,!albeit!with!very!wide!confidence!intervals:!Xenon!0.6!(−2.1!to!30.2),!propofol!1.85!(−1.4!to!14.3),! sevofluorane!5.95! (2.7–18.9)!(414).! ! In!contrast! to! IL(6,! the! largest! fold!changes!occurred!in!the!sevofluorane!group.!!TNFα!fold!changes!are!similar!to!IL(10:!Xenon!0.25!(−5.7!to!3.4),!propofol!1.45!(−6.4!to!12.9),!sevofluorane!3.95!(−3.3!to!8.9).!!Chachkhiani!et#al!compared!cytokine!levels!after!laparoscopic!gastric!banding!and!colorectal! resection!(413).! !They! found!that!cytokine!rises!were!much!smaller! in!the! obese! patients! undergoing! gastric! banding! than! the! non(obese! colorectal!patients.!!Both!groups!had!lower!cytokine!levels!than!controls!with!proven!sepsis.!!They!also!found!that!leptin!increased!significantly!and!concluded!that!it!should!be!considered! as! an! acute! phase! reactant.! ! Chung! et# al! compared! the! cytokine!response!to!RYGB!and!laparoscopic!gastric!cancer!surgery!(415).!!They!also!found!much!greater!rises!in!the!non(obese!cancer!patients!than!in!the!RYGB!group!(mean!BMI! 24! vs! 43),! despite! baseline! TNFα! and! IL(6! levels! not! being! significantly!different.! !The!gastric!cancer!patients!were!significantly!older!(mean!61!years!vs!28).! !Gastric!cancer! is!known!to!be!associated!with!increased!cytokine!levels!and!surgery! is! likely! to! be! more! complex! than! RYGB.! ! Despite! these! confounding!factors,! the!authors!postulate! that!obesity!may!also!be!associated!with!a!blunted!inflammatory!response!compared!with!non(obese!patients,!despite!the!presence!of!a! chronic! inflammatory! state! at! baseline!(348).! ! Contradicting! these! findings,! Di!Vita! et# al! measured! inflammatory! markers! in! obese! and! non(obese! patients!undergoing! laparoscopic! cholecystectomy!(416).! ! ! Compared! with! non(obese!patients,!the!obese!group!had!significantly!higher!baseline!levels!and!a!greater!rise!in!IL(6!and!Leptin!24!hours!post(operatively.!!In!contrast,!the!non(obese!group!had!much! higher! baseline! IL(10! and! adiponectin! and! these! levels! rose! significantly,!whilst!the!obese!group!had!much!smaller!non(significant!rises!at!24!hours.! !They!suggest! that! this! data! confirms! that! high! levels! of! IL(10! and! adiponectin! in!non(obese!patients!dampens!the!inflammatory!response!and!account!for!other!studies!which! show! an! association! between! obesity! and! post(operative!complications!(417).!!!
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5.7.3$Acute$changes$in$adipocytokines$after$laparoscopic$bariatric$surgery$In!this!study,!the!changes!in!adipocytokines,!leptin,!resistin!and!adiponectin,!were!not!significant!over!the!first!2!post(operative!days!and!do!not!support!the!existing!literature! suggesting! that! these! hormones! play! an! important! role! in! the! acute!phase!response.!!Given!that!adiponectin!and!TNFα!expression!in!adipose!tissue!is!inversely! correlated!(418)! and! that! TNFα! may! control! adiponectin! expression!from! adipocytes!(419),! the! findings! described! here! that! both! adiponectin! and!TNFα! levels! fell! significantly! from! baseline! on! the! second! post(operative! day! is!difficult!to!explain.! !Butner!et#al!reviewed!18!studies!measuring!adiponectin!after!bariatric! surgery! and! found! levels! increase! by! a! mean! 69.9%! after! RYGB! and!35.8%!after!restrictive!surgery!(361).!!!!As!discussed!in!Chapter!1,!the!rationale!for!evaluating!post(operative!adiponectin!response! was! following! interest! in! its! potential! use! as! a! therapy! to! ameliorate!ischaemia(reperfusion!injury!in!human!liver!transplantation.!!Jimenez(Castro!et#al!found! that! steatotic! livers!had! lower! levels!of!adiponectin!mRNA!expression!and!administration! of! adiponectin! reduced! post(transplantation! transaminase! rises!compared!with!sham!and!non(steatotic!controls!(196).! !Low!levels!of!adiponectin!may! facilitate! a! pro(inflammatory! response,! whilst! exogenous! supplementation!may! decrease! oxidative! stress,! increase! free! fatty! acid! clearance! (reducing!steatosis)! and! suppress! TNFα! expression!(195).! ! Baseline! adiponectin! levels! in!this!study!did!not!correlate!with!post(operative!liver!injury,!as!represented!by!ALT!and!CK(18!M30!and!M65!fragments!(including!1!and!24!hour!fold!changes!and!area!under!curve,!AUC).!!The!post(operative!change!in!adiponectin,!represented!by!AUC,!was!strongly!associated!with!the!changes! in! leptin!and!IL(6!but!did!not!correlate!with! BMI,! NAFLD! activity! score! or! operating! time.! ! These! findings! suggest! that!adiponectin!is!not!an!important!determinant!of!liver!injury!in!this!cohort.!!AUC!IL(6!is!the!only!cytokine!measured!in!this!study!that!correlates!strongly!with!AUC!CRP,!confirming!its!known!association!with!the!inflammatory!response!(90).!!
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5.7.4$CK-18$and$apoptosis$marker$results$Although! liver! biopsies! taken! from! bariatric! surgery! patients! have! been! used! to!evaluate!its!diagnostic!utility!in!NAFLD/NASH!(420),!there!is!only!one!longitudinal!study!showing! that!CK(18! fragment! levels! fall!6!months!after!surgery! in!patients!with!NASH!(224).!!The!data!presented!above!is!the!first!of!its!kind!measuring!CK(18! fragments! in! the! first! four! days! after! weight! loss! surgery.! ! Similar! to! the!elevation! in! transaminases,! this! study! shows! that! both! M30! and! M65! fragment!concentrations! increase! dramatically! on! the! first! post(operative! day,! before!returning! to! near! baseline! by! day! 4.! ! Although! the! arithmetic!mean! of!M30! and!M65! levels! on! day! 1! are! higher! in! the! NAC! group,! there! were! no! significant!differences! between! treatment! groups.! ! Of! note,! there! are! very!wide! confidence!intervals!on!days!1!and!2,!suggesting!that!the!extent!of! injury!measured!by!these!caspase(cleaved!fragments! is!very!heterogenous.! !This! feature! is!also!reflected! in!other!outcome!measures!in!this!study!and!discussed!at!length!in!Chapter!2.!!!!There! has! also! been! some! interest! in! the! use! of!M30:M65! ratio! as! a!method! of!differentiating! between! modes! of! cell! death,! with! higher! relative! levels! of! M30!reflecting! greater! apoptosis! than! necrosis!(421-423).! ! However,! there! are! no!specific!reports!specifying!the!utility!of!this!ratio! in!any!particular!disease!group,!let# alone! any! reports! confirming! its! validity.! ! Previously,! the! reasons! have! been!discussed! that! steatotic! liver! is!more! susceptible! to! ischaemia(reperfusion! injury!and! that!hepatocellular!necrosis! is!more! likely! in!NASH! than! in!both!NAFLD!and!non(steatotic! liver!(181).! ! In! this!study,!M30:M60!ratio! fell!significantly!by!day!2!from! baseline! 0.75! (95%! CI! 0.47! to! 1.03)! to! 0.53! (0.40! to! 0.66).! ! Despite! a!significant! increase! in!M30! on! day! 1! indicating! that! apoptotic! hepatocyte! death!does!occur,!the!balance!in!mode!of!injury!is!towards!hepatocellular!necrosis.!!Pre(operative!starvation!for!surgery!may!contribute!to!this,!as!shown!in!mice!models!where!fasting!caused!depletion!of!intracellular!ATP,!limiting!the!extent!of!energy(dependent! apoptosis!(381).! ! These! data! also! show! that! the! rapid! elevation! and!decline!in!these!markers!within!2!days!of!surgery!suggest!that!the!liver!injury!is!of!a! limited! duration! and! no! lasting! damage! is! sustained.! ! The! initial! rise! in! M30!correlates!strongly!with!ALT!and! is!also!strongly!associated!with!BMI.! !However,!there!were!no!other!significant!associations!between!CK(18! fragments!and!other!markers!or!an!association!with!NAFLD!activity!score.!!!
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Given!the!CK(18!data!showing!that!proportional!levels!of!apoptosis!do!not!increase!significantly!after!surgery,!it!is!not!surprising!that!TRAIL!and!FasL!do!not!increase.!!Increased!circulating!FasL!is!not!significantly!associated!with!NAFLD/NASH!(424)!but! is! implicated!in!ischaemia(reperfusion!injury.! !There!is!also!indirect!evidence!of!a!potential!role!for!TRAIL!with!increased!expression!of!TRAIL(death!receptor!5!in! association!with! increased! apoptosis! in! steatotic! hepatocytes!(425).! ! Steatotic!livers! are! more! sensitised! to! FasL! and! TRAIL! mediated! apoptosis!(375).! ! The!significance! of! the! fall! in! TRAIL! on! day! 1! is! not! clear.! ! ! Falls! in! TRAIL! over! the!longer! term!may!be! associated!with!weight! loss! and! reduction! in! other!markers!and!this!will!be!explored!in!the!subsequent!chapter.!!
5.7.4.1$Proteome$profiler$-$what$does$it$show?$The! proteome! profile! array! was! able! to! give! comparative! non(quantitative! data!only,! in! the! form! of! fold! changes.! ! There! were! no! significant! changes! between!treatment!groups!in!the!apoptosis!profile!and!there!was!huge!individual!variation!in!protein!expression.! !Despite! the!profiles!of!each! treatment!group! looking!very!different!from!each!other,! it! is!not!possible!to!draw!any!firm!conclusions!or!even!discern!any!vague!patterns.!!Figure!5.10!presents!the!aggregated!results!for!all!14!patients! included.! !Again,! confidence! intervals! are!wide!and! there! are!no! similar!studies!known!with!which!to!compare!the!patterns!of!mean!fold!changes.!!!!From!the!increased!expression!of!bax,!bcl2,!proCaspase3,!cIAP!1!and!2!and!reduced!expression! of! extrinsic! pathway! death! receptors,! one!may! loosely! infer! that! the!intrinsic!mitochondrial! pathway! of! apoptosis!may! have! predominated.! ! It! is! not!clear! what! effect! hepatocyte! necrosis! would! have! on! the! protein! levels.! ! Taken!together!with! the! concomitant! rise! in!both!M30!and!M65! levels,! the! inference! is!that!a!process!of! “necroptosis”!occurs! following!surgery!–!a!combined!process!of!apoptosis!and!necrosis!due! to!a!combination!of! ischaemia!and!IRI!(290).! !Future!studies! would! require! both! larger! numbers! of! samples! and! confirmatory!immunohistochemistry!studies!to!reach!clearer!conclusions.!!Proteomic!studies!in!NAFLD! have! used! various! mass! spectrometry! based! techniques! to! generate!potential!biomarkers!and!guide!future!avenues!for!research!(426).!
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5.7.5$Limitations$of$this$study$The!numerous!potential! flaws! in! study!design!have!been!discussed! in!Chapter!2.!!With! early! stoppage! after! only! 20! participants! were! recruited,! the! study! is!underpowered!and!therefore!the!statistical!conclusions!are!at!risk!of!Type!II!error.!!!The! various! oxidative! stress!markers!measured!here! are! subject! to! variations! in!sample!processing!and!analysis!and!can!be!affected!by!patient! factors!as!well.! ! It!was!also!not!possible!for!financial!reasons!to!perform!more!assays!at!all!selected!timepoints! in! order! to! get! a!more! accurate! trend! in! changes! over! time.! ! Using! a!larger!number!of!oxidative!stress!markers!or!using!different!markers,! such!as!4(hydroxynonenal! or! F2(isoprostanes! to! measure! lipid! peroxidation! and! oxidised!amino!acids!to!measure!protein!oxidation,!may!have!given!better!results!(366).!!As!discussed!in!Chapter!2,!patients!were!taking!their!regular!medications!and!some!of!these!may! have! had! an! effect.! ! One! patient! in! each! group!was! taking! insulin! for!glycaemic! control.! ! Fluctuations! in! blood! glucose! levels,! with! episodes! of!hyperglycaemia,!are!associated!with!increased!oxidative!stress!(112).!!All!patients!were! given! sevofluorane! anaesthesia! and! the! effect! of! this! agent! on! oxidative!stress! is! uncertain.! ! Experiments! in! animal! models! show! increased! levels! of!oxidative!stress!after!sevofluorane!exposure,!whilst!others!have!used!it!as!a!pre(!or!post(conditioning!agent!to!reduce!oxidative!stress!(332,$427).!The!administration!of! low!molecular!weight!heparin!has!also!been!shown!to!affect!TBARS!(428)!and!all! patients! in! this! study! routinely! received! enoxaparin! for! venous!thromboprophylaxis!as!per!standard!practice.!!Oxidative!stress!and!cytokines!may!be! affected! by! various! concomitant! medical! conditions,! especially! diabetes! and!obstructive! sleep! apnoea!(429-431).! ! In! the! only! published! trial! of! NAC! use! in!laparoscopic! surgery,! the! NAC! treatment! group! had! higher! levels! of! MDA! and!glutathione!S(transferase!by!the!end!of!surgery!(395).!!!!!! $
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6.1$Introduction$In!the!previous!chapters,!the!acute!inflammatory!response!after!bariatric!surgery!has! been! evaluated,! including! markers! specifically! looking! at! liver! injury.! ! In!contrast,! bariatric! surgery! has! beneficial! effects! in! the! long! term! in! terms! of!reducing! inflammatory!markers!and!oxidative!stress.! !This! is!achieved! through!a!combination! of! weight! loss,! improved! glycaemic! control! and! changes! in! gut!hormone! profiles.! ! NASH/NAFLD! improves! after! bariatric! surgery,! as!demonstrated! by! a! number! of! paired! liver! biopsy! studies! showing! reduction! in!steatosis,!incidence!of!NASH!and!variable!improvements!in!fibrosis.!!These!findings!are!detailed!in!Chapter!1(3.!!!!As!discussed!in!Chapter!4,!recruitment!to!the!NAC!Trial!consisted!solely!of!patients!undergoing! Laparoscopic! Sleeve! Gastrectomy! for! logistical! reasons! rather! than!through!trial!design.!!This!presented!an!opportunity!to!not!only!study!the!effects!of!bariatric!surgery(induced!weight!loss!on!markers!of!liver!injury!and!inflammatory!response!as!planned!in!the!longer!term,!but!also!to!examine!whether!LSG!had!any!specific!related!effects,!including!on!bile!acid!metabolism.!!
6.2$Background$
6.2.1$Enterohepatic$cycling$of$bile$The! development! of! accurate! profiling! techniques,! such! as! mass!spectrophotometry,! and! the! functional! characterisation! of! orphan! receptors,!including! the! nuclear! bile! receptor! farnesoid! X! receptor(α! (FXR),! have! lead! to!increased! interest! in! the!metabolic! and! signalling! effect! of! circulating! bile! acids!(BA)!(432).! !Little!was!known!of! the!more! intricate!properties!of!bile!beyond! its!
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role! in! the! emulsification! and! solubilisation! of! dietary! fats! to! allow! efficient!digestion!and!absorption.!!!Bile! production! by! the! liver! is! the! end(stage! of! cholesterol! metabolism! and! the!breakdown!of!haemoglobin!(433).!BA!are!end(products!of!cholesterol!metabolism,!formed! in!hepatocytes.! !Two!primary!BA,! cholic! acid! (CA)! and! chenodeoxycholic!acid! (CDCA)!are!conjugated!with!glycine!or! taurine.! !Conjugated!BA!are!excreted!into! the! biliary! tree,! following! concentration! of! bile! in! the! gallbladder.!!Solubilisation! of! ingested! dietary! lipids! occurs! in! the! duodenum! and! proximal!jejunum,! leading! to! the! formation! of! mixed!micelles.! ! ! Micelle! formation! allows!more!rapid!uptake!of! fatty!acids! into!enterocytes,! from!where!they!are!esterified!and!circulated!in!the!portal!blood!stream!as!chylomicrons!(433).!!Up!to!50mmol!of!BA!are!secreted!in!to!the!digestive!tract!daily,!with!only!approximately!1(5mmol!of!new!BA!being! synthesised! in! the! liver.! ! Primary! conjugated!BA!are! converted! to!secondary!BA!by! gut!microbes,! and! then! can! be! reabsorbed! in! the! ileum.! ! Thus,!over!95%!of!BA!are!recirculated!to!the!liver!by!the!portal!circulation!and!can!be!re(conjugated!with!glycine!and!taurine.! !Previous!animal!studies!have!demonstrated!that! bile! exerted! a! negative! feedback! effect! on! cholesterol! metabolism! and! BA!production!!(432).!!More! recently,! in# vitro! and! subsequent! animal! studies! have! showed! that! the!enterohepatic!circulation!of!BA!is!regulated!at!two!points!in!the!cycle.!!Within!the!liver,!cholesterol!7α(hydroxylase!(CYP7A1)!activity! is! the!rate(limiting!step! in!BA!synthesis!from!cholesterol!(434).!!Multiple!ligands!exert!control!on!CYP7A1#via!the!nuclear!RXR(FXR,!which!produces!SHP!protein!that!binds!to!the!promoter!site!on!the!CYP7A1.!!Ileal!enterocytes!produce!fibroblast!growth!factor!19!(FGF(19)!via!an!FXR(mediated! pathway.! ! FGF(19! has! a! negative! feedback! on!BA! synthesis! in! the!liver!(435).!!!Nuclear! receptors! are! transcription! factors!which! can! be! directly! activated! by! a!ligand,! either! promoting! or! inhibiting! a! wide! variety! of! cellular! metabolic!processes!at!the!gene!transcription!level.! !48!nuclear!receptors!were!identified!in!humans,! including! a! number! of! orphan! receptors! without! known! ligands.! ! FXR!provides! a! prototypical! example! of! how! knowledge! of! the! processes! controlling!cellular! metabolism! have! been! reverse(engineered,! in! contrast! with! more!
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traditional! endocrine! research,! where! hormones! such! as! insulin! were! first!identified! and! purified! before! downstream! targets! were! identified! many! years!later!(435).!!!FXR!was!found!in!high!concentration!in!the!liver!and!intestines!and!subsequently!a!large!number!of! ligands! for!FXR!were! identified.! ! !Wang!et#al! demonstrated! in!a!series!of! in#vitro!cell! line!experiments!that!a!number!of!endogenous!BA!including!lithocholic! acid! (LCA)! and! chenodeoxycholic! acid! (CDCA)! bind! FXR!(436).!!!Subsequently!Inagaki!et#al!demonstrated!in!a!rat!model!that!activation!of!intestinal!
'
Figure' 6.1' The' enterohepatic' circulation' of' bile' is' controlled' by' FGFM19,' via' FXR'
(adapted'from'Modica'et#al,'2010)''(432)'
Fibroblast!growth!factor!(FGFC19)!production!in!the!terminal!ileum!is!stimulated!by!bile!
acids! (BA)!and!has!pleiotropic!effects!on! the! liver!via! the!Farnesoid!X! receptor! (FXR)!
and!the!FGF!receptor!(FGFR).!!The!synthesis!of!BA!from!cholesterol!is!inhibited!by!SHP!
via! suppression! of! CYP7A1) activity,! the! rateClimiting! step! in! BA! synthesis.! ! FXR!
activation!also!leads!to!increased!conjugation!and!excretion!of!BA!from!the!liver.!It! is!






6.2.2$A$wider$role$for$BA,$FXR$and$FGF-19$Recent!years!have!seen!an!exponential!interest!in!the!potential!role!of!bile!beyond!merely!emulsification!and!solubilisation!of!dietary!fats!to!allow!efficient!digestion!and!absorption.! !The! identification!of! the!FXR! transcription!pathway!has! in! turn!lead!to!characterisation!of!a!number!of!other!related!receptor!pathways,!including!liver!orphan!receptor!(LXR),!retinoid!X!receptor!(RXR),!pregnane!X!receptor!(PXR)!and!other!BA!regulating!genes,!including!CYP7B1!and!CYP27A1!(437).!!There!are!a!large! number! of! individual! BA! that! act! as! ligands! of! FXR,! as! well! as! other!intracellular! compounds,! including! various! cholesterol!moieties! and! arachidonic!acid!metabolites.!!Many!of!these!potential!ligands!have!been!identified!as!having!an!action! at! supraphysiological! doses! and! it! is! unclear! if! they! have! a! significant! or!specific! role! in# vivo.! ! The! role! of! FXR! has! now! extended! beyond! cholesterol!regulation! to! include! lipoprotein,! glucose! metabolism! and! liver! regeneration.!!Aberrant! FXR! function! is! also! implicated! in! carcinogenesis! and! chronic! liver!diseases.! ! Loss! of! regulation! via! FXR! can! lead! to! high! circulating!BA,!which!may!cause!liver!toxicity!(438).!!!!BA!also!act!through!TGR5,!a!G(protein!coupled!receptor!found!in!enteroendocrine!cells,! in! high! concentrations! in! brown! adipose! tissue,! stomach,! pancreas! and!liver!(439).!!Via!a!cAMP(dependent!pathway,!TGR5!activation!is!associated!with!an!increase!in!GLP(1.!!Thomas!et#al!were!able!to!demonstrate!that!TGR5!activation!by!a! synthetic! agonist! lead! to! calcium! dependent! release! of! GLP(1! from! a! cultured!enteroendocrine! cell! line!(440).! ! They! then! used! the! same! agonist! in! various!knockout! and! diabetic! mice! models! to! show! that! TGR5! activation! leads! to!improved! glucose! homeostasis! and! decreased! insulin! resistance,! associated!with!increased! GLP(1.! ! TGR5! may! also! suppress! production! of! inflammatory!cytokines!(51).! !TGR5! is!also! linked! to!resting!energy!expenditure,!by!promoting!
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the! activation! of! intracellular! thyroid! hormone.! ! Watanabe! et# al! were! able! to!reduce!weight! gain! in! a! high(fed!mouse!model! by! supplementing! their! diet!with!Cholic! Acid! CA,! leading! to! higher! energy! expenditure! as! measured! by! indirect!calorimetry!and!also!decreased!accumulation!of!white!adipose!tissue!(441).!!TGR5!is!present!in!the!liver!and!in!TGR5!knockout!mice,!total!BA!pool!size!is!reduced!by!≤25%,!indicating!some!involvement!in!BA!homeostasis!(439).!!!!
6.2.3$FXR,$FGF-19,$Bile$Acids$and$Glucose$regulation$Following!binding!with! ligand,!nuclear! receptors! such!as!FXR!are!able! to! initiate!transcription!of! the! target!genes!via! their!DNA(binding!domain.! !These!receptors!act! as! sensors! within! the! cell! milieu! and! able! to! modulate! cell! processes! in!response!to!any!changes.!!Transgenic!mice!experiments!provided!much!of!the!early!evidence! for! FXR.! ! FXR! knockout! mice! have! increased! insulin! resistance.!!Administration!of!a!synthetic!FXR!agonist!to!diabetic!mice!lowered!blood!glucose!and! increased! hepatic! glycogen! production,! whilst! overexpression! of! FXR! also!produced!the!same!changes!(442).!!FXR!activation!also!increased!intestinal!FGF(19!and! FGF(21! production.! ! Exogenous! FGF(19! caused! weight! loss! and! improved!insulin!sensitivity!in!another!mouse!model.!!Clinical!studies!have!also!demonstrated!that!the!FXR(FGF(BA!axis! is! important! in!humans.! ! Administration! of! the! bile! acid! sequestrant! colesevelam! leads! to!improved! glucose! control! in! Type! II! diabetics! (T2DM)! whose! existing! glucose!control!was!poor,!in!a!number!of!large!scale!placebo(controlled!studies!of!patients!taking! either! metformin! or! insulin(based! therapy!(443).! ! This! improvement! is!through! the! changes! in! circulating! BA! profile,! mediating! effects! via! the! FXR!pathway!(444).!!!!
6.2.4$Bile$acids$and$Fatty$liver$disease$As!discussed!in!Chapter!2,!the!crucial!events!in!the!pathogenesis!of!NAFLD/NASH!are! the! accumulation! of! intra(hepatocyte! lipid,! formation! of! damaging! Reactive!Oxygen! Species! due! to! mitochondrial! fatty! acid! oxidation! and! dysfunction! and!activation! of! a! local! inflammatory! response,! eventually! leading! to! hepatocyte!
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apoptosis! and! necrosis.! ! These! activities! also! stimulate! fibrosis.! ! This! process!occurs! in! the! context! of! hepatic! insulin! resistance.! ! Both! FXR! and! TGR5! play!important! roles! in! regulating! lipid! metabolism! and! hepatic! triglyceride! (TG)!synthesis,! as! well! as! modulating! production! of! inflammatory! cytokines! in! liver!macrophages,! monocytes! and! Kuppfer! cells!(51).! ! FXR! knockout! mice! have!elevated!plasma!TG!levels,!hepatic!steatosis!and!elevated!levels!of!TNFα!and!other!pro(inflammatory!cytokines.!!Studies!involving!TGR5!knockout!mice!suggest!that!it!also! mediates! anti(steatotic! and! anti(inflammatory! effects!(439).! ! ! The! range! of!effects!of!FXR!and!TGR5!activation!on!metabolism!are!summarised! in!Figure!6.2.!!There!is!ongoing!clinical! interest! in!the!use!of!exogenous!BA!for!the!treatment!of!NAFLD/NASH.! ! Ursodeoxycholic! acid! (UDCA)! is! a! secondary! BA! that! has! been!shown! to! exert! an! anti(apoptotic! effect! on! hepatocytes,! reduce! circulating! TNFα!levels! and! improve!hepatic! insulin! sensitivity!(445).! ! ! A! systematic! review!of!12!studies!of!UDCA!in!1160!patients!has!shown!that!treatment!with!oral!UDCA!leads!to! reduction! in! ALT! and! reduced! fibrosis! and! steatosis!(446).! ! Methodological!quality! of! these! studies! is! poor! and! open! to! risk! of! bias! so! UDCA! cannot! be!unequivocally!recommended!as!a!treatment.!!Nevertheless,!there!is!much!interest!in!the!concept.!!Recently,!a!synthetic!version!of!CDCA,!obeticholic!acid!(OBCA)!has!been!developed.! !OBCA!has!a!100(fold!greater!affinity! to! the!FXR!receptor!and!a!number! of! cell! line! and! animal! studies! have! shown! that! it! can! exert! anti(inflammatory! effect! in! the! liver,! reduce!hepatic! fatty! acid! synthesis! and! improve!hepatic! insulin! sensitivity!(447).! ! A! phase! II! clinical! trial! of! a! 6! week! course! of!OBCA! in! patients! with! T2DM! and! NAFLD! showed! improvements! in! insulin!sensitivity!and!reduced!non(invasive!markers!of!hepatic! fibrosis! in!the!treatment!groups!(448).!!
6.2.5$Bile$Acids$and$Bariatric$Surgery$With! increasing! interest! in! the! role! of! BA! in! diabetes! and! introduction! of! bile!sequestrants!as! treatment! for!T2DM,! it! is!no!surprise! that! there!are!a!number!of!studies! looking! at! the! effects! of! bariatric! surgery! on! BA! profile.! ! As! detailed! in!Chapter!1,!bariatric! surgery! leads! to!dramatic! improvement! in! insulin! resistance!and!glycaemic!control.! !After!RYGB,! the! improvement! in!IR!occurs!within!days!of!
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surgery! before! any! significant! weight! loss! occurs.! ! A! number! of! groups! have!studied!both!immediate!and!long(term!changes!in!BA!after!bariatric!surgery.!!Of! 10! published! studies! including! patients! undergoing! bariatric! surgery,! nine!studies! included! patients! undergoing! RYGB! (see! Appendix! 3! Table! C.1! for! a!summary!of!these!studies)!(449-458).!!All!nine!studies!show!that!total!BA!increase!following! RYGB! surgery,! although! the! timing! of! the! increase! is! variable.! ! In! the!largest! cohort! study,! Gerhard! and! colleagues! included! 186! patients! undergoing!RYGB! (BMI>35)! and! also! included! 110! overweight! controls! (BMI! 30(35)!(450).!!This! was! a! cross(sectional! study! with! RYGB! patients! included! at! variable!timepoints! following! surgery! (median! 140(150! days).! ! In! patients! who! had! not!been!operated,!diabetic!patients!had!lower!circulating!FGF19!and!higher!total!BA!compared! with! patients! without! diabetes.! ! Although! total! BA! and! FGF19! levels!were! lower! in!obese!patients!who!went!on!to!have!surgery,! the!differences!were!not!significant!and!there!was!no!correlation!when!the!whole!group!was!analysed!together.! There!was! an! inverse! correlation! between! FGF19! and! hepatic! CYP7A1!expression.!!In!patients!post(RYGB,!FGF19!and!total!BA!increased!non(significantly.!!Subgroup!analysis!showed!that!the!increases!were!significantly!higher!in!patients!





FXR! improves! insulin! resistance,! reduces! inflammation! and! decreases! energy!
expenditure.! ! The! interaction!with! the! effects! of! TGR5! is! not! fully! elucidated! but! it!
appears! that! TGR5!has!mainly! effects! on! improving! insulin! resistance! and! increasing!
energy! expenditure.! ! FXR! agonists! are! already! in! clinical! use! and! there! is! increasing!
interest!in!harnessing!the!effects!of!TGR5!for!clinical!use.!suggest!that!diabetes!is!associated!with!lower!FGF19!and!BA!levels!and!that!these!rise! post(RYGB,! especially! in! diabetic! patients! whose! glucose! control! improves.!!Most!pertinently,! even! in! this! relatively! large! study,! the!variability!of!FGF19!and!BA!levels!is!high,!with!standard!deviations!often!exceeding!the!given!mean!value.!!!Dynamic!measurement! of! the! post(prandial! BA! response!was! performed! in! two!smaller! studies! by! Ahmad! et# al! (5! patients! with! RYGB)! and! Kohli! et# al! (8!RYGB)!(449,$ 453).! ! Ahmad! et# al! show! that! the! post(prandial! rise! in! total! BA! is!smaller! in! obese! patients! compared! with! non(obese! controls.! ! Post(RYGB,! both!fasting! and! post(prandial! BA! rise! is! greater.! ! Kohli! et# al! similarly! demonstrate! a!significant!increase!in!the!post(prandial!BA!rise!compared!with!the!pre(operative!values.!!Ahmad!et#al!do!not!specifically!look!at!the!role!of!diabetes!and!Kohli!et#al!excluded!diabetic!patients.! !Pournaras!et#al! showed! that! the! rise! in! total!BA!and!FGF19! occur! at! 4! days! and! 42! days,! before! significant! weight! loss! has!occurred!(456).!!!!The! overall! inferences! to! be! drawn! from! these! studies! are! that! RYGB! leads! to!increases!in!FGF!(4!studies)!and!BA,!either!fasting!and/or!post(prandial!(450,$452,$
455,$ 456).! ! Given! the! dramatic! and! rapid! reduction! in! insulin! resistance! after!RYGB,!one!might!postulate!that!the!FGF(BA!axis!is!implicated!in!this!improvement.!!In!contrast,!the!effect!of!LSG!on!enterohepatic!circulation!has!not!been!studied!in!depth.! ! Nakatani! et# al! included! 15! (/34)! patients! who! underwent! restrictive!surgery!and!had!an!undefined!mixed!group! including!both!LSG!and!LAGB!(454).!!LAGB!has!been!shown!to!have!no!significant!effect!on!circulating!total!BA! in! two!other!studies!with!a!total!of!18!LAGB!patients!(Kohli!et#al,!2013!and!Pournaras!et#al!2012).!!However!Nakatani!et#al!report!dramatic!rises!in!BA!in!the!restrictive!group!
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that! exceed! the! levels! seen! in! their!malabsorptive! group! of! patients! undergoing!RYGB!and!BPD.!!Steinert!et#al!report!no!significant!difference!in!total!BA!over!the!first! year! after! LSG! in! 7! patients,! compared!with! the! RYGB! group!who! only! had!significant! increases!at! the!12!month!timepoint!(458).! !Haluzikova!et#al! included!17! non(diabetic! females! undergoing! LSG! and! compared! them! with! 15! healthy!controls!(451).!!They!report!a!significant!increase!in!FGF19!after!6!months!but!no!significant!changes!in!total!BA.!
6.3$Aims$of$this$chapter$The!aim!of!this!study!is!to!evaluate!the!effects!of!LSG!at!6!months!post(surgery!on!markers! of! inflammation,! oxidative! stress! and! liver! injury.! ! Given! the! interest! in!the!effects!of!bile!acids!on!fatty!liver!disease,!the!aim!was!to!determine!if!there!is!any! relationship! between!weight(loss! related! changes! in! insulin! resistance,! lipid!profiles!and!circulating!BA!levels.!!There!is!a!paucity!of!research!into!the!effects!of!LSG! on! BA! metabolism! and! the! findings! of! this! study! will! further! aid! the!understanding!of!these!changes.!!!! $
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6.4$Methods$
6.4.1$Patients$and$Samples$Patients! were! recruited! as! part! of! the! NAC! Trial.! ! Protocol! details! are! given! in!













6.4.3.1$Plasma$Fibroblast$Growth$Factor$19$FGF(19!was!measured!using!Quantikine!Human!FGF(19! Immunoassay! from!R&D!Systems! Europe! Ltd! (Abingdon,! UK).! ! This! is! another! sandwich! enzyme!immunoassay! and! the! protocol! is! exactly! the! same! as! that! given! in! Chapter! 3!Section!3.4.3.2!for!TRAIL!and!FasL.! !The!only!substitutions!are!Calibrator!Diluent!RD5P!is!used!instead.!!FGF(19!standards!used!were!of!the!same!concentrations!as!described!in!the!TRAIL!and!FasL!ELISAs.!!!!
6.4.3.2$Hyaluronic$Acid$The!TECO!Hyaluronic!Acid!ELISA!kit!!(TECOmedical!AG,!Sissach,!Switzerland)!was!used!to!measure!HA.!!This!is!sandwich!enzyme!immunoassay,!using!a!horseradish!peroxidase! (HRP)! conjugated!HA!binding! protein! (HABP).! ! This! is! coated! on! the!microplates!and!catalyses!a!substrate!reaction!in!a!quantitative!manner.!!Sample!timepoints!used!for!HA!assay!were!Pre(operative!and!6!months.!
6.4.3.2.1$Reagents$and$Standards$used$in$the$assay$
HA!binding!protein(coated!96!well!plate!HABP(HRP!conjugate!6!premixed!HA!Standards:!0,!15,!50,!150,!450!and!1000!ng/ml!Sample!diluent!Tetramethylbenzidine! Solution! in! two! parts! ! (! stabilised! TMB! and! stabilized!hydrogen!peroxide!Wash!Buffer!–!buffered!surfactant!with!preservatives!
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Stop!Solution!–!sulphuric!acid!1M!Deionised!water!Standards!came! in! separate!prefilled!vials.! !Each!standard!was!diluted!1:50!with!sample!diluent! in! a! ratio!of!10μl! Standard:490μ!diluent.! ! 100μl!of! each! standard!was!transferred!to!the!96!well!plate!in!duplicate.!!
6.4.3.2.2$Reagent$and$Sample$Preparation$
All!reagents!were!brought! to!room!temperature!before!use.! !Wash!and!Cell!Lysis!buffer!concentrates!were!diluted!with!deionised!water.!!!Serum!sample!aliquots!were! thawed!on! ice.!1:50!sample!dilution!was!performed!by!mixing!10μl!of!sample!in!490μl!of!Sample!Diluent.!!100μl!of!diluted!sample!per!well! were! transferred! to! the! ELISA! plates! in! duplicate,! according! to! a!predetermined!plate!map.!
6.4.3.2.3$Assay$procedure$
100!μl!of!sample!and!standard!was!added!to!each!well,!in!duplicate!according!to!a!plate! map.! ! The! covered! microplate! was! incubated! for! 2! hours! at! room!temperature,!placed!on!a!horizontal!shaker!set!at!500!rpm.!At!the!end!of!this!period,!the!wells!were!aspirated!and!washed!three!times,!with!a!volume!of!350μl!Wash!Buffer!per!well! per!wash.! !After! the! last!wash,! the!plates!were! inverted! forcefully!onto!blotting!paper! to! ensure! all!Wash!Buffer!had!been!removed.! !100!μl!of! the! relevant!HABP(HRP!was!added! to!each!well.! !The!plates!were! again! incubated! for! 30! hours! at! room! temperature,! on! a! shaker! as! before.!!The!washing!step!was!repeated!five!times!as!above.! !100!μl!of!the!relevant!TMB(Substrate! solution!was! added! to! each!well.! ! Both! plates!were!mixed! gently! and!incubated! for! 30! minutes! at! room! temperature,! in! the! dark,! on! a! shaker! set! at!500rpm.!At! the! end! of! this! period,! 100! μl! Stop! Solution!was! added! to! each!well! and! the!plates!were!gently!shaken!to!ensure!mixing.!The! absorbance!was! read! by! a!microplate! reader! at! 450! nm!with! the! reference!filter! set! between! 590(650nm! (Dynex! MRX,! Dynex! technologies! Ltd.! Worthing,!
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UK).!The! standard! curves!were!generated,!using!Linear! regression!with!Log/Log!axes!scaling.!!R2!was!0.99!for!both!plates.!!Concentrations!of!HA!were!interpolated!from!the!standard!curves.!!!!
$
6.4.4$Bile$acids$by$LC-MS/MS$$BA! were! measured! by! Dr! Royce! Vincent,! Consultant! in! Clinical! Biochemistry! at!King’s!College!Hospital!in!the!Department!of!Biochemistry.!!He!kindly!provided!the!protocol!described!below.!!Sample!timepoints!used!for!BA!analysis!were!pre(operative!and!6!months.!
6.4.4.1$Reagents$and$Standards$used$in$the$assay$
All! solvents! and! chemicals! were! sourced! from! Sigma(Aldrich! (Sigma(Aldrich!Company!Ltd,!Dorset,!UK)!unless!otherwise!stated.!!




Extraction! of! BA! from! EDTA(plasma! was! performed! as! described! previously! by!Tagliacozzi!et#al!(459).!A!protein!precipitating!solution!of!acetonitrile!containing!each! of! the! internal! standards;! a! 2,2,4,4,d4(! DC! for! each! of! the! BA! chemistries:!unconjugated,! glycine(! and! taurine(! conjugated! was! prepared.! 800μL! of! protein!precipitating! solution!was! added! to!250μL!of! sample! and!vortex(mixed.! Samples!were! centrifuged! at! 13000! RPM! for! 10!minutes.! ! 900μL! of! the! supernatant!was!transferred! into! fresh! microtubes.! The! supernatant! was! then! blown! to! dryness!using! compressed! air! in! a! 60°C! heated! block.! The! residue!was! re(constituted! in!250μL!of!a!50:50!(v/v)!mix!of!mobile!phases!A!and!B.!The!re(constituted!solution!was!transferred!to!HPLC!vials!and!10μL!injected!onto!the!column.!!
6.4.4.3$Assay$Procedure$$












6.4.5$$Statistical$Analysis$Statistical!analyses!were!performed!using!SPSS!20!(SPSS,!USA).!!Before!comparative!statistical!tests!were!performed,!outliers!were!sought!visually!using!boxplots.!!The!assumption!of!normality!was!tested!for!each!parameter,!using!values!of!the!difference!between!paired!samples!before!and!6!months!after!surgery!using!the!Shapiro(Wilk’s!test!(p>0.05).!!Only!BMI,!ALT!and!AST!met!the!criteria!of!having!minimal!numbers!of!outliers! and!normally!distributed!paired!differences.!!These! data! are! therefore! presented! as!Mean!with! 95%! confidence! intervals! and!paired! t(tests! were! performed! to! compare! the! two! timepoints.! ! All! other!parameters! are! presented! as!median!±! interquartile! range! and!Mann(Whitney(U!tests! were! performed! to! compare! timepoints.! ! For! ease! of! comparison,! all!continuous!data!were!presented!graphically! as!boxplots,! including!BMI,!ALT!and!AST.! ! Note! that! the! median! values! for! these! three! parameters! were! almost! the!same!as!mean!values.!!!!For! parameters! whose! values! changed! significantly! between! timepoints,! a! fold!change! ratio! was! calculated! as! [6month! value]/[Baseline! value].! ! These! values!were! log2! transformed.! ! The! assumption!of! normality!was! tested!using! Shapiro(Wilk’s!test!(p>0.05).!!Linearity!was!checked!visually!using!scatterplots.!!Pearson’s!correlation!was!performed!between! these!parameters! to! look! for! any! significant!associations.!!The!sample!size!was!too!small!to!perform!regression!analysis.!!Clinical!significance!was!determined!if!p<0.05.!! $
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6.5$Results$





! Before!LSG! After!6months! p!value!
Weight!kg! 167$(155$–$182)$ 121$(104$–$139)$ <0.001$
BMI!kg/m2! 60.6$(55.3165.8)$ 45.8$(41.5$1$50.1)$ <0.001$
ALT!IU/L! 31$(26$1$37)$ 18$(15$1$22)$ <0.001$
AST!IU/L! 27$(23$1$30)$ 20$(17$1$23)$ <0.001$
Fasting!Glucose!mmol/L! 7.2$(6$1$8.8)$ 4.8$(4.4$1$5.7)$ 0.004$
Fasting!Insulin!mIU/L! 25$(14.2$1$33.8)$ 8.6$(5.5$1$13.4)$ 0.001$
HOMADIR! 7.7$(5.3$1$11.8)$ 1.7$(1.2$1$3.1)$ 0.001$
HBA1c!!%! 6.5$(5.9$1$7.7)$ 5.5$(5.1$1$6.1)$ 0.008$
Cholesterol!mmol/L! 4$(3.7$1$4.6)$ 4$(3.6$1$4.7)$ ns$
Triglycerides!mmol/L! 1.6$(1.1$1$2.2)$ 1.3$(0.9$1$1.7)$ ns$
LDL!mmol/L! 2.2$(1.7$1$2.7)$ 2.4$(1.8$1$3.3)$ ns$
HDL!mmol/L! 1.1$(1$1$1.2)$ 1.1$(0.9$1$1.2)$ ns$
NEFA!mmol/L! 0.7$(0.48$1$0.93)$ 0.45$(0.37$1$0.56)$ 0.008$
! $ $ $
TBARS!nmol/ml! 14.4$(6.6$1$24.7)$ 13.8$(5.7$1$16.6)$ ns$
GPX!U/ml! 8.9$(4$1$11.9)$ 10.8$(8.8$1$12.9)$ ns$
! $ $ $CRP!mg/L! 10.3$(6.8$1$20.7)$ 6$(5$1$17.4)$ 0.05$
ILD6!pg/ml! 6$(3.5$1$8.3)$ 4.3$(3.2$1$5.5)$ 0.04$
ILD10!pg/ml! 0.7$(0.3$1$1.1)$ 0.7$(0.7$1$0.7)$ ns$
TNFα!pg/ml! 7$(4.1$1$7.6)$ 7.3$(6.2$1$9.4)$ ns$
! $ $ $
Leptin!ng/ml! 142$(101$–$206)$ 48$(20$1$84)$ 0.001$
Resistin!ng/ml! 8.5$(6.1$–$15.2)$ 9.9$(6.2$–$13.8)$ ns$
Adiponectin!ng/ml! 9285$(6956$1$11917)$ 9760$(6403$1$12154)$ ns$
! $ $ $
HA!μg/L! 30.7$(20.1$1$53.5)$ 25.8$(11.9$1$63.8)$ ns$
M65!IU/L! 249$(202$1$535)$ 240$(163$1$264)$ 0.015$
M30!IU/L! 174$(123$1$251)$ 132$(105$1$140)$ 0.001$
CK18ratio! 0.64$(0.36$1$0.89)$ 0.55$(0.45$1$0.67)$ ns$
TRAIL!pg/ml! 100.6$(65.3$1$120.3)$ 95.4$(81.6$1$116.4)$ ns$
FasLigand!pg/ml! 94.6$(63.4$1$107.1)$ 84.3$(80.2$1$112.1)$ ns$
























6.5.2$FGF-19$and$Bile$Acids$FGF(19! levels! rose! significantly! over! the! study! period,! from! a! baseline! median!128.1!(89.4!(!210.1)! to!177.1(121.8! (!288.9,!p=0.045).! !This!was!accompanied!by!no! significant! changes! in! total!bile! acid! concentration.! !More!detailed!analysis!of!specific!constituent!bile!acids!showed!significant!rise!in!glycoursodeoxycholic!acid!(GUDCA)! and! falls! in! glycocholic! acid! (GCA),! deoxycholic! acid! (DCA)! and!taurocholic! acid! (TCA)! (see! Table! 6.2).! ! Fold! change! values! were! calculated! as!ratios!of!6!month:!Baseline!concentrations!and!represented!in!Figure!6.7.!!!!! $
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Table$6.2:$Bile$acid$profiles$before$and$6$months$after$LSG$surgery$
Abbreviations:! RYGB,! RouxCenCY! gastric! bypass;! BAs,! Bile! acids;! CA,! CDCA,!DCA,! LCA,!
UDCA,! cholic,! chenodeoxycholic,! deoxycholic,! lithocholic! and! ursodeoxycholic! acids,!






Fasting%BAs%(µmol/L)% !! !! !!
Total!BA!! 2.35!(1.41!0!3.66)! 2.41!(1.84!0!3.04)! ns!
Total!GCBA!! 1.14!(0.67!0!1.96)! 1.49!(0.73!0!2.14)! ns!
Total!TCBA! 0.24!(0.16!0!0.36)! 0.17!(0.14!0!0.32)! ns!
Total!unconjugated!BA! 0.58!(0.41!0!0.95)! 0.46!(0.25!0!0.81)! ns!
!! ! ! !
Primary'BAs! ! ! !
CA!! 0.06!(0.02!0!0.2)! 0.03!(0.03!0!0.08)! ns!
CDCA!! 0.14!(0.08!0!0.31)! 0.09!(0.05!0!0.23)! ns!
!! ! ! !
Primary'conjugated'BAs! ! ! !
GCA!! 0.2!(0.08!0!0.3)! 0.09!(0.04!0!0.17)! 0.048*!
TCA!! 0.01!(0!0!0.07)! 0!(0!0!0.02)! 0.039*!
GCDC!! 0.51!(0.22!0!1.21)! 0.56!(0.25!0!1.12)! ns!
TCDC!! 0.09!(0.04!0!0.15)! 0.03!(0.02!0!0.14)! ns!
!! ! ! !
Secondary'BAs! ! ! !
DCA!! 0.24!(0.16!–!0.42)! 0.13!(0.09!–!0.23)! 0.048*!
UDCA!! 0.06!(0.04!0!0.07)! 0.07!(0.03!0!0.32)! ns!
LCA!! 0.01!(0.01!0!0.02)! 0.01!(0.01!0!0.02)! ns!
!! ! ! !
Secondary'conjugated'BAs! ! ! !
GDCA!! 0.19!(0.12!–!0.36)! 0.15!(0.10!–!0.37)! ns!
TDCA!! 0.08!(0.05!0!0.11)! 0.07!(0.05!0!0.08)! ns!
GUDCA!! 0.1!(0.05!0!0.15)! 0.26!(0.06!0!0.63)! 0.004*!
TUDCA!! <LOD! <LOD! !
GLCA!! 0.07!(0.06!0!0.08)! 0.07!(0.06!0!0.08)! ns!





Abbreviations:! RYGB,! RouxCenCY! gastric! bypass;! BAs,! Bile! acids;! CA,! CDCA,!DCA,! LCA,!




• between! markers! of! liver! injury! and! inflammatory! markers/oxidative!stress!
• whether! the! parameters! that! changed! significantly! over! the! study!period!were!related!to!individual!changes!in!bile!acids.!!Pre(operative! BMI! correlated! with! CRP! (Spearman’s! rho=0.596,! p=0.007)! and!HOMA!correlated!significantly!with!baseline!Resistin!(rho=!0.574,!p=0.02).!!There!was!no!correlation!with!other!inflammatory!markers!or!oxidative!stress.!
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FGF19! BMI! Insulin! HOMA! NEFA! IL46! CRP! Leptin! M30! M65!
GCA! 0.21! 0.21! 0.45! 0.47! 0.26! 0.14! 40.05! 0.48! .70**! 0.32!
TCA! 0.56! 0.31! 0.56! 0.59! 0.46! 40.34! 40.52! .68*! 0.63! 0.14!
DCA! 0.27! 0.02! .60*! 0.42! 40.31! 0.48! 40.08! 0.24! 0.41! .50*!
GUDCA! 0.11! 40.28! 0.11! 0.09! 40.40! 40.06! 0.20! 40.07! 0.30! 0.35!!
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6.6$Discussion$
6.6.1$Clinical$results$This! study!demonstrates! that! LSG! is! associated!with! significant!weight! loss! over!the!first!6!months,!along!with!dramatic!improvements!in!insulin!resistance,!HBA1c!and! reduction! in! co(morbidities.! ! Mean! %EBWL! of! 42%! concords! with! the!published!literature!!(36).!!Diabetes!mellitus!improved!in!9!of!10!patients!and!only!3!of!15!patients!with!OSA!still!required!CPAP!machines!at!the!end!of!the!study.!!In!a!meta(analysis! looking! at! diabetes! resolution! after! LSG,! Yip! et# al! reported! that!resolution!rates!(as!defined!by!HBA1c<6.5%)!were!56%!at!3!months,!68%!at!1!year!and!80%!at!36%!after!SG.! !This!study!confirms!the! findings!of!other!centres!that!LSG!offers!comparable!short!and!medium(term!results!to!RYGB.!!Lipid! profiles! did! not! change! significantly! over! 6! months! and! this! reflects! the!aggressive! pre(operative! treatment! of! the! study! participants!with! lipid(lowering!medications.! ! Perioperative! statin! use! is! associated! with! a! lower! risk! of!cardiovascular! events! in! patients! undergoing! cardiac! and! non(cardiac! vascular!surgery!and!is!recommended!for!use!in!all!high(risk!patients!(460).! !The!patients!in! this! cohort! were! at! higher! risk! of! complications! due! to! their! multiple! co(morbidities,! including!diabetes!mellitus,!hypertension!and!OSA,!and!the!extent!of!their!morbid!obesity! (mean!BMI>60kg/m2)!(461).! !Only! two!patients!had!a! total!cholesterol! >5mmol/L,! both! of!whom!had!no!previous!diagnosis! of! dyslipidemia!and!were!not!on!lipid(lowering!medications.!!All!patients!on!statin!medications!had!pre(operative!cholesterol!<5mmol/l! (mean!3.9).! !Similarly,! it!was!not!possible! to!show!any!relationship!between!TG!levels!and!severity!of!NAFLD!(as!measured!by!NAS)!as!concentrations!were!within!normal!range!before!and!after!surgery!(462).!!NEFA!levels!fell!significantly!in!the!study!cohort.!!NEFA!or!free!fatty!acids!(FFA)!are!released! into! the! plasma! by! breakdown! of! adipocyte! triglycerides! (TG)! and! are!taken! up! in! other! organs! either! to! synthesis! TG! or! be! used! as! an! energy!source!(463).! !NEFA!levels!are!higher!in!obese!and!diabetic!subjects!although!the!relationship! is! complex! and! not! linear!(463).! ! Decrease! in! NEFA! are! associated!with!improvements!in!insulin!resistance,!reflecting!decreased!lipolysis! in!adipose!tissue,!improved!peripheral!glucose!utilisation!and!changes!in!whole(body!energy!
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metabolism!(464).! ! The! fall! in! NEFA! levels! do! not! correlate! with! changes! in!biomarkers!or!bile!acid!profile! in!this!study.! ! !However,! there! is!much!interest! in!post(prandial! NEFA! levels! in! T2DM,! with! studies! showing! that! post(bariatric!surgery!falls! in!circulating!NEFA!correspond!to!resolution!of!diabetes!(465-468).!!There! are! no! published! studies! evaluating! NEFA! post(LSG.! ! Kawano! et# al! have!studied!FFA!concentrations!after!SG!and!GB!in!an!obese!rat!model!and!showed!that!FFA! is! significantly! lower! after! SG! than! GB!(469).! ! Although! there! are! no!comparative!RYGB!data!in!the!present!study,!the!results!presented!above!are!novel!and! add! to! the! growing! literature! regarding! the! metabolic! impact! of! LSG!(56).!!Further!studies!including!evaluation!of!the!incretin!effect,!along!with!post(prandial!changes,!are!required!to!elucidate!the!mechanisms!of!this!metabolic!impact.!!!
6.6.2$Oxidative$stress$after$LSG$As! discussed! at! length! in! the! Introduction,! obesity! is! associated! with! increased!markers!of!oxidative!stress!and!bariatric!surgery!is!associated!with!reduction!(70).!!Levels!of!TBARS,!measuring!MDA!as!a!marker!of!lipid!peroxidation,!and!GPX,!used!here! as! a! measure! of! antioxidant! defense,! did! not! change! significantly! after! 6!months.! ! This! is! in! contrast! to! a! number! of! studies,! as! described! in! Chapter! 1!Section!1.6.4.!!Cabrera!et#al!measured!a!decrease!in!MDA!from!16.7!to!9.11!nmol/g!protein!12!months!after!RYGB,!a!45%!reduction!!(110).!!Uzun!et#al!recorded!a!22(24%!reduction!in!TBARS!6!months!after!open!and!laparoscopic!adjustable!gastric!banding!(108).! !GPX!has!not!been!studied!previously!in!bariatric!surgery!patients!over! a! 6! month! time! period,! although! it! is! the! most! abundant! cytosolic!antioxidant!(389)! and! an! increase! within! 1! week! of! RYGB! has! been!measured!(390).!!The!results!here!may!be!due!to!the!participants!having!very!high!BMIs,! so! that! at! 6!months,!mean!BMI!was! still! >45! kg/m2.! ! This! indicates! these!patients! were! still! morbidly! obese! and! still! subject! to! the! pathophysiological!sequelae!of!obesity.!!The!patients!in!the!studies!quoted!above!had!baseline!BMI!of!47!and!53(54,!falling!to!30!and!40(41!respectively!(108,$110).!!Boesing!et#al!found!that!TBARS! levels! increased!dramatically!by!84%!6!months!after!RYGB,!although!levels!of!all!antioxidants!also!increased.!!Myeloperoxidase,!an!enzyme!secreted!by!activated!neutrophils!that!generates!ROS!and!causes!lipid!peroxidation,!decreased!significantly!by!40%!over!the!same!time!period!(113).!!The!authors’!conclude!that!lipid! peroxidation!may! persist! for! some! time! after! surgery,! despite! weight! loss.!!
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Taken! together!with! the! findings! presented! here,! the! inferences! are! that! TBARS!and!GPX!either!do!not!accurately!reflect! the!state!of!oxidative!stress!or! that! they!both! measure! a! particular! end(product! that! is! specifically! not! changed! after!surgically(induced!weight!loss.!!!!There!were!no!demonstrable!correlations!between!oxidative!stress!and!glycaemic!parameters.!!Although!there!is!convincing!evidence!that!diabetes!is!associated!with!oxidative! stress,!many! of! these! studies! looked! at! tissue!markers!(68)! and! direct!relationships!with! blood! glucose,! HOMA! or! HBA1c! have! not! been! demonstrated!elsewhere!either!(110).!
6.6.3$Cytokines$In!keeping!with!much!of!the!published!literature,!these!results!show!that!LSG!had!a!measurable! impact! on! inflammatory! markers,! reducing! CRP! and! IL(6!significantly! !(90).! ! TNFα! levels!did!not! change! significantly! and! this! reflects! the!findings!of!multiple!other!studies!!(90).! !This!may!reflect!limitations!of!the!use!of!circulating! TNFα! as! a! marker! of! inflammation,! as! other! studies! have! shown!decreased! adipose! tissue! expression! and! decreased! circulating! levels! of! TNF!receptors,!as!discussed!in!Chapter!1!Section!1.6.3.1!!(93,$470).!!IL(10!levels!are!not!significantly!different.!!Although!it!has!anti(inflammatory!effects!in!animal!models!and! in# vitro,! the! relationship! between! IL(10,! obesity! and! NAFLD/NASH! is! not!clearly! elucidated!(351).! ! Dalmas!et# al! reported! a! biphasic! change! in! IL(10! after!RYGB,!with!a!fall!to!33%!of!baseline!at!3!months,!return!to!approximate!baseline!levels!at!6!months!and!then!a!further!fall!to!66%!baseline!at!1!year!!(406).!!Levels! of! pro(inflammatory! cytokines! correlate! with! BMI! and! confirm! the!relationship!between!increasing!obesity!and!inflammation!(68).!!!!There!were!no!strong!correlations!between! inflammatory!markers!and!oxidative!stress.!!The!majority!of!similar!published!studies!have!focused!on!one!or!other!and!no!previous!direct!relationships!have!been!shown.!!Nevertheless,!there!is!strong!in#
vitro!and!animal!model!evidence!of!the!relationship!between!obesity,!inflammation!and!oxidative!stress,!as!discussed!at!length!in!Chapter!1.!!Although!this!study!does!not! clearly! demonstrate! this! relationship! in! the! context! of! weight! loss,! it! seems!
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reasonable! to!assume!this!may!reflect! limitations!of! the!study.! !These! limitations!are!discussed!further!below.!
6.6.4$Adipocytokines$Leptin! levels! fell! by!>50%!over! the! six!months!of! this! study!and! this! echoes! the!results! of! other! studies! showing!a! fall! after!bariatric! surgery! and! relationship! to!adipose! mass!(101).! ! However,! many! other! authors! report! corresponding!increases!in!adiponectin!associated!with!weight!loss!(361).!!These!results!show!no!significant!changes,!despite!comparable!weight!loss!to!other!published!studies.!!As!discussed! above,! the! lack! of! change! in! adiponectin! may! reflect! the! continuing!extent!of!obesity!in!this!patient!cohort!and!there!is!certainly!no!evidence!to!suggest!leptin! and! adiponectin! levels! are! inversely! correlated.! ! Weight! loss! may! exert!differential! effects! on! each! of! their! levels.! ! Butner! et# al! found! a! significant!correlation!between!decrease!in!BMI!and!increase!in!adiponectin!levels!in!a!meta(analysis! of! 18! studies!(361).! ! Such! a! finding! would! imply! that! the! results! here!might! reflect! a! Type! II! statistical! error! (that! is,! adiponectin! levels! do! rise! after!surgery! but! this! study! fails! to! demonstrate! this).! ! Arvaniti! et# al! found! that!adiponectin! levels! were! lower! in! patients! with! biopsy(proven! NASH! compared!with!NAFLD,!and!slightly!lower!in!patients!with!normal!ALT!and!AST,!and!did!not!correlate!with! BMI! or! HOMA!(471).! ! In! the! cohort! of! patients! studied! here,! the!majority!of!patients!had!NASH!rather!than!simple!steatosis,!as!well!as!normal!liver!function!and!these!factors!may!be!important!confounders.!!Although! resistin! does! not! change! significantly! after! LSG,! there! is! a! significant!correlation! to! both! pre(! and! post(operative! HOMA.! ! This! association! has! been!demonstrated!previously!and!may!reflect!a!causative!relationship!between!resistin!and! hepatic! insulin! resistance! !(364,$ 472).! ! Resistin! has! been! found! to! increase!after!RYGB!and!LSG!(365)!and!may!be!associated!with!NASH!(363).!!!
6.6.5$Liver$injury$and$Apoptosis$after$LSG$Although! a! number! of! studies! using! serial! liver! biopsies! after! bariatric! surgery!have!demonstrated!improvement!in!NAFLD/NASH,!the!significant!reduction!in!CK(18!fragments!described!adds!to!the!growing!weight!of!evidence!of!its!usefulness!as!a! marker! of! fatty! liver! disease!(221).! ! Only! two! other! studies! have! serially!
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measured!CK(18!levels!after!bariatric!surgery.! !Diab!et#al!reported!a!median!M30!level! of! 226U/L! (IQR! 177(298),! which! fell! a! median! 44%! after! 6months!(223).!!Kahraman! et# al! also! report! a! significant! fall! in! both!M30! and!M65! after! various!types!of! bariatric! surgery!(224).! ! In!Chapter!3,! a! significant! correlation!between!acute! post(operative! ALT! and! rises! in! CK(18!M30!was! demonstrated.! !M30! also!correlates! significantly! with! NAS,! confirming! its! utility! as! a! marker! of! NAFLD!severity! as! shown! by! others! !(223).! ! CK(18! M30/M65! ratio! does! not! change!significantly!over!6!months.!!Taken!together!with!the!lack!of!changes!in!TRAIL!and!FasL! levels,! the! inference! is! that! the! improvement! in!obesity(induced! liver! injury!does!not!occur!through!a!particular!change!in!the!levels!of!necrosis!and!apoptosis.!!These!data!favour!a!concept!of!global!amelioration!of!these!functions!rather!than!one!specific!mechanism.!!This!is!supported!by!a!lack!of!any!strong!associations!of!CK(18!M30!or!M65! fold! changes!with!particular! changes! in! individual! cytokines.!!Although!pre(operative!M30!correlates!with!GPX!and!Leptin,! confirming! that! the!pre(existing!liver!injury!is!associated!with!oxidative!stress!and!inflammation,!these!relationships!are!not!maintained!after!weight!loss.!
6.6.6$Bile$acids$and$their$potential$metabolic$effects$after$LSG$Total!BA!concentration!does!not!change!significantly!after!LSG!whilst!FGF(19!levels!do! rise! significantly,!by!a!median! increase!of!51%! from!baseline,!over!6!months.!!These! findings! echo! Haluzikova! et# al,! who! recorded! approximate! increase! from!100pg/ml! to! ~180! pg/ml! (estimated! visually! from! graph)! in! 6! months!(451).!!They!found!that!FGF(19!levels!approximated!those!in!non(obese!controls!6!months!after!surgery!in!a!cohort!of!non(diabetic!women.!!This!study!differs!substantially!in!that!a!mixed!cohort!of!men!and!women,!with!and!without!diabetes!were!studied,!without! any! independently! evaluated! non(obese! controls.! ! Nevertheless,! the!concentrations! presented! above! are! within! the! same! range! of! values.! ! BA!stimulates! FGF(19! release! in! the! terminal! ileum,! which! then! acts! as! negative!feedback!on!hepatic!BA!synthesis.!!After!RYGB,!FGF(19!levels!also!increase!and!this!is!associated!with!an!increase!in!total!BA!(450,$473).!!!In!one!RYGB!study,!a!control!group! of! AGB! patients! demonstrated! no! changes! in! FGF(19! or! BA!(456).! ! The!explanation! of! why! increases! in! FGF(19! after! both! RYGB! and! LSG! are! not!associated!with!a!corresponding!decrease!in!total!BA,!as!would!be!assumed!given!
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the!role!of!FGF(19!as!a!negative!feedback!inhibitor!of!hepatic!BA!synthesis,!is!not!clear.!!The! proposed!mechanism! for! the! increase! in! FGF(19! is! by! increased! delivery! of!unmixed!BA! to! the! terminal! ileum!after! the! anatomical! changes! in!RYGB.! !These!anatomical! changes! are! not! seen! after! LSG.! !However,! a! number! of! studies! have!shown! that! gastric! empyting! and! intestinal! transit! are! both! increased! after!LSG!(474-476).!!The!increase!in!FGF(19!is!accompanied!by!an!increase!in!incretin!release!and!postulated!to!be!a!possible!mechanism!for!improvements!in!post(RYGB!diabetes!mellitus!(473).! !Small!animal!surgical!models! in!which!nutrient!and!bile!delivery! to! the! terminal! ileum! is! expedited! anatomically! confirm! this! incretin!effect!(477).! ! Chambers! et# al! have! also! shown! in! a! rat! model! of! SG! that! direct!nutrient! delivery! into! the! duodenum! in! rats! with! SG! is! associated! with! an!increased! release! of! GLP(1! compared! with! sham! animals.! ! This! increase! is!comparable!to!RYGB!rats!and!SG!rats!taking!nutrients!orally!and!indicates!that!SG!induces! intestinal! adaptations! and! hormonal! alterations! outwith! the! effect! of!anatomical!bypass!(478).!!Similar!studies!have!not!yet!been!performed!in!humans.!!!!In! this! study,! two! primary! conjugated! BA,! TCA! and! GCA! levels! fell! significantly!along! with! secondary! BA! DCA.! ! The! secondary! BA! GUDCA! was! increased!significantly.! ! Taken! together,! these! changes! may! be! due! to! altered! BA!conjugation/deconjugation! metabolism! by! gut! microbiota.! ! Gut! microbiota! have!been! shown! to! change! after! RYGB,! with! heterogenous! changes! in! the! variety! of!bacterial! species,! which! are! associated! with! changes! in! the! expression! of!inflammation(associated! genes! in! adipose! tissue!(479).! ! This! clinical! study!confirms!multiple!animal!model!experiments!that!have!shown!an!association!with!weight!loss!surgery,!changes!in!gut!microbiota!and!alterations!in!BA!profile!(480,$
481).! ! Part! of! the! mechanism! of! these! microbiota(induced! changes! is! due! to!alterations! in!circulating! lipopolysaccharides!(LPS).! !LPS,!also!known!as!bacterial!endotoxins,! are! structural! components! within! gut!microbiota! and! are! known! to!exert!an!immune!response!(482).!!This!low(grade!inflammation!is!also!implicated!in! the!development! of! insulin! resistance! and!other! components! of! the!metabolic!syndrome,!including!NASH!(483,$484).! !Monte!et#al!have!demonstrated!reduction!
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in! circulating! LPS! after! RYGB,! associated! with! improvements! in! insulin!resistance!(117).!!The! strong! correlations! between! falls! in! TCA! and! Leptin! and! DCA! and! fasting!insulin!highlight!the!myriad!possibilities!of! individual!BA!as!signalling!molecules.!!DCA!is!a!ligand!for!both!FXR!and!TGR5,!both!of!which!are!involved!in!glucose!and!lipid!metabolism! (see! Figure! 4.2)!(485).! ! TCA! has! been! shown! to! downregulate!
CYP7A1! transcription! in! a!model! of! rat! hepatocytes!(486).! ! Although! the! role! of!
CYP7A1! is!mainly! recognised! as! the! rate(limiting! step! in!BA! synthesis,! increased!hepatic! CYP7A1! expression! was! also! associated! with! lower! FGF(19! levels! in!diabetic!patients!undergoing!RYGB!!(450).!!Falling!leptin!levels!are!associated!with!reductions! in! pro(inflammatory! cytokines! and! it! is! thus! possible! to! make! a!speculative!inference!that!changes!in!BA!profile!are!responsible,!in!this!case!a!fall!in!TCA.!The! relationships!demonstrated! in! this! study!give! rise! to!many!potential!avenues! of! further! research! into! the! potential! effects! on! glycaemic! control! and!metabolism!of!BA.!
6.6.7$BA,$LSG$and$the$effect$on$fatty$liver$disease$Along! with! the! potential! effect! on! inflammation! and! insulin! resistance,! there! is!great! interest! in!BA!as!modulators!of!NAFLD/NASH,! including! the! clinical! use!of!exogenous!BA!or!synthetic!derivatives!as!FXR!ligands!(446,$448).!!The!fall!in!GCA!correlates!with! reduction! in!post(operative!CK(18!M30! levels.! !Although! there! is!little! other! supporting! evidence! for! a! direct! role! of! GCA! in! inducing! NASH! from!either! in# vitro! or! animal! studies,! there! are! studies! suggesting!GCA! is! involved! in!liver!injury.!!Luo!et#al!looked!at!patterns!of!BA!fractions!in!various!mouse!models!of! drug(induced! liver! injury! and! found! differentially! altered! CA,! GCA! and! TCA!levels!associated!with!particular!patterns!of!injury!(487).!!In!particular,!they!found!increased!levels!of!conjugated!primary!BA!after!induction!of!necrosis!and!bile!duct!hyperplasia.! ! Zhang! et# al! found! increased! urinary! GCA! in! patients! with!hepatocellular! carcinoma! and! used! bioinfomatic! tools! to! generate! potential!pathways!by!which!GCA!could!be! implicated! in!carcinogenesis! in! the! liver!(488).!!In!NASH,!CA,!DCA!and!CDCA!were!found!in!elevated!concentrations!compared!with!controls!and!CA!levels!correlated!with!histological!grading!of!inflammation!(489).!!Of! note! in! this! study,! the! authors! did! not! specifically! profile! GCA,! TCA! or! any!secondary!conjugated!BA.!
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!The!most!statistically!significant!change!in!BA!profile!was!the! increase! in!GUDCA!after! LSG.! ! Given! the! interest! and! substantial! experimental! evidence! for!ursodeoxycholic! acid! (UDCA)! as! a! potential! treatment! for! NASH,! it! is! especially!pertinent! to! consider! the! importance! of! this! finding,! as! GUDCA! is! the! active!metabolite!of!UDCA!after!glycine!conjugation.!!In!a!mouse!hepatocyte!model,!UDCA!administration! was! associated! with! a! hepato(protective! effect,! inhibiting!apoptosis!(445).! ! The! authors! of! this! study! concluded! that! this! protective! effect!was!mediated! by! alteration! of! the! intracellular! FFA! pool! by! shifting!metabolism!from!saturated!to!monounsaturated!fatty!acids.!!In!both!high(fat!diet!steatotic!mice!and! a! NASH!mouse!model,! Pathil! et# al! showed! that! intraperitoneal! injections! of!UDCA! ameliorated! signs! of! liver! injury! and! altered! lipid! metabolism!(490).!!Similarly,! Buko! et# al! found! that! UDCA! reduced! liver! steatosis! and! inflammatory!markers!in!a!rat!model!of!NASH!(491).!!Finally,! Bechmann! et# al! investigated! BA! profiles! in! obese! patients! with!NAFLD/NASH!and!found!that!serum!BA!was!higher!in!NASH!than!simple!steatosis,!as! was! CK(18! M30!(492).! They! showed! that! BA! inversely! correlated! with!adiponectin.! ! They! also! showed! that! both! adiponectin! and! FFA! upregulated!
CYP7A1! expression! and! blocked! the! effect! of! FGF(19! signalling! in! hepatocytes.!!Thus,!they!demonstrate!a!potential!role!for!BA,!adiponectin!and!FFA/NEFA!in!the!pathogenesis! of! NASH,! whilst! also! showing! how! increased! FFA!may! disrupt! the!regulation! of! hepatic!BA! synthesis! by! FGF(19,! although! a! full! explanation! of! this!mechanism!is!still!not!known.! !This!study!has!not!demonstrated!any!correlations!between!FGF(19,!adiponectin,!NEFA!or!M30!but!future!studies!are!required!to!test!these!relationships!more!robustly.!!!
6.6.8$Limitations$One! major! criticism! of! this! study! is! the! lack! of! a! control! group! of! non(obese!patients! not! undergoing! any! intervention.! ! In! the! absence! of! an! accepted! and!widely!used! reference! range!of!normal!values!of! the!various!biomarkers!used! in!this!study,!use!of!a!negative!control!group!establishes!a!site(specific!normal!range!
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and! is!an!additional! form!of!validation.! !Unfortunately!at! the!time!of! inception!of!these!studies,!no!ethics!approval!or!extra!funding!was!sought!for!these!additional!assays.! ! The! biomarker! values! presented! above! do! fall! within! the! range! of! the!published!values!and!so!these!results!do!still!have!merit.!!Although! the!main! aim! of! this! study!was! to! evaluate! changes! at! 6!months! after!surgery,! it! is! pertinent! to! note! that! the! metabolic! effects! of! LSG! evolve! over! a!longer! time! period.! ! In! common! with! many! other! cohort! studies! in! bariatric!surgery,!the!6!month!interval!studied!here!may!be!too!short.! !Steinert!et#al!noted!that! total! BA! concentration! peaked! at! 1! year! after! both! LSG! and! LRYGB!(458).!!Similarly,! Illan(Gomez! et# al! found! that! adiponectin! levels! were! highest! and! IL(6!lowest! at! 12!months! after! bariatric! surgery,!with! significant! changes! between! 6!and!12!months!!(99).!!!!The! changes! in! BA! profile! described! here! are! novel! and! interesting.! ! As!well! as!performing! studies!with! larger! sample! sizes!over!a! longer! time!period,! it!will!be!important!to!measure!dynamic!post(prandial!changes!in!BA!levels,!in!conjunction!with!changes!in!gut!hormone!release.!!Steinert!et#al!have!shown!that!post(prandial!!incretin!release!increases!within!one!week!of!LSG!and!is!associated!with!a!decrease!in! fasting! insulin,!before!any!changes!to!BA! levels!are!seen!(458).! !This! indicates!that!there!may!not!be!a!direct!relationship!between!BA!metabolism,!changes!in!gut!hormones!and!improvement!in!insulin!resistance.!!Furthermore,!any!exploration!of!potential!hypothesis!to!explain!the!relationship!between!individual!BA,!changes!in!gut! microbiota! and! improved! markers! of! NAFLD/NASH! will! benefit! from!measurement! of! circulating! LPS,! as! a! marker! of! gut! bacterial! load,! and! 7alpha(hydroxy(4(cholesten(3(one!(C4),!which!is!an!indirect!measure!of!BA!synthesis!via!the!action!of! the! rate(limiting!enzyme!CYP7A1!(448).! !Measurement!of! faecal!BA!levels! will! also! improve! the! understanding! of! changes! in! BA! absorption! after!LSG!(480).!!! $
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7.1$Overall$conclusions$from$this$thesis$!The!main!aim!of!this!thesis!was!to!determine!the!extent!and!clinical!significance!of!post(operative! inflammatory! response! and!metabolic! changes! in!morbidly! obese!patients! with! fatty! liver! disease.! ! As! discussed! at! length! in! the! introductory!chapters,!there!are!many!studies!investigating!the!changes!in!cytokines!and!other!biomarkers!after!bariatric!surgery,!the!aetiology!and!progression!of!NAFLD/NASH,!and!also!of!laparoscopy(induced!oxidative!stress!and!inflammatory!response.!!The!studies!presented!here!are!the!first!attempt!to!amalgamate!these!different! issues!and! investigate! their! relationships! in! one! cohort! of! patients.! ! The! patients!recruited!were!in!the!“super”(obese!category,!with!a!mean!BMI>60!kg/m2!and!this!itself!is!novel!as!most!similar!studies!include!less!obese!patients.!!!!The!NAC!Trial!results!showed!that!N(acetylcysteine!did!not!reduce!post(operative!inflammatory! response!or! liver! transaminase! rise,! compared!with!controls.! !This!conclusion! can! be! drawn! from! the! results! of! a! comprehensive! range! of! clinical,!oxidative! stress! and! cytokine!markers.! ! Nevertheless! it! is! clear! that! there! were!limitations! in! both! study! design! and! study! conduct.! ! There! was! a! lack! of!standardisation! of! the! intraoperative! insult! and! no! stratification! according! to!severity!of!NAFLD/NASH.!!These!limitations!may!have!been!counterbalanced!with!a! larger! sample! size! and! with! recruitment! of! patients! undergoing! lengthier!surgeries,!such!as!LRYGB!or!laparoscopic!BPD(DS.!!!!The! NAC! Trial! did! reveal! some! interesting! new! observations! about! the! post(operative! response.! ! Transaminase! rises,! corroborated! by! a! rise! in! CK(18!fragments,!were!dramatic!over!the! first!day!after!surgery,! indicating!a!significant!liver!injury!is!incurred!during!surgery.! !This!injury!may!be!a! ! ! form!of!ischaemia(reperfusion! injury,! given! the! timing! and! pattern! of!M30! and!M60! changes.! ! The!injury! is! associated!with! a! rise! in!both!pro(inflammatory! cytokines,! such! as! IL(6!
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and! CRP! but! also! a! rise! in! IL(10! and! adds! to! the! growing! body! of! evidence! that!cytokine!changes!cannot!easily!be!divided!into!purely!pro(!and!anti(inflammatory!actions!(351).! !The!interpretation!of!changes!in!oxidative!stress!markers!was!less!straightforward! and! both! the! literature! review! and! these! results! indicate! that!further! work! is! required! to! identify! and! standardise! which! markers! should! be!used.! ! There! was! an! excess! of! complications! in! the! NAC! trial! and! it! would! be!interesting! to! definitively! rule! out! any! adverse! effects! of!NAC.! ! A! trial! of!NAC! in!severe! acute! pancreatitis! showed! a! higher!mortality! in! the!NAC! group,! although!that!study!also!closed!before! the!planned!sample!size!was!reached!{Siriwardena,!2007!#225}.!!Most!importantly,!the!biomarker!changes!did!not!appear!to!have!any!impact!on!the!clinical!outcome.!!Recovery!to!baseline!occurred!in!most!markers!within!1(2!days!of! surgery.! ! Given! the! good! safety! profile! of! bariatric! surgery!(36),! large! scale!comparative! studies! using! clinical! endpoints! (such! as! rate! of! infective!complications,! length! of! stay! or! mortality)! would! require! many! hundreds! of!patients! to! demonstrate! if! a! particular! intervention! is! effective! in! improving!outcomes.! ! Biomarker! outcome! measures! are! poor! surrogate! endpoints! in! this!context.! ! However,! intra(operative! liver! injury! during! laparoscopic! bariatric!surgery!may! have! potential! as! an! in! vivo! human!model! of! steatotic! liver! IRI,! to!investigate! the! clinical! efficacy! of! other! potential! therapeutic! interventions! that!have!proved!effective!in!experimental!animal!models.!!One! further! question! remains! about! the! importance! of! post(operative!inflammatory!response!as!a!natural!and!necessary!defence!mechanism.!!At!present!these!mechanisms!are!poorly!understood!and!modulation!of!the!immune!response!by! targeting! specific! pro(inflammatory! cytokines! has! had! little! clinical! success!{Hutchins,!2014!#634}.! !Abrogation!of!the!inflammatory!response!may!even!have!deleterious!effects!and!this!hypothesis!deserves!further!study.!!The! longitudinal! results! confirmed! the! findings! of! other! studies! that! bariatric!surgery! leads! to! significant! improvements! in! glycaemic! control! and! reduced!inflammatory!markers.! ! The! fall! in! CK(18! fragments! suggests! that! there!may! be!improvements! in! liver! pathology! beyond! simply! reduction! in! the! degree! of!
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steatosis,!but!there!is!a!pressing!need!to!corroborate!these!conclusions!with!other!measures! of! liver! fibrosis! and! inflammatory! changes.! ! There! is! little! published!work!on!bile! acid!profile! after!LSG!and! these! findings!are!of! great! interest!(451,$
458).!!This!is!the!first!study!in!patients!undergoing!LSG!to!present!such!a!detailed!analysis! of! individual! BA! changes.! ! Although! these! findings,! especially! the!correlations!with!other!biomarkers,! need! to!be! confirmed! in! larger! studies,! they!substantiate! the! concept! of! alterations! in!BA!metabolism!being! important! in! the!pathogenesis!of!fatty!liver!disease!(485).!!Taken!together!with!the!published!trials!using! exogenous! synthetic! BA! to! treat! NAFLD/NASH,! these! results! should!stimulate!further!interest!in!this!field.!!!Overall,!the!studies!presented!in!this!thesis!have!shown!that!laparoscopic!bariatric!surgery! has! a! significant! post(operative! inflammatory! response! and! does! cause!liver!injury,!but!that!these!changes!are!of!a!short!duration.!!In!the!longer!term,!the!overall! health! of! patients! improved! dramatically,! including! resolution! of! co(morbidities! and! significant! improvements! in! glycaemic! control,! markers! of!inflammation!and!liver!injury.!!!!
7.2$Future$work$arising$from$this$thesis$!Building! on! the! work! in! the! NAC! Trial! and! the! longitudinal! study! presented! in!Chapter!6,! there! are! a!number!of! research!questions! that!have! arisen! that!merit!attention:!!
1.# Would# a# larger# trial,# possibly# multi/centre,# using# a# wider# range# of# operations,#
including#LRYGB,#help#to#definitively#answer#if#NAC#has#a#role#as#a#hepato/protectant#
during#laparoscopic#bariatric#surgery?#!The! initiation! of! another! NAC! Trial! focussing! on! extending! the! indications! and!recruiting! a! larger! number! of! patients! is! under! consideration.! ! Measurement! of!intraoperative! liver! ischaemia!and!blood! flow!using!newer!devices,! such!as! laser!
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Doppler! fluximetry!(328),!may!help! to!both!standardise! the! intraoperative! insult!and!determine!if!NAC!improves!liver!blood!flow!in!this!setting.!!!
2.#How#do#markers#of#liver#injury,#NAFLD#and#NASH#change#(deteriorate#or#improve)#
during# the# first# few#weeks#after#bariatric# surgery,#and# is# this# related# to# changes# in#
other#biomarkers#or#the#alterations#in#glycaemic#control#and/or#BA#metabolism?#!This!would!involve!another!longitudinal!cohort!study!with!increased!frequency!of!biomarker!and!BA!measurement,!at!weekly!or!monthly!intervals.!!The!main!benefit!would!be!to!identify!the!most!vulnerable!period!after!surgery!for!the!liver.!!There!is! concern! that! some! patients! experience! worsening! of! liver! fibrosis! following!surgery!(218).! ! This! may! be! associated! with! specific! events,! such! as! infections,!during! the! post(operative! period! that! act! as! the! “second! hit”! in! the! evolution! of!NASH/cirrhosis!(128).!
3.#How#does#LSG#improve#diabetes?#!There!are!a!number!of!studies!investigating!the!rapid!change!in!insulin!resistance!following! RYGB! that! merit! repeating! in! patients! after! LSG,! including! ! dynamic!measurements! of! post(prandial! insulin/glucose/incretin! kinetics,! changes! in! BA!and!alterations!in! lipolysis!(56,$465,$493).! ! It! is! increasingly!recognised!that!LSG!may! lead! to!weight! loss! through! changes! in! gut! hormones,! increase! in! intestinal!transit! and! unidentified! neurohormonal! mechanisms,! and! not! just! through!mechanical! restriction! of! intake.! ! As! discussed! in! Chapter! 6,! the! design! of! BA!studies! can! be! improved! by! additional!measurements! of! LPS! as! a!marker! of! gut!microbiota!changes!and!C4,!as!a!marker!of!BA!synthesis!(494).!!!
4.#Potential#role#for#non/hypothesis#driven#“/omic”#studies.#!The!fall!in!NEFA!demonstrated!in!this!thesis!indicates!the!potential!role!of!changes!in!lipid!profiles!as!a!mechanism!for!other!metabolic!changes.! !Repeated!lipidomic!investigations! in! a! cohort! of! bariatric! patients! may! reveal! that! individual! lipid!species!play!a!significant!role!(495,$496).!!!
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!There!is!also!great!interest!in!the!role!of!microRNAs,!small!non(coding!fragments!of!nucleic!acids,!which!are!involved!in!the!regulation!of!expression!and!interaction!of!other!genes.! !A!number!of!microRNAs!have!been! implicated! in!progression!of!chronic! liver! diseases! and! there! is! also! interest! in! identifying! individual!microRNAs! as! prognostic! markers! and! measures! of! liver! injury,! fibrosis! and!cardiovascular! risk!(497).! ! Identification! of! potential! candidate! markers! using!array! technology! on! both! serum! and! tissue,! liver! and/or! adipose,! can! then! be!followed!up!with!serial!serum!assays!for!each!potential!microRNA!marker!(498).! $
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Major#!Anastomotic! leak!–!objective!evidence!of! leakage!(either!on!contrast!radiography!or! visual! confirmation! at! re(operation)! with! or! without! clinical! signs! and!symptoms.!!Fluid!collection!(!!CT!scan!or!ultrasound!presence!of!fluid!collection!at!least!5!cm!in!diameter!with!or!without!clinical!relevance.!!Hemorrhage!(!!Requirement!of!at!least!3!units!of!packed!Red!blood!cells!(1000!mL)!within!24!h!after!the!operation.!!Chest!Infection!–!signs!of!sepsis!or!septic!shock!accompanied!by!clinical!signs!and!symptoms!of!chest!infection!!Sepsis!–!pulse!>90bpm,!temperature!<36oC!or!>38oC,!respiratory!rate!>20!or!paO2,!White!cell!count!<4!or!>12000cells/mm3!in!presence!of!proven!infection!!Renal!Failure!–!Creatinine!>!150!or!doubling!of!pre(operative!value,!persisting!for!at!least!72!hours!!Myocardial! infarction!–! relevant!ECG!changes!accompanied!by!clinical! symptoms!and!signs,!with!a!raised!Troponin!I!!!Pulmonary!embolism!–!relevant!clinical! signs!and!symptoms!with!corresponding!appearance!on!Computed!Tomography!(CTPA)!or!Ventilation/Perfusion!scanning!!Delayed!gastric!emptying:!failure!to!resume!oral!liquid!intake!by!postoperative!day!10,!and/or!emesis!over!500!ml!on!or!after!postoperative!day!5,!and/or!continued!nasogastric!drainage!>500!ml!on!or!after!postoperative!day!5.!!Cardiac!Arrhythmias!–!ECG(proven!new!onset!arrhythmias,!eg.!atrial!fibrillation!!
Minor#!Wound!infection!–!erythema,!purulent!discharge!and!pain!at!wound!site!persisting!for!more!than!48!hours!!Post(op! pyrexia! –! temperature! above! 38oC! lasting! less! than! 48! hours! with! no!progression!to!sepsis!or!accompanying!clinical!signs!of!local!infection!!Deep!vein!thrombosis!–!relevant!clinical!symptoms!with!sonographic!evidence!of!thrombosis!in!the!absence!of!signs!of!suspected!pulmonary!embolism!! !
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B1.4$Protocol$Changes$The! various! protocol! changes! are! described,! including! amendments! that! were!required!before! and! at! the! start! of! the!NAC!Trial! for! completeness.! ! These!were!mainly!minor!changes.!!!
B1.4.1$$1st$Substantive$Protocol$change:$$ $!Protocol!amendment:! ! ! dated!1st!April!2009!!Old!Protocol!version:! ! ! Version!Final!1.0!(01May08)!New!Protocol!version:! ! ! Version!2.0!(01Apr09)!!!1. Major!change!to!inclusion/exclusion!criteria.!!Sleeve! gastrectomy! operation! was! included! in! the! study! as! this! had! become! an!increasingly! common! operation! performed! on! patients! in! the! unit! over! the!preceding!year.!!2. Minor!clarification!of!one!exclusion!criterion.!!The!exclusion! criterion!of!psychiatric! illness!was! clarified! to! specify! exclusion!of!patients! with! active! illness.! ! Many! morbidly! obese! patients! have! a! history! of!psychiatric! illness,! either! as! a! causative! factor! or! a! sequel! of! obesity.! ! It! was!obviously! not! practical! to! include! patients! with! ongoing! active! psychiatric!symptoms,! as! the! validity! of! the! assessment! of! their! autonomy! and! ability! to!consent!would!have!been!in!question.!!3. Correction!of! inconsistencies!between!text!and!schedule!of! investigations!in!the!protocol.!!Various!transcription!errors!between!various!parts!of!the!protocol!were!corrected.!!4. Change!to!AE!reporting!guidelines!in!the!protocol.!!
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It! was! stipulated! that! common! surgical! post(operative! complications! would! be!recorded! as! AEs! but! not! necessarily! SAE,! unless! they! fulfilled! the! SAE! criteria.!!Indeed,! this! part! of! the! protocol! probably! should! have! been! revised! further! as!some! post(operative! issues,! such! as! wound! pain! and! nausea,! are! universal! and!classification!of!them!as!AEs!was!probably!not!appropriate.!!!!5. Change!to!blinding!procedure.!!Text!changes!were!as!follows:!Version! 1:! The! researcher! will! be! blinded! to! the! intervention! until! after! data!collection!and!sample!analysis!has!occurred.!This!blinding!will!occur!by!marking!the! data! and! samples! with! a! pre(arranged! identification! code,! which! will! be!contained!within!the!envelope!for!randomisation.!!After!data!collection!and!sample!analysis!has!occurred,!the!research!will!be!made!aware! of! study! allocation,! so! that! comparative! statistical! analysis! can! be!undertaken.!!Version!2:!After!data!collection!and!sample!analysis!has!occurred,! the!researcher!can!check!the!randomisation!schedule!and!will!be!aware!of!study!allocation,!so!that!comparative!statistical!analysis!can!be!undertaken.!!This!is!discussed!above.!!Briefly,!it!became!apparent!that!Pharmacy!would!require!some! time! to! dispense! the! IMP.! ! Also,! organising! the! appropriate! per! protocol!dispensation!of!IMP!would!have!to!be!the!Research!Fellow’s!responsibility!due!to!the! clinical! commitments! of! all! other! parties,! including! Operating! Surgeon! and!Anaesthetist.!!6.! Correction!of!typos/inconsistencies!in!protocol.!!!! $
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B1.4.2$$2nd$Substantive$Protocol$change$!Protocol!Change:!! ! dated!26th!July!2009!Old!Protocol!version:!! Version!2.0!(01Apr09)!New!Protocol!version:!! Version!3.0!(26Jul09)!!!1. Change!to!inclusion!criteria!(upper!age!limit)!!The!upper!age! limit!was! increased! to!75! from!65!years! in! line!with! the!evolving!clinical!practice!of!the!Unit.!!2. Change!to!unit!of!measurement!of!alcohol!intake!in!exclusion!criteria!!This!was! changed! to! “units”! as! defined! as! being! approximately! 8(10g!of! alcohol,!corresponding!to!1!glass!of!wine,!a!25ml!measure!of!whisky!or!approximately!half!a!pint!of!lager.!!!3. Extra!study(specific!blood!test!to!be!taken!96hrs!post(surgery!!It!had!always!been!the!Investigators!intention!to!take!study(specific!blood!tests!up!to! 4! days! after! surgery! but! this! was! left! out! in! error! during! previous! protocol!versions.!!4. Clarification!of!when!participants!are!approached!about!the!study!!Text!changes!were!as!follows:!Version! 2:! Patients! seen! in! the!Multidisciplinary!Morbid! Obesity! Clinic! at! King’s!College! Hospital,! who! are! being! referred! for! morbid! obesity! surgery,! will! be!eligible!for!inclusion!They!will! have! until! the! time! of! their! admission! (usually! 10(12!weeks)! to!make!their!decision.!They!will!have!a!second!opportunity!to!discuss!the!study!further!at!the!Pre(operative!Assessment!Clinic,!approximately!1!week!prior!to!admission.!!
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Version! 3:! Patients! seen! in! the! Multidisciplinary! Morbid! Obesity! Clinic! or! Pre(operative!Assessment!Clinic!at!King’s!College!Hospital,!who!are!being!referred!for!morbid!obesity!surgery,!will!be!eligible!for!inclusion.!They!will!have!until!the!time!of!their!admission!to!make!their!decision.!There!will!be! another! opportunity! to! discuss! the! study! at! the! Pre(operative! Assessment!Clinic.!!This!change!was!required!as!the!timings!between!initial!assessment!and!allocation!of! the!date! on! the!waiting! list! became!more!unpredictable!due! to! organisational!changes!in!practice,!NHS!targets!and!the!ad!hoc!availability!of!extra!operating!lists.!!Nevertheless,! the! importance! of! giving! potential! participants! multiple!opportunities!to!discuss!the!study!and!adequate!time!to!make!decisions!regarding!their!consent!to!participate!was!still!pre(eminent.!!5. Clarification!about!running!time!of!2nd!NAC!infusion!!Version!2:!Subjects!randomised! to! the! intervention!will! receive!N(acetyl!cysteine!infusion,!at!standard!150mg/kg!in!200ml!5%!dextrose!over!15mins!at!induction!of!anaesthesia!followed!by!an!infusion!of!50mg/kg!in!500mls!of!5%!dextrose!during!surgical! retraction! of! liver! for! a! maximum! of! 4! hours,! together! with! standard!anaesthetic!medications.!!Version!3:!Subjects!randomised! to! the! intervention!will! receive!N(acetyl!cysteine!infusion,!at!standard!150mg/kg!in!200ml!5%!dextrose!over!15mins!at!induction!of!anaesthesia!followed!by!an!infusion!of!50mg/kg!in!500mls!of!5%!dextrose!during!surgical! retraction! of! liver! for! a! maximum! of! 4! hours,! together! with! standard!anaesthetic!medications.! If# surgery# lasts# for# less# than#4#hours,# the# infusion#will# be#
continued#until#it#finishes.#!The! last! sentence! was! added! as! the! length! of! operating! became! increasingly!shorter! over! the! preceding! year! or! so! (as! a! natural! consequence! of! increasing!operative! experience).! ! Therefore! this! stipulation! was! required! so! that! patients!received!the!same!dose!of!IMP.!!
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2013! 17!female!LSG!!15!healthy!controls! LSG!43.2!vs!22!controls! No! GC/MS! PreRop,!6,!12!(&24)!months! No! Lower!than!controls,!no!sig!change!total!BA!!Graphed!≈2R3! Yes!Lower!than!controls,!sig!increase!after!6month!
Adipokines,!ghrelin,!CRP,!subcut!fat!adipokine!mRNA! Increased!FGF19,21,!Adiponectin,!reduced!ghrelin,!leptin!No!change!in!BA!
